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Blane Philip Zavesky: Enhancing the Synthetic Utility of Enantioconvergent Addition 
Reactions and Progress Towards a Convergent, De Novo Synthesis of Jervine 
(Under the direction of Jeffrey S. Johnson) 
I.  Direct Zn(II)-Catalyzed Enantioconvergent Additions of Terminal Alkynes to -
Keto Esters 
 
The addition of terminal alkynes to -stereogenic-keto esters was achieved in high 
levels of stereoselectivity, affording versatile tertiary propargylic alcohols containing two 
stereocenters. This environmentally benign enantioconvergent reaction proceeds with perfect 
atom economy, requires no solvent, and is catalyzed by an abundant and non-toxic zinc salt. 
The alkyne moiety can be leveraged in downstream transformations including hydrogenation 
to the corresponding saturated tertiary alcohol, which represents the product of a formal 
enantioconvergent aliphatic nucleophile addition.   
 
 
II. Palladium-Catalyzed -Arylation of -Keto Esters 
 
A catalyst system derived from commercially available Pd2(dba)3 and P
tBu3 has been 
applied to the coupling of α-keto ester enolates and aryl bromides. The reaction provides access 
to a versatile array of β-stereogenic α-keto esters. When the air stable ligand precursor 
PtBu3·HBF4 is employed, the reaction can be carried out without use of a glovebox. The 
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derived products are of broad interest given the prevalence of the β-keto acid substructure in 
biologically important molecules. 
 
III. Progress Towards a Convergent, De Novo Synthesis of Jervine 
 
A convergent approach towards the synthesis of the Veratrum alkaloid jervine is 
presented. The two requisite complex fragments were stereoselectively and efficiently 
fashioned from cheap and readily available reagents. Key to this route were the uses of a highly 
diastereoselective Ireland-Claisen rearrangement to set the relative configuration of the amine 
and exocyclic methyl group present on the tetrahydrofuran ring, and a selenoetherification 
reaction, which enabled the assembly of the quaternary stereocenter present at the D and E ring 
junction.   
 
IV. Progress Towards the First Asymmetric Synthesis of Matrine 
 
The captivating biological activity of matrine has been of interest since its isolation in 
1889 from the traditional medical herb Sophora flavescens, however no asymmetric synthesis 
of the molecule exists. Herein, we disclose the synthesis of an advanced enantiopure piperidone 
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building block beginning from commercial L-aspartic acid -methyl ester hydrochloride, and 
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Direct Zn(II)-Catalyzed Enatioconvergent Additions of Terminal Alkynes to α-Keto 
Esters * 
 
1.1 Dynamic Kinetic Resolution 
The ability to isolate highly enantioenriched compounds is of critical importance to 
many applications of organic molecules. Due to the chiral nature of biological 
macromolecules, opposite enantiomers of drug molecules can trigger vastly different 
responses.1 Because of this, a single enantiomer of drug may bind more tightly to a protein 
than its enantiomeric counterpart, resulting in a racemic mixture that is either less effective or 
even potentially detrimental. The ability to administer only one enantiomer of the therapeutic 
clarifies the specific pharmacological properties of each enantiomer. Accordingly, the United 
States Food and Drug Administration requires pharmacokinetic evaluation of all isomers of 
chiral drug molecules in order to determine the safest and most efficacious drug.2 
Despite the recent advances of asymmetric synthesis, the most widely used method for 
the isolation of enantioenriched molecules remains to be the resolution of racemic mixtures.3 
One reason for this is due to the fact that accessing racemates is often significantly easier and 
more cost efficient than using asymmetric reactions. In many cases, racemates are much less 
than half the cost of the corresponding enantiopure molecules.4 Resolutions are broadly 
classified as one of three types (Scheme 1-1). In a classical resolution, a stoichiometric chiral 
resolving agent is covalently or non-covalently bound to the racemate, forming two different 
                                                          
* Reproduced with permission from Zavesky, B. P.; Johnson, J. S. Angew. Chem., Int. Ed. 
2017, 56, 8805. Copyright 2017 Wiley-VCH. 
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diastereomers, which can be separated based upon differing physical properties (Scheme 1-
1A).4 Though this strategy finds wide use for many compounds, it is usually restricted to 
substrate classes that are able to form ion pairs (e.g. carboxylic acids and amines). Chiral 
chromatography uses a chromatography column containing a chiral stationary phase to 
separate a pair of enantiomers (Scheme 1-1B). While a reliable method, the large amount of 
solvent required to separate substantial amounts of material is undesirable, and the cost of 
chiral preparative columns creates a large financial barrier. Finally, kinetic resolutions employ 
a chiral catalyst or reagent that reacts at a faster rate with one enantiomer of substrate compared 
to the opposite enantiomer (Scheme 1-1C). Provided the substrate and product are separable, 
kinetic resolution ideally allows for the isolation of highly enantioenriched starting material 
and product. This method is advantageous because enantioenriched material can be obtained 
using only a catalytic source of chirality. 




In a kinetic resolution, the relative reaction rates of substrate enantiomers, which can be 
expressed as s or krel = kfast/kslow (Scheme 1-2A), are determined by the difference in energies 
of diastereomeric transition states (G‡). In order to obtain a substrate enriched to an 
enantiomeric ratio (er) of 95:5, a kinetic resolution with a krel of 10 must reach 62.1% 
conversion, which makes the maximum yield 37.9%. Similarly, in order to obtain the same er, 
a reaction with a krel of 50 must only reach 50.4% conversion. This illustrates the largest 
shortcoming of kinetic resolutions; even reactions exhibiting exquisite selectivity have a 
maximum yield of 50%. Dynamic kinetic resolution (DKR) overcomes this limitation by 
merging the resolution step of a kinetic resolution with a facile racemization pathway between 
substrate enantiomers (Scheme 1-2B). Provided the racemization pathway is fast and the 
catalyst is selective for a single enantiomer of substrate, the theoretical yield of enantioenriched 
product is 100%. In order for the enantioselectivity of the reaction to be high, krel should be at 
least 20, and the rate of racemization (krac) should be faster than the rate of the faster reacting 
enantiomer. Additionally, the bond forming event should render the previously interconverting 











Scheme 1-2 Kinetic Resolution and Dynamic Kinetic Resolution 
 
 The first observation of a DKR was reported by the Tai group in 1979 (Scheme 1-3A).7 
These seminal results showed that when 2-ethyl-3-oxobutyrate (1.8) was exposed to a 
hydrogen pressure of 106 atm and a catalyst system composed of hydrogenated nickel(II) oxide 
(HNi) and (R,R)-tartaric acid, -hydroxy ester 1.9 was isolated in 71% yield, 2.4:1 dr, and 
90:10 er (major diastereomer). This reaction’s stereoselectivities proved that substrate 1.8 must 
be racemizing; because the amount of enantiopure 1.9 formed in the reaction is 64%, it can be 
concluded that a dynamic kinetic resolution is occurring. If no substrate racemization occurs, 
the maximum yield of a single enantiomer is 50%. The DKR hydrogenation -keto esters was 
later improved upon by the Noyori group. In this reaction, a ruthenium/BINAP catalyst 
improved diastereo- and enantioselectivities of the hydrogenation of racemic -keto ester 1.10 
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(Scheme 1-3B) to near perfect values.8,9  Kinetic data for this reaction established that the rate 
of racemization (krac) is  6.1 times faster than the rate of the faster reacting enantiomer (kS), a 
requisite of a highly enantioselective DKR reaction. The asymmetric hydrogenation of -keto 
esters is highly utilized in industry, and is performed on >100 ton scale annually.10 
Scheme 1-3 Seminal DKR Reactions 
 
 Since the foundational report from Noyori and co-workers describing the dynamic 
kinetic hydrogenation of -keto esters, enantioconvergent reactions that proceed by addition 
to racemic, configurationally labile electrophiles have been recognized for their ability to 
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furnish stereochemically complex alcohol building blocks. Because of their high acidity, which 
facilitates substrate racemization, -dicarbonyl derivatives have remained the conventional 
substrate in enantioconvergent alcohol syntheses and the majority of these reactions proceed 
via reduction to furnish secondary alcohols.11–18 In contrast, examples of enantioconvergent 
reactions employing less activated substrates are underexplored.19–26 Considering the utility of 
the DKR hydrogenation of -keto-esters, our group sought to identify novel enantioconvergent 
addition substrates that could afford useful and interesting products. In 2012, our group 
discovered that in the presence of tertiary amine bases, -stereogenic -keto esters 1.13 
undergo facile racemization and could participate in an asymmetric transfer hydrogenation to 
form interesting glycolate products (Scheme 1-4A).27  While the enantioconvergent 
hydrogenation of carbonyl electrophiles are well explored, relatively few enantioconvergent 
additions proceed via carbon-carbon bond formation to furnish tertiary alcohol products.28–37 
Our group aimed to expand upon this paradigm and further increase the amount of chemical 
space that could be explored. Equipped with the knowledge that -keto esters can be racemized 
using amine bases, we began by studying carbon pronucleophiles that could be activated by 
these bases, and found success with these stabilized carbon nucleophiles. For example, the 
addition of nitromethane to -halo -keto esters 1.15 proceeds smoothly to afford tertiary 
alcohol products 1.16 in good yields and selectivities (Scheme 1-4B).30  Looking to increase 
the scope of nucleophiles available for these additions to include unstabilized organometallic 
nucleophiles, we recently reported an enantioconvergent addition employing arylboronic acids 
and -keto ester electrophiles catalyzed by a chiral(diene) rhodium(I) complex which furnishes 
complex tertiary glycolate derivatives (Scheme 1-4C).38 The integration of other unstabilized 
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nucleophilic partners under this reaction manifold carries with it the opportunity to generate 
novel, stereochemically complex glycolate architectures. 
Scheme 1-4 Enantioconvergent Additions to -Keto Esters 
 
1.2 Synthesis of Propargyl Alcohols via Acetylide Addition Reactions 
 As a result of their versatility,39 propargyl alcohols are routinely employed in total 
synthesis.40–42 The addition of metal acetylides to carbonyls is a venerable method for the 
synthesis of propargyl alcohols.43–48 Following Mukaiyama’s pioneering report describing the 
asymmetric addition of lithium acetylides to aldehydes,49 many synthetically useful 
asymmetric acetylide additions have been disclosed.  The Zn(OTf)2/N-methylephedrine 
catalyzed variant reported by Carreira is a preeminent example (Scheme 1-5A);50,51 the use of 
Zn(OTf)2 as a catalyst avoids the use of pyrophoric dialkyl zinc promoters and allows the 
reaction to be rendered catalytic in zinc.52–56 While this discovery has led to a thorough 
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investigation of compatible aldehyde substrates, much less attention has been paid to ketone 
electrophiles.44,45,47 A notable exception comes from the Jiang group, who disclosed the 
alkynylation of -keto esters (Scheme 1-5B).57 Despite the reaction’s reported poor tolerance 
of enolizable substrates, we were intrigued by the potential to construct complex tertiary 
propargylic alcohols via enantioconvergent acetylide additions (Scheme 1-5C). 
Scheme 1-5 Prior Art 
 
1.3 Optimization Studies 
Our investigation began with the coupling of -keto ester 1.19a and phenyl acetylene 
(Table 1-1). Initially, we chose to carry out the reaction using stoichiometric Zn(OTf)2 and 
ligand in order to first to probe the diastereo- and enantioselectivity of the reaction. Following 
Carreira’s conditions,50,51 glycolate product 1.21a was formed in 2.5:1 dr and 87:13 er (entry 
1). When the ligand was changed to the amino alcohol developed by the Jiang group, which is 
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accessible in 2 steps from commercially available (1R,2R)-2-amino-1-(4-nitrophenyl)propane-
1,3-diol,57,58 an increase in both diastereo- and enantioselectivity was observed (entry 2). 
Encouraged by this result, we next turned to rendering the process catalytic. Increasing the 
temperature while reducing catalyst loading to 20 mol % resulted in low conversion to product 
1.21a (entry 3). Zinc acetylide additions are ligand accelerated,59 thus we probed the 
hypothesis that reactivity could be improved by employing stoichiometric Zn(OTf)2 and 
catalytic ligand without negatively impacting enantioselectivity (entry 4). Although conversion 
was increased, a significant drop in enantioselectivity led us to abandon this strategy. When 
the reaction was run neat at 70 °C,52–56 excellent conversion and enantioselectivity were 
obtained (entry 5). Finally, lowering the temperature of the reaction to 40 °C improved the 
diastereoselectivity of the reaction, affording product 1.21a in quantitative conversion, 8.7:1 




















aUnless otherwise noted, reactions conditions are as follows: 1.0 equiv of 1.13a, 3.0 equiv of 
1.14a, variable amounts of Zn(OTf)2, 50 mol % NEt3, 22 mol % ligand, PhMe ([1.13a]0 = 0.2 
M), 24 h. bDetermined by 1H NMR analysis of the crude reaction mixture. cDetermined by 
chiral HPLC analysis. Represents the enantiomeric ratio of the major diastereomer. d120 mol 
% ligand employed. eReactions were conducted using no solvent. 
 
1.4 Scope of Enantioconvergent Acetylide Addition  
 Under our optimized conditions, a variety of terminal alkynes were added to -keto 
ester 1.19a (Table 1-2). Electron-rich aryl alkyne 1.20b was used to deliver alcohol 1.21b in 
good diastereo- and enantiocontrol. 4-Fluorophenyl acetylene (1.20c) proved to be an excellent 
coupling partner as well. Ene-yne product 1.21d was obtained in 6.3:1 dr and 98.5:1.5 er. Alkyl 
substituted alkynes also proved to be viable substrates. In general, forming these products 




















































gave satisfactory results. The use of a protected primary alcohol, as represented by product 
1.21f, was well tolerated. Acetal 1.21g was assembled with only modest diastereoselectivity 
(4.6:1 dr) but almost perfect enantioselectivity (99.5:0.5 er). Amine 1.20h restored higher 
levels of diastereoselectivity. When alkynes with -tertiary centers (1.20i, 1.20j) were added 
to 1.19a, the highest levels of diastereoselectivity were obtained. A free alcohol was tolerated 
in the formation of 1.21i. Finally, ()-citronellal-derived alkyne 1.20k was employed, which 
gave product 1.21k in excellent selectivity and yield.  
Next, the generality of the -keto ester partner was probed (Table 1-2). -Keto ester 
1.19l, which contains an electron-rich substituent on the aryl ring, provided glycolate product 
1.21l with exquisite selectivity. The formation of product 1.21m in 78% yield, 8.2:1 dr, and 
96.5:3.5 er indicates that this reaction is viable for substrates containing electron-poor 
substituents and arenes bearing ortho substitution. When -allyl -keto esters were employed 
(1.19n and 1.19o), an increase in temperature to 50 °C was required, resulting in reduced levels 
of diastereoselectivity. Glycolate product 1.21o, containing a meta-substituted aryl ring, was 
formed with the lowest enantioselectivity (93.5:6.5 er), which indicates that substitution about 
the arene can have a noticeable effect on enantioselectivity. When -keto esters containing 
strongly electron-withdrawing groups on the arene or substitution at the  position, poor 








Table 1-2 Scope of Alkynylation Reactiona 
 
aReaction conditions: 1.0 equiv 1.19, 3.0 equiv 1.20, 20 mol % Zn (OTf)2, 22 mol % C, 50 mol 
% NEt3, 24 h. All diastereomeric pairs were separated via column chromatography on silica 
gel.  The reported enantiomeric ratio is of the major diastereomer. bReaction conducted at 50 









1.5 Synthetic Utility 
 An X-ray diffraction study revealed the stereochemistry of 1.21b to be (2S,3R) (Figure 
1-1).60 The relative configuration indicates that the favored transition state follows the Felkin–
Ahn model61 and the absolute stereochemistry agrees with the results of Carreira52–56 and 
Jiang.57,58  









To show the synthetic utility of the propargylic alcohol products, a number of 
secondary transformations were carried out (Scheme 1-6). Tetrabutylammonium fluoride 
(TBAF) mediated removal of the trimethylsilyl group from compound 1.21j afforded free 
alkyne product 1.22 in 59% yield. Compound 1.21a underwent nickel boride-catalyzed partial 
hydrogenation to form syn-alkene 1.23 in high yield. Boron substituted alkene 1.24 was formed 
through the method of Tsuji and coworkers.62 Finally, a palladium on carbon catalyzed 
hydrogenation furnished product 1.25 in excellent yield. This hydrogenation shows that for 
these products, the alkyne functionality can act as an alkane surrogate,57 an important feature 
due to a lack of alternative reliable methods for accomplishing this net transformation 
stereoselectively.63 Furthermore, the enantioconvergent alkynylation reaction of 1.19a and 
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phenylacetylene was conducted on 1 g scale to prove its scalability. Since excess alkyne served 
only the role of solubilizing the reaction mixture, the amount of phenylacetylene was decreased 
to 1.5 molar equivalents. An equal volume amount of toluene was added in place of excess 
alkyne to dissolve the reagents.64 This modification produced no significant decrease in yield 
or stereoselectivity.   





















Conditions: (a) TBAF (1 M solution in H2O, 1.2 equiv), THF, 0 °C, 15 minutes; (b) Ni(OAc)2 
(30 mol %), NaBH4 (60 mol %), ethylenediamine (1 equiv), H2 (1 atm), EtOH, rt, 8 h; (c) E (2 






 In conclusion, we have developed a stereoconvergent alkynylation reaction of -
stereogenic -keto esters. The DKR between -keto esters and alkynes constitutes a rare 
example of the addition of a nonstabilized carbon nucleophile to a C=O -electrophile in an 
enantioconvergent fashion. The reaction proceeds with 100% atom economy and is conducted 
neat. The substituted glycolate products can be converted into useful alkene and alkane 
products. Studies aimed at the use of this reaction in the arena of total synthesis are ongoing. 
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1.8 Experimental Details 
Methods  
General: Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform infrared 
spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were 
recorded on a Bruker model Avance 400 (19F NMR at 376 MHz), Bruker Avance III 500 (1H 
NMR at 500 MHz), or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 151 
MHz) spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 
ppm; 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, br s = broad singlet, app s = apparent singlet, d = doublet, t = triplet, 
app t = apparent triplet, q = quartet, app q = apparent quartet, dd = doublet of doublets, td = 
triplet of doublets, app td = apparent triplet of doublets, ddd = doublet of doublet of doublets, 
ddt = doublet of doublet of triplets, app ddt = apparent doublet of doublet of triplets, dddd = 
doublet of doublet of doublet of doublets, m = multiplet), coupling constants (Hz), and 
integration. Optical rotations were measured using a 2 mL cell with a 1 dm path length on a 
Jasco DIP 1000 digital polarimeter. Mass spectra were obtained using a Thermo LTqFT mass 
spectrometer with electrospray introduction and external calibration. All samples were 
prepared in methanol. Analytical thin layer chromatography (TLC) was performed on Sorbent 
Technologies 0.20 mm Silica Gel TLC plates. Visualization was accomplished with UV light, 
KMnO4, and/or Seebach’s stain (2.5 g phosphomolybdic acid, 1.0 g Ce(SO4)2, 6.0 mL conc. 
H2SO4, 94 mL H2O) followed by heating. Purification of the reaction products was carried out 
by flash column chromatography using Siliaflash-P60 silica gel (40-63μm) purchased from 
Silicycle. Unless otherwise noted, all reactions were carried out under an atmosphere of dry 
nitrogen in flame-dried glassware with magnetic stirring. Yield refers to isolated yield of pure 
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material unless otherwise noted. Yields are reported for a specific experiment and as a result 

























General: Tetrahydrofuran (THF), diethyl ether (Et2O), methylene chloride (CH2Cl2), and 
toluene (PhMe) were dried by passage through a column of neutral alumina under nitrogen 
prior to use. Ligands C57 and D,65 alkynes 1.20f,66 1.20g,67 1.20h,68 and 1.20k,69 -keto esters 






















Preparation and Characterization of -Keto Ester Substrates 
 
Method A for the Preparation of -Methyl Substituted Substrate 1.19a 
Ethyl 2-oxo-3-phenylbutanoate (1.19a): The title compound was 
synthesized according to modified procedures published by Jana71 and 
Johnson,72 respectively. A flame-dried round-bottomed flask equipped with a reflux condenser 
and stirbar was cooled under a stream of N2, and charged with methylene chloride (89 mL, 
[ethyl acetoacetate]0 = 0.25 M), 1-phenylethan-1-ol (3.0 mL, 24.7 mmol, 1.11 equiv), ethyl 
acetoacetate (2.8 mL, 22.3 mmol, 1.0 equiv), and FeCl3 (397 mg, 2.45 mmol, 0.11 equiv). The 
reaction mixture was heated at reflux (external bath at 50 °C). Analysis of a reaction aliquot 
by 1H NMR spectroscopy indicated completion after 20 h; the reaction mixture was 
subsequently filtered through a pad of silica gel using 70/30 hexanes/ethyl acetate and 
concentrated to afford crude product 1.19a′ as a yellow liquid, existing as an inconsequential 
mixture of diastereomers.  
The crude -keto ester product was added to a round-bottomed flask and stirbar, and dissolved 
in MeCN (52 mL, 1 mL/100 mg -keto ester). Next, Cu(NO3)2·3H2O (933 mg, 4.45 mmol, 0.2 
equiv) was added and the resulting green homogenous solution was sparged with O2 gas (O2 
balloon attached to penetration needle) for 10 min. The reaction was stirred for 44 h at room 
temperature under an atmosphere of oxygen, at which point 1H NMR analysis indicated full 
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consumption of the starting -keto ester. The reaction mixture was diluted with water and 
extracted with ethyl acetate (3 × 20 mL). The combined organic extracts were then washed 
with brine, dried over Na2SO4 and concentrated in vacuo. Purification of the resulting residue 
by silica gel column chromatography (column 1: EtOAc/hexanes = 2.5/97.5, column 2: 
methylene chloride) afforded 2.34 g (51% over 2 steps) of the title compound as a light yellow 
liquid. Analytical data for 1.19a: 1H NMR (400 MHz, CDCl3)  7.377.33 (m, 2 H), 7.317.27 
(m, 1 H), 7.267.23 (m, 2 H), 4.51 (q, J = 7.0 Hz, 1 H), 4.264.14 (m, 2 H), 1.49 (d, J = 7.0 
Hz, 3 H), 1.23 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3)  194.0, 161.3, 137.7, 
129.0, 128.4, 127.6, 62.2, 48.4, 16.7, 13.8; IR (thin film): 3062, 3030, 2982, 2937, 2905, 2875, 
1728 cm–1; HRMS: (ESI+): Calcd. for C12H14O3: ([M+Na]): 229.0841, Found: 229.0838. TLC 
(EtOAc/hexane = 2.5/97.5): Rf = 0.1.  
 
 
Method B for the Preparation of β-allyl Substituted Substrate 1.19n: 
Ethyl 2-(allyloxy)-3-(4-chlorophenyl)-3-hydroxypropanoate (1.19n′) Step 1: A flame-
dried round-bottomed flask equipped with a stirbar was cooled under a stream of N2, and n-
BuLi (7.3 mL, 1.72 M, 12.5 mmol, 1.2 equiv) was added dropwise to a solution of 
diisopropylamine (1.9 mL, 13.5 mmol, 1.3 equiv) in THF (21 mL), cooled to -78 °C. After the 
resulting solution had stirred for 10 min, ethyl 2-(allyloxy)acetate (1.50 g, 10.4 mmol, 1.0 
equiv) was added dropwise as a solution in THF (15.0 mL, [ethyl 2-(allyloxy)acetate] = 0.7 
M) and the reaction was stirred for 15 min at -78 °C. Next, 4-chlorobenzaldehyde (1.90 g, 13.5 
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mmol, 1.3 equiv) was added dropwise in THF (10 mL, [4-ClPhCHO] = 1.35 M). The reaction 
was stirred for an additional 45 min at -78 °C before being quenched with saturated aqueous 
NH4Cl (20 mL). The aqueous layer was extracted with methylene chloride (3 × 15 mL) and 
the combined organic extracts were dried over Na2SO4 and concentrated in vacuo. Purification 
of the resulting residue by silica gel column chromatography (EtOAc/hexanes = 10/90 to 
EtOAc/hexanes = 20/80) afforded 2.23 g (75%) of the title compound as a clear and colorless 
liquid. Analytical data for 1.19n′: 1H NMR (reported as 2.2:1 mixture of diastereomers 
normalized to the methine resonance corresponding to the minor diastereomer at  4.91, 600 
MHz, CDCl3)  7.397.27 (m, 13.2 H), 5.835.74 (m, 3.1 H), 5.245.16 (m, 6.4 H), 4.98 (d, J 
= 5.9 Hz, 2.2 H), 4.91 (d, J = 5.6 Hz, 1 H), 4.194.04 (m, 11.7 H), 3.993.96 (m, 4.4 H), 3.01 
(s, 3 H), 1.201.12 (m, 9.4 H); 13C NMR (151 MHz, CDCl3)  170.3, 170.2, 137.9, 137.6, 
133.9, 133.8, 133.3, 133.2, 128.4, 128.3, 128.1, 128.1, 118.7, 118.5, 82.3, 81.3, 74.1, 73.4, 
72.1, 72.1, 61.2, 61.2, 14.0, 14.0. IR (thin film): 3082, 2982, 2934, 2906, 2871, 1739 cm–1; 
HRMS: (ESI+): Calcd. for C14H17ClO4: ([M+Na]): 307.0713, Found: 307.0709. TLC: 
(EtOAc/hexane = 2.5/97.5): Rf = 0.1. 
 
Ethyl 2-(allyloxy)-3-(4-chlorophenyl)acrylate (1.19n′′) Step 2: A flame-dried round-
bottomed flask equipped with a stirbar was cooled under a stream of N2, and charged with 
1.19n′ (1.83 g, 6.4 mmol, 1.0 equiv) and triethylamine (1.2 mL, 8.33 mmol, 1.3 equiv) in 
methylene chloride (19 mL, [1.19n′]0 = 0.3 M) cooled to 0 °C was added methanesulfonyl 
chloride (0.60 mL, 7.7 mmol, 1.2 equiv) dropwise. The resulting solution was allowed to warm 
to room temperature slowly and was then stirred for an additional 12 h before being quenched 
with saturated aqueous NaHCO3 (20 mL). The aqueous layer was extracted with methylene 
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chloride (3 × 15 mL), and the combined organic extracts were dried over Na2SO4 and 
concentrated in vacuo. The crude mesylate was dissolved in tetrahydrofuran (13 mL, 
[mesylate]0 = 0.5 M) and treated with 1,8-diazabicycloundec-7-ene (2.9 mL, 19.2 mmol, 3.0 
equiv) at room temperature. The reaction was stirred for 12 h before being diluted with water 
(2 mL/mmol substrate, 13 mL). The aqueous layer was extracted with methylene chloride (3 × 
15 mL) and the combined organic extracts were dried over Na2SO4 and concentrated in vacuo. 
Purification of the resulting residue by silica gel column chromatography (EtOAc/hexanes = 
5/95 to EtOAc/hexanes = 10/90) afforded 1.48 g (87% over 2 steps) of the title compound as 
a light yellow liquid. Analytical data for 1.19n′′ was not collected because the compound was 
not isolated cleanly, due to the room temperature Claisen rearrangement to compound 1.19n.  
 
Ethyl 3-(3-bromophenyl)-2-oxohex-5-enoate (1.19n, Step 3): A 
flame-dried pressure vessel equipped with a stirbar was cooled under a 
stream of N2, and charged with 1.19n′′ (1.47 g, 4.71 mmol) and toluene 
(12 mL, [1.19n′′]0 = 0.4 M). The pressure vessel was sealed and stirred at 95 °C for 6 h, after 
which time concentration provided the title compound as a light yellow liquid in quantitative 
yield. Analytical data for 1.19n: 1H NMR (600 MHz, CDCl3)  7.30 (d, J = 8.4 Hz, 2 H), 7.16 
(d, J = 8.4 Hz, 2 H), 5.685.60 (m, 1 H), 5.054.97 (m, 2 H), 4.48 (app t, J = 7.5 Hz, 1 H), 
4.254.15 (m, 2 H), 2.832.77 (m, 1 H), 2.512.44 (m, 1 H), 1.25 (app t, J = 7.1 Hz, 4 H); 13C 
NMR (151 MHz, CDCl3):  192.4, 160.7, 134.3, 134.1, 133.8, 130.3, 129.1, 117.7, 62.6, 52.3, 
35.6, 13.8; IR (thin film): 3080, 2982, 2918, 1730, 1643; IR (thin film): 3080, 2982, 2918, 
1730, 1643 cm–1; HRMS (ESI+): Calcd. for C14H15ClO3 ([M+H
+]): 267.0788, Found: 
267.0782. TLC (EtOAc/hexane = 2.5/97.5): Rf = 0.1.  
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Preparation of Racemic Standards 
General Procedure for the Addition of Lithium Acetylides to -Keto Esters: A flame dried 
vial was cooled under a stream of N2, and charged with the appropriate alkyne (2.0 equiv) and 
THF ([alkyne]0 = 0.4 M). The solution was cooled to -78 °C, and a 2.5 M solution of 
nBuLi 
(2.1 equiv) was added dropwise. (Exception: 4.1 equiv of nBuLi was used for the synthesis of 
(±)-1.21i.) The solution was warmed to 0 °C, and stirred for 30 min. The solution was then 
cooled to -78 °C, and a 0.4 M solution of the appropriate -keto ester (1.0 equiv) in THF was 
added to the acetylide solution dropwise. The solution was stirred at -78 °C (warmed to rt 
slowly overnight for the synthesis of (±)-1.21i and (±)-1.21j) until TLC indicated completion 
of the reaction (generally about 1 h). The mixture was quenched with an aqueous solution of 
saturated NH4Cl. The mixture was warmed to rt, and added to a separatory funnel. The mixture 
was diluted with methylene chloride (15 mL) and aqueous saturated NH4Cl. The organic layer 
was collected, and the aqueous layer was extracted with methylene chloride (2 × 15 mL). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The 











Preparation and Characterization of Tertiary Glycolate Products 
General Procedure for the Zn-Catalyzed Alkynylation of -Keto Esters: A flame dried 
vial was cooled under a stream of N2, and charged with ligand C (0.22 equiv). The vial was 
transferred to a N2 filled glovebox, and charged with Zn(OTf)2 (0.2 equiv). The vial was 
removed from the glovebox, and charged with the appropriate alkyne (3.0 equiv) and NEt3 (0.5 
equiv). The mixture was stirred under N2 for 30 min to generate the active catalyst. The 
appropriate -keto ester was then added to the solution, and the solution was stirred at the 
indicated temperature for the indicated time period. The reaction mixture was loaded onto a 
short plug of silica gel, and the plug was washed with ether (3 × 2 mL). The solution was 
concentrated in vacuo to afford the crude tertiary glycolate product. The crude material was 
purified by column chromatography on silica gel.  
 
Ethyl (S)-2-hydroxy-4-phenyl-2-((R)-1-phenylethyl)but-3-ynoate 
(1.21a): The general procedure was employed for the coupling of 1.19a 
(88.7 mg, 90 L, 0.43 mmol) and phenylacetylene (131.8 mg, 141 L, 1.29 
mmol). The reaction time was 24 h, and the reaction temperature was 40 °C. The diastereomer 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at  4.37 (minor diastereomer) and  4.19 
(major diastereomer). The crude material was purified by column chromatography 
(EtOAc/hexanes = 2.5/97.5 to 5/95 EtOAc/hexanes) to afford 105.4 mg (76%) of the title 
compound as a clear and colorless liquid: 1H NMR (600 MHz, CDCl3)  7.54–7.51 (m, 2 H), 
7.40–7.34 (m, 5 H), 7.33–7.25 (m, 3 H), 4.25–4.12 (m, 2 H), 3.60 (s, 1 H), 3.52 (q, J = 7.2 Hz, 
1 H), 1.67 (d, J = 7.2 Hz, 3 H), 1.29 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 
25 
 
171.8, 140.2, 131.8, 128.8, 128.7, 128.2, 128.1, 127.4, 122.1, 87.4, 84.9, 74.6, 63.0, 48.3, 
16.0, 14.0; IR (thin film): 3492, 2981, 2936, 2227, 1736 cm–1; HRMS: (ESI+): Calcd. for 
C20H20O3: ([M+Na]): 331.1310, Found: 331.1304; HPLC (99:1 hexanes:
iPrOH, Daicel 
CHIRALCEL OJ-H): 99:1 er, tR (major) = 22.7 min, tR (minor) = 17.4 min; []D: 83.4 (c = 0.01, 
CHCl3); TLC (EtOAc/hexane = 15/85): Rf = 0.45. 
 
Ethyl (S)-2-hydroxy-4-(4-methoxyphenyl)-2-((R)-1-phenylethyl)but-
3-ynoate (1.21b): The general procedure was employed for the coupling 
of 1.19a (88.7 mg, 90 L, 0.43 mmol) and 1.20b (170.4 mg, 167 L, 1.29 
mmol). The reaction time was 24 h, and the reaction temperature was 40 
°C. The diastereomer ratio was determined by 1H NMR spectroscopic analysis of the crude 
reaction mixture by comparison of the integration of the resonances at  1.67 (major 
diastereomer) and  1.43 (minor diastereomer). The crude material was purified by column 
chromatography (EtOAc/hexanes = 5/95 to 10/90 EtOAc/hexanes) to afford 115.1 mg (79%) 
of the title compound as a white solid: 1H NMR (600 MHz, CDCl3)  7.477.43 (m, 2 H), 
7.367.34 (m, 2 H), 7.327.24 (m, 3 H), 6.906.86 (m, 2 H), 4.244.11 (m, 2 H), 3.84 (s, 3 H), 
3.58 (s, 1 H), 3.51 (q, J = 7.2 Hz, 1 H), 1.66 (d, J = 7.2 Hz, 3 H), 1.28 (app t, J = 7.1 Hz, 3 H); 
13C NMR (151 MHz, CDCl3) 172.0, 159.8, 140.3, 133.3, 128.8, 128.0, 127.3, 114.2, 113.8, 
86.0, 84.9, 74.7, 62.9, 55.3, 48.3, 16.0, 14.0; IR (thin film): 3491, 2979, 2936, 2225, 1736, 
1605 cm–1; HRMS: (ESI+): Calcd. for C21H22O4: ([M+Na]): 361.1416, Found: 361.1410; 
HPLC (97:3 hexanes:iPrOH, Daicel CHIRALCEL OJ-H): 96.5:3.5 er, tR (major) = 26.8 min, tR 
(minor) = 31.6 min; []D: 70.7 (c = 0.01, CHCl3); mp: 7172 °C; TLC (EtOAc/hexane = 15/85): 




ynoate (1.21c): The general procedure was employed for the coupling of 
1.19a (88.7 mg, 90 L, 0.43 mmol) and 1.20c (155.0 mg, 147 L, 1.29 
mmol). The reaction time was 24 h, and the reaction temperature was 40 °C. 
The diastereomer ratio was determined by 1H NMR spectroscopic analysis of the crude 
reaction mixture by comparison of the integration of the resonances at  1.66 (major 
diastereomer) and  1.42 (minor diastereomer). The crude material was purified by column 
chromatography (EtOAc/hexanes = 5/95) to afford 105.7 mg (75%) of the title compound as a 
clear and colorless liquid: 1H NMR (600 MHz, CDCl3)  7.527.47 (m, 2 H), 7.367.25 (m, 5 
H), 7.087.03 (m, 2 H), 4.254.11 (m, 2 H), 3.60 (s, 1 H), 3.50 (q, J = 7.2 Hz, 1 H), 1.66 (d, J 
= 7.2 Hz, 3 H), 1.28 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 171.8, 162.7 (d, 
J13C-19F = 249.9 Hz), 140.1, 133.8 (d, J13C-19F = 8.4 Hz), 128.8, 128.1, 127.4, 118.2, 118.2, 115.6 
(d, J13C-19F = 21.9 Hz), 87.1, 83.8, 74.6, 63.0, 48.3, 16.0, 14.0; IR (thin film): 3493, 2981, 2936, 
2229, 1737, 1601 cm–1; HRMS: (ESI+): Calcd. for C20H19FO3: ([M+Na]): 349.1216, Found: 
349.1210; HPLC (97:3 hexanes:iPrOH, Daicel CHIRALCEL OJ-H): 99:1 er, tR (minor) = 12.0 




ynoate (1.21d): The general procedure was employed for the coupling of 
1.19a (88.7 mg, 90 L, 0.43 mmol) and 1.20d (155.0 mg, 147 L, 1.29 
mmol). The reaction time was 24 h, and the reaction temperature was 40 °C. The diastereomer 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
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comparison of the integration of the resonances at  4.32 (minor diastereomer) and  4.14 
(major diastereomer). The crude material was purified by column chromatography 
(EtOAc/hexanes = 5/95) to afford 113.9 mg (85%) of the title compound as a clear and 
colorless liquid: 1H NMR (600 MHz, CDCl3) 7.347.21 (m, 5 H), 6.226.18 (m, 1 H), 
4.214.05 (m, 2 H), 3.48 (s, 1 H), 3.41 (q, J = 7.2 Hz, 1 H), 2.222.08 (m, 4 H), 1.701.54 (m, 
7 H), 1.25 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 172.0, 140.3, 136.2, 128.8, 
128.0, 127.2, 119.8, 86.7, 84.7, 74.5, 62.7, 48.2, 28.9, 25.6, 22.1, 21.4, 16.0, 13.9; IR (thin 
film): 3493, 2980, 2935, 2214, 1736 cm–1; HRMS: (ESI+): Calcd. for C20H24O3: ([M+Na]): 
335.1623, Found: 335.1617; HPLC (97:3 hexanes:iPrOH, Daicel CHIRALCEL OJ-H): 99:1 
er, tR (minor) = 7.5 min, tR (major) = 6.6 min; []D: 66.9 (c = 0.01, CHCl3); TLC (EtOAc/hexane 
= 15/85): Rf = 0.45. 
 
Ethyl (S)-2-hydroxy-2-((R)-1-phenylethyl)non-3-ynoate (1.21e): The 
general procedure was employed for the coupling of 1.19a (88.7 mg, 90 L, 
0.43 mmol) and 1-hexyne (124.1 mg, 169 L, 1.29 mmol). The reaction time 
was 24 h, and the reaction temperature was 50 °C. The diastereomer ratio was determined by 
1H NMR spectroscopic analysis of the crude reaction mixture by comparison of the integration 
of the resonances at  4.31 (minor diastereomer) and  4.13 (major diastereomer). The crude 
material was purified by column chromatography (EtOAc/hexanes = 5/95) to afford 83.0 mg 
(64%) of the title compound as a clear and colorless liquid: 1H NMR (600 MHz, CDCl3) 
7.327.22 (m, 5 H), 4.204.06 (m, 2 H), 3.43 (s, 1 H), 3.37 (q, J = 7.1 Hz, 1 H), 2.29 (app t, 
J = 7.1 Hz, 2 H), 1.621.54 (m, 5 H), 1.461.32 (m, 4 H), 1.25 (app t, J = 7.1 Hz, 3 H), 0.94 
(app t, J = 7.2 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 172.3, 140.4, 128.8, 128.0, 127.2, 
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86.0, 78.6, 74.2, 62.7, 48.2, 31.0, 28.0, 22.1, 18.7, 15.9, 14.0, 13.9; IR (thin film): 3503, 2958, 
2934, 2872, 2861, 2235, 1736 cm–1; HRMS: (ESI+): Calcd. for C19H26O3: ([M+Na]): 
325.1780, Found: 325.1774; HPLC (95:5 hexanes:iPrOH, Daicel CHIRALPAK IC): 98:2 er, 
tR (minor) = 5.0 min, tR (major) = 5.7 min; []D: 53.6 (c = 0.01, CHCl3); TLC (EtOAc/hexane = 
15/85): Rf = 0.55. 
 
Ethyl (S)-5-((tert-butyldimethylsilyl)oxy)-2-hydroxy-2-((R)-1-
phenylethyl)pent-3-ynoate (1.21f): The general procedure was employed for 
the coupling of 1.19a (88.7 mg, 90 L, 0.43 mmol) and 1.20f (219.7 mg, 1.29 
mmol). The reaction time was 24 h, and the reaction temperature was 60 °C. The diastereomer 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at  1.33 (minor diastereomer) and  1.25 
(major diastereomer). The crude material was purified by column chromatography 
(EtOAc/hexanes = 5/95) to afford 94.0 mg (58%) of the title compound as a clear and colorless 
liquid: 1H NMR (600 MHz, CDCl3) 7.317.22 (m, 5 H), 4.434.42 (m, 2 H), 4.174.06 (m, 
2 H), 3.50, (s, 1 H), 3.39 (q, J = 7.2 Hz, 1 H), 1.58 (d, J = 7.2 Hz, 3 H), 1.25 (app t, J = 7.1 Hz, 
3 H), 0.95 (s, 9 H), 0.180.15 (m, 6 H); 13C NMR (151 MHz, CDCl3) 171.8, 140.2, 128.8, 
128.0, 127.3, 83.6, 83.0, 74.1, 62.9, 51.7, 48.0, 25.7, 18.2, 15.9, 13.9, -5.1, -5.2; IR (thin film): 
3500, 2955, 2931, 2858, 1737 cm–1; HRMS: (ESI+): Calcd. for C21H32O4Si: ([M+Na]): 
399.1968, Found: 399.1962; HPLC (97:3 hexanes:iPrOH, Daicel CHIRALCEL OJ-H): 
97.5:2.5 er, tR (minor) = 4.0 min, tR (major) = 4.5 min; []D: 44.2 (c = 0.01, CHCl3); TLC 




ynoate (1.21g): The general procedure was employed for the coupling of 
1.19a (88.7 mg, 90 L, 0.43 mmol) and 1.20g (162.7 mg, 1.29 mmol). The 
reaction time was 24 h, and the reaction temperature was 50 °C. The 
diastereomer ratio was determined by 1H NMR spectroscopic analysis of the crude reaction 
mixture by comparison of the integration of the resonances at  1.33 (minor diastereomer, 
resonance represents 6 protons) and  1.57 and 1.23 (major diastereomer, resonances represent 
a total of 6 protons). The crude material was purified by column chromatography 
(EtOAc/hexanes = 10/90 to EtOAc/hexanes = 15/85 to EtOAc/hexanes = 20/80) to afford 94.9 
mg (66%) of the title compound as a clear and colorless liquid: 1H NMR (600 MHz, CDCl3) 
7.317.21 (m, 5 H), 5.00 (app t, J = 4.6 Hz, 1 H), 4.284.05 (m, 2 H), 4.033.86 (m, 4 H), 
3.44 (s, 1 H), 3.36 (q, J = 7.2 Hz, 1 H), 2.43 (app t, J = 7.5 Hz, 2 H), 1.961.91 (m, 2 H), 1.56 
(d, J = 7.2, 3 H), 1.24 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 172.1, 140.3, 
128.8, 128.0, 127.2, 103.0, 84.8, 78.8, 74.2, 64.9, 62.7, 48.2, 32.7, 15.9, 13.9, 13.6; IR (thin 
film): 3491, 2979, 2936, 2880, 2236, 1738 cm–1; HRMS: (ESI+): Calcd. for C19H24O5: 
([M+Na]): 355.1522, Found: 355.1515; HPLC (95:5 hexanes:iPrOH, Daicel CHIRALPAK 
IA): 99:1 er, tR (minor) = 19.4 min, tR (major) = 15.8 min; []D: 50.3 (c = 0.01, CHCl3); TLC 
(EtOAc/hexane = 40/60): Rf = 0.65. 
 
Ethyl (S)-5-(dibenzylamino)-2-hydroxy-2-((R)-1-phenylethyl)pent-3-
ynoate (1.21h): The general procedure was employed for the coupling of 
1.19a (88.7 mg, 90 L, 0.43 mmol) and 1.20h (303.6 mg, 1.29 mmol). The 
reaction time was 48 h, and the reaction temperature was 60 °C. The diastereomer ratio was 
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determined by 1H NMR spectroscopic analysis of the crude reaction mixture by comparison of 
the integration of the resonances at  4.40 (minor diastereomer) and  4.22 (major 
diastereomer). The crude material was purified by column chromatography (EtOAc/hexanes = 
5/95) to afford 120.8 mg (64%) of the title compound as a clear and colorless liquid: 1H NMR 
(600 MHz, CDCl3) 7.467.43 (m, 4 H), 7.407.35 (m, 6 H), 7.347.26 (m, 5 H), 4.274.13 
(m, 2 H), 3.75 (app s, 4 H), 3.55 (s, 1 H), 3.49 (q, J = 7.2 Hz, 1 H), 3.37 (app s, 2 H), 1.69 (d, 
J = 7.2 Hz, 3 H), 1.32 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 172.2, 140.2, 
138.7, 129.0, 128.8, 128.1, 127.4, 127.2, 84.2, 80.1, 74.3, 62.9, 57.6, 48.4, 41.3, 16.1, 14.1; IR 
(thin film): 3500, 3062, 3024, 2981, 2933, 2823, 2342, 1737 cm–1; HRMS: (ESI+): Calcd. for 
C29H31NO3: ([M+Na]): 464.2202, Found: 464.2198; HPLC (93:7 hexanes:
iPrOH, Daicel 
CHIRALCEL OJ-H): 97:3 er, tR (minor) = 15.0 min, tR (major) = 24.0 min; []D: 36.6 (c = 0.01, 
CHCl3); TLC (EtOAc/hexane = 15/85): Rf = 0.45. 
 
Ethyl (S)-2,5-dihydroxy-5-methyl-2-((R)-1-phenylethyl)hex-3-ynoate 
(1.21i): The general procedure was employed for the coupling of 1.19a (88.7 
mg, 90 L, 0.43 mmol) and 1.20i (108.5 mg, 125 L, 1.29 mmol). The 
reaction time was 24 h, and the reaction temperature was 60 °C. The diastereomer ratio was 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture by comparison of 
the integration of the resonances at  4.31 (minor diastereomer) and  4.12 (major 
diastereomer). The crude material was purified by column chromatography (EtOAc/hexanes = 
20/80 to EtOAc/hexanes = 30/70) to afford 90.5 mg (76%) of the title compound as a clear and 
colorless viscous liquid: 1H NMR (600 MHz, CDCl3) 7.317.22 (m, 5 H), 4.214.14 (m, 1 
H), 4.134.06 (m, 1 H), 3.50 (s, 1 H), 3.38 (q, J = 7.2 Hz, 1 H), 2.25 (br s, 1 H), 1.601.54 (m, 
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9 H), 1.24 (app t, J = 7. Hz, 3 H); 13C NMR (151 MHz, CDCl3) 171.8, 140.0, 128.8, 128.0, 
127.4, 89.6, 80.3, 74.1, 65.1, 62.8, 48.1, 31.2, 31.1, 15.9, 13.9; IR (thin film): 3448, 2981, 
2935, 2359, 2342, 1736, 1494 cm–1; HRMS: (ESI+): Calcd. for C17H22O4: ([M+Na]): 
313.1416, Found: 313.1410; HPLC (99:1 hexanes:iPrOH, Daicel CHIRALCEL OJ-H): 
93.5:6.5 er, tR (minor) = 31.1 min, tR (major) = 38.4 min; []D: 51.9 (c = 0.01, CHCl3); TLC 
(EtOAc/hexane = 50/50): Rf = 0.45. 
 
Ethyl (S)-2-hydroxy-2-((R)-1-phenylethyl)-4-(trimethylsilyl)but-3-ynoate 
(1.21j): The general procedure was employed for the coupling of 1.20a (88.7 
mg, 90 L, 0.43 mmol) and ethynyltrimethylsilane (128.6 mg, 186 L, 1.29 
mmol). The reaction time was 24 h, and the reaction temperature was 70 °C. The diastereomer 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at  4.34 (minor diastereomer) and  4.16 
(major diastereomer). The crude material was purified by column chromatography 
(EtOAc/hexanes = 2.5/97.5) to afford 84.2 mg (63%) of the title compound as a clear and 
colorless liquid: 1H NMR (600 MHz, CDCl3)  7.317.22 (m, 5 H), 4.244.16 (m, 1 H), 
4.134.06 (m, 1 H), 3.503.37 (m, 2 H), 1.58 (d, J = 7.2 Hz, 3 H), 1.25 (app t, J = 7.1 Hz, 3 
H), 0.23 (s, 9 H); 13C NMR (151 MHz, CDCl3)  171.7, 140.1, 128.8, 128.0, 127.3, 103.2, 
90.0, 74.5, 62.8, 48.0, 15.8, 13.9, -0.3; IR (thin film): 3503, 3062, 3030, 2964, 2937, 2901, 
2165, 1737 cm–1; HRMS: (ESI+): Calcd. for C17H24O3Si: ([M+Na]): 327.1393, Found: 
327.1386; HPLC (98:2 hexanes:iPrOH, Daicel CHIRALPAK IA): 97.5:2.5 er, tR (minor) = 4.9 





9-en-3-ynoate (1.21k): The general procedure was employed for the 
coupling of 1.19a (77.7 mg, 0.38 mmol) and 1.20k (169.8 mg, 1.13 mmol). 
The reaction time was 24 h, and the reaction temperature was 70 °C. The 
diastereomer ratio was determined by 1H NMR spectroscopic analysis of the crude reaction 
mixture by comparison of the integration of the resonances at  4.29 (minor diastereomer) and 
 4.13 (major diastereomer). No other diastereomers were visible by 1H NMR spectroscopy. 
The crude material was purified by column chromatography (EtOAc/hexanes = 5/95) to afford 
92.3 mg (69%) of the title compound as a clear and colorless liquid: 1H NMR (600 MHz, 
CDCl3)  7.327.22 (m, 5 H), 5.155.11 (m, 1 H), 4.214.05 (m, 2 H), 3.43 (s, 1 H), 3.37 (q, 
J = 7.2 Hz, 1 H), 2.28 (dd, J = 16.7, 5.5 Hz, 1 H), 2.19 (dd, J = 16.6, 6.9 Hz, 1 H), 2.091.97 
(m, 2 H), 1.781.69 (m, 4 H), 1.64 (s, 3 H), 1.58 (d, J = 7.2 Hz, 3 H), 1.521.45 (m, 1 H), 
1.331.23 (m, 4 H); 13C NMR (151 MHz, CDCl3)  172.3, 140.4, 131.4, 128.8, 128.0, 127.2, 
124.4, 84.7, 79.6, 74.2, 62.6, 48.3, 36.1, 32.0, 25.9, 25.7, 25.5, 19.4, 17.6, 15.9, 13.9; IR (thin 
film): 3504, 2968, 2925, 2875, 2854, 2233, 1736 cm–1; HRMS: (ESI+): Calcd. for C23H32O3: 
([M+Na]): 379.2249, Found: 379.2244; []D: 61.2 (c = 0.01, CHCl3); TLC (EtOAc/hexane 
= 10/90): Rf = 0.45. 
 
Ethyl (S)-2-hydroxy-2-((R)-1-(4-methoxyphenyl)ethyl)-4-
phenylbut-3-ynoate (1.21l): The general procedure was employed 
for the coupling of 1.19l (96.0 mg, 0.41 mmol) and phenylacetylene 
(124.5 mg, 133 L, 1.22 mmol). The reaction time was 24 h, and the reaction temperature was 
40 °C. The diastereomer ratio was determined by 1H NMR spectroscopic analysis of the crude 
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reaction mixture by comparison of the integration of the resonances at  4.37 (minor 
diastereomer) and  4.19 (major diastereomer). The crude material was purified by column 
chromatography (EtOAc/hexanes = 2.5/97.5) to afford 117.5 mg (86%) of the title compound 
as a clear and colorless liquid: 1H NMR (600 MHz, CDCl3)  7.517.47 (m, 2 H), 7.367.31 
(m, 3 H), 7.277.23 (m, 2 H), 6.846.80 (m, 2 H), 4.244.10 (m, 2 H), 3.78 (s, 3 H), 3.55 (s, 
3.55), 3.45 (q, J = 7.2 Hz, 1 H), 1.61 (d, J = 7.2 Hz, 3 H), 1.28 (app t, J = 7.1 H, 3 H); 13C 
NMR (151 MHz, CDCl3)  171.9, 158.7, 132.1, 131.8, 129.8, 128.6, 128.2, 122.2, 113.4, 87.5, 
84.8, 74.7, 62.9, 55.1, 47.4, 16.2, 14.0; IR (thin film): 3481, 2979, 2935, 2836, 2226, 1735 cm–
1; HRMS: (ESI+): Calcd. for C21H22O4: ([M+Na]): 361.1416, Found: 361.1410; HPLC (95:5 
hexanes:iPrOH, Daicel CHIRALCEL OJ-H): >99.5:0.5 er, tR (minor) = 24.6 min, tR (major) = 21.6 
min; []D: 84.8 (c = 0.01, CHCl3); TLC (EtOAc/hexane = 15/85): Rf = 0.35. 
 
Ethyl (S)-2-((R)-1-(2-fluorophenyl)ethyl)-2-hydroxy-4-phenylbut-3-
ynoate (1.21m): The general procedure was employed for the coupling of 
1.19m (99.0 mg, 0.44 mmol) and phenylacetylene (135.3 mg, 145 L, 1.33 
mmol). The reaction time was 48 h, and the reaction temperature was 60 °C. The diastereomer 
ratio was determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at  4.40 (minor diastereomer) and  4.17 
(major diastereomer). The crude material was purified by column chromatography 
(EtOAc/hexanes = 5/95) to afford 112.5 mg (78%) of the title compound as a clear and 
colorless liquid: 1H NMR (600 MHz, CDCl3) 7.627.58 (m, 1 H), 7.517.48 (m, 2 H), 
7.377.31 (m, 3 H), 7.237.18 (m, 1 H), 7.127.07 (m, 1 H), 7.017.96 (m, 1 H), 4.234.09 
(m, 2 H), 3.98 (q, J = 7.2 Hz, 1 H), 3.67 (s, 1 H), 1.61 (d, J = 7.2 Hz, 3 H), 1.23 (app t, J = 7.1 
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Hz, 3 H); 13C NMR (151 MHz, CDCl3)  172.0, 160.1 (d, J13C-19F = 245.5 Hz), 131.9, 130.0 
(d, J13C-19F = 3.8 Hz), 128.7, 128.6 (d, J13C-19F = 8.4 Hz), 128.3, 127.4 (d, J13C-19F = 14.2 Hz), 
124.0 (d, J13C-19F = 3.6 Hz), 122.1, 114.9 (d, J13C-19F = 23.6 Hz), 87.1, 84.9, 74.2, 63.2, 38.9 (d, 
J13C-19F = 2.8 Hz), 16.0, 13.7; IR (thin film): 3488, 2982, 2937, 2227, 1735, 1490 cm
–1; HRMS: 
(ESI+): Calcd. for C20H19FO3: ([M+Na]): 349.1216, Found: 349.1211; HPLC (97:3 
hexanes:iPrOH, Daicel CHIRALCEL OJ-H): 97:3 er, tR (minor) = 12.0 min, tR (major) = 14.3 min; 
[]D: 64.1 (c = 0.01, CHCl3); TLC (EtOAc/hexane = 15/85): Rf = 0.45. 
 
Ethyl (2S,3R)-3-(4-chlorophenyl)-2-hydroxy-2-
(phenylethynyl)hex-5-enoate (1.21n): The general procedure was 
employed for the coupling of 1.19n (98.7 mg, 0.37 mmol) and 
phenylacetylene (113.4 mg, 121 L, 1.11 mmol). The reaction time was 48 h, and the reaction 
temperature was 50 °C. The diastereomer ratio was determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the integration of the resonances at  
4.36 (minor diastereomer) and  4.17 (major diastereomer). The crude material was purified 
by column chromatography (EtOAc/hexanes = 5/95) to afford 95.9 mg (70%) of the title 
compound as a white solid: 1H NMR (600 MHz, CDCl3)  7.507.47 (m, 2 H), 7.387.32 (m, 
3 H), 7.24 (app s, 4 H), 5.58 (app ddt, J = 17.1, 10.2, 7.0 Hz, 1 H), 4.99 (dd, J = 17.1, 1.7 Hz, 
1 H), 4.924.87 (m, 1 H), 4.234.06 (m, 2 H), 3.36 (dd, J = 11.9, 3.5 Hz, 1 H), 3.10 (dddd, J 
= 12.9, 6.4, 3.3, 1.6 Hz, 1 H), 2.792.71 (m, 1 H), 1.25 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 
MHz, CDCl3)  171.4, 136.3, 135.9, 133.3, 131.9, 130.9, 128.9, 128.3, 218.2, 121.9, 116.8, 
87.1, 85.3, 74.2, 63.2, 53.1, 34.5, 14.0; IR (thin film): 3488, 3079, 2980, 2937, 2228, 1737 cm–
1; HRMS: (ESI+): Calcd. for C22H21ClO3: ([M+Na]): 391.1077, Found: 391.1073; HPLC 
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(98:2 hexanes:iPrOH, Daicel CHIRALPAK IC): 96:4 er, tR (minor) = 5.7 min, tR (major) = 7.6 min; 
[]D: 76.2 (c = 0.01, CHCl3); mp: 5455 °C; TLC (EtOAc/hexane = 15/85): Rf = 0.45. 
 
Ethyl (2S,3R)-3-(3-bromophenyl)-2-hydroxy-2-
(phenylethynyl)hex-5-enoate (1.21o): The general procedure was 
employed for the coupling of 1.19o (112.3 mg, 0.36 mmol) and 
phenylacetylene (110.6 mg, 118 L, 1.08 mmol). The reaction time was 48 h, and the reaction 
temperature was 50 °C. The diastereomer ratio was determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the integration of the resonances at  
4.36 (minor diastereomer) and  4.18 (major diastereomer). The crude material was purified 
by column chromatography (EtOAc/hexanes = 5/95) to afford 100.9 mg (68%) of the title 
compound as a clear and colorless liquid: 1H NMR (600 MHz, CDCl3)  7.517.47 (m, 2 H), 
7.447.42 (m, 1 H), 7.397.32 (m, 4 H), 7.297.25 (m, 1 H), 7.15 (t, J = 7.8 Hz, 1 H),  5.59 
(app ddt, J = 17.1, 10.1, 7.0 Hz, 1 H), 5.034.99 (m, 1 H), 4.944.89 (m, 1 H), 4.214.11 (m, 
2 H), 3.71 (s, 1 H), 3.34 (dd, J = 11.9, 3.5 Hz, 1 H), 3.10 (dddd, J = 13.0, 6.7, 3.5, 1.9 Hz, 1 
H), 2.802.72 (m, 1 H), 1.27 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3)  171.3, 
140.2, 135.8, 132.8, 131.9, 130.5, 129.6, 128.9, 128.3, 128.1, 122.0, 121.9, 116.9, 87.0, 85.4, 
74.1, 63.3, 53.5, 34.3, 14.0; IR (thin film): 3481, 3078, 2980, 2937, 2228, 1737 cm–1; HRMS: 
(ESI+): Calcd. for C22H21BrO3: ([M+Na]): 435.0572, Found: 435.0568; HPLC (98:2 
hexanes:iPrOH, Daicel CHIRALPAK IC): 96:4 er, tR (minor) = 10.0 min, tR (major) = 15.3 min; 





Preparation and Characterization of Derivatized Glycolate Products 
Ethyl (S)-2-hydroxy-2-((R)-1-phenylethyl)but-3-ynoate (1.22): A flame 
dried vial was cooled under a stream of N2, and charged with 1.21j (37.0 mg, 
0.12 mmol, 1.0 equiv) and THF (1.3 mL, [1.21j]0 = 0.1 M). The solution was 
cooled to 0 °C, and a 1 M solution of tetrabutylammonium fluoride in water was added 
dropwise (146 L, 0.15 mmol, 1.2 equiv). The solution was stirred at 0 °C for 15 min, then 
quenched with saturated aqueous NH4Cl (1 mL). The solution was transferred to a separatory 
funnel, and diluted with methylene chloride (15 mL) and saturated aqueous NH4Cl (15 mL). 
The layers were separated, and the organic layer was collected. The aqueous layer was 
extracted with methylene chloride (2 × 15 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude material was purified by column 
chromatography on silica gel (EtOAc/hexanes = 5/95) to afford 16.7 mg (59%) of the title 
compound as a clear and colorless liquid: 1H NMR (600 MHz, CDCl3) 7.327.23 (m, 5 H), 
4.224.09 (m, 2 H), 3.53 (s, 1 H), 3.41 (q, J = 7.2 Hz, 1 H), 2.61 (s, 1 H), 1.60 (d, J = 7.2 Hz, 
3 H), 1.26 (app t, J = 7.1 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 171.5, 139.9, 128.7, 128.1, 
127.4, 82.1, 74.0, 73.2, 63.1, 48.1, 15.8, 13.9; IR (thin film): 3491, 3285, 2982, 2937, 1737 
cm–1; HRMS: (ESI+): Calcd. for C14H16O3: ([M+Na]): 255.0997, Found: 255.0992; TLC 
(EtOAc/hexane = 10/90): Rf = 0.3. 
 
Ethyl (R,Z)-2-hydroxy-4-phenyl-2-((R)-1-phenylethyl)but-3-enoate 
(1.23): A flame dried vial was cooled under a stream of N2, and charged with 
Ni(OAc)2•4 H2O (7.5 mg, 0.03 mmol, 30 mol %) and ethanol (0.5 mL, [Ni(OAc)2•4 H2O]0 = 
0.06 M). The blue solution was sparged with a balloon of hydrogen gas, then left to stir under 
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a fresh balloon of hydrogen gas. A freshly prepared 0.24 M solution of sodium borohydride in 
ethanol (250 L, 0.06 mmol, 0.6 equiv) was added to the solution, followed by 
ethylenediamine (6.0 mg, 7 L, 0.1 mmol, 1.0 equiv). The black reaction mixture was stirred 
under a balloon of hydrogen gas for 30 min. A 0.2 M solution of 1.21a (30.8 mg, 0.1 mmol, 
1.0 equiv) in ethanol (0.5 mL) was added to the catalyst solution dropwise. The reaction 
mixture was stirred under a balloon of hydrogen gas for 8 h. The reaction mixture was loaded 
onto a short plug of silica gel, and the plug was washed with a 40/60 mixture of EtOAc/hexanes 
(3 × 2 mL). The solution was concentrated in vacuo. The crude material was purified by column 
chromatography on silica gel (EtOAc/hexanes = 2.5/97.5 to EtOAc/hexanes = 5/95) to afford 
30.4 mg (98%) of the title compound as a clear and colorless liquid: 1H NMR (600 MHz, 
CDCl3) 7.347.19 (m, 10 H), 6.76 (d, J = 12.6 Hz, 1 H), 5.89 (d, J = 12.4 Hz, 1 H), 4.043.94 
(m, 2 H), 3.32 (q, J = 7.1 Hz, 1 H), 3.06 (s, 1 H), 1.45 (d, J = 7.2 Hz, 3 H), 1.19 (app t, J = 7.1 
Hz, 3 H); 13C NMR (151 MHz, CDCl3) 174.5, 141.3, 136.9, 133.0, 131.3, 128.8, 128.6, 
127.9, 127.7, 127.0, 80.1, 62.0, 48.1, 15.0, 14.0; IR (thin film): 3519, 3059, 3027, 2979, 1935, 
1729 cm–1; HRMS: (ESI+): Calcd. for C20H22O3: ([M+Na]): 333.1467, Found: 333.1462; 
TLC (EtOAc/hexane = 10/90): Rf = 0.45. 
 
Ethyl (R,Z)-2-hydroxy-4-phenyl-2-((R)-1-phenylethyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-enoate (1.24): A flame dried 
Schlenk tube was cooled under a stream of N2, and charged with catalyst E 
(1.0 mg, 0.002 mmol, 0.02 equiv), sodium tert-butoxide (1.2 mg, 0.012 mmol, 0.12 equiv), 
and toluene (0.5 mL). The reaction mixture was stirred under N2 for 15 min at rt. The reaction 
mixture was cooled to 0 °C, and pinacolborane (19.2 mg, 22 L, 0.15 mmol, 1.5 equiv) was 
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added, and the reaction was stirred at that temperature for 5 min. A 0.2 M solution of 1.21a 
(30.8 mg, 0.1 mmol, 1.0 equiv) in toluene (0.5 mL) was added to the catalyst solution, and the 
reaction was warmed to rt. The reaction was then stirred at 50 °C for 16 h. The reaction mixture 
was cooled to rt, and was loaded onto a short plug of silica gel. The plug was washed with 
ether (3 × 2 mL), and the solution was concentrated in vacuo. The crude material was purified 
by column chromatography on silica gel (EtOAc/hexanes = 5/95 to EtOAc/hexanes = 10/90) 
to afford 19.4 mg (44%) of the title compound as a white solid: 1H NMR (600 MHz, CDCl3) 
7.327.15 (m, 8 H), 7.117.07 (m, 2 H), 6.71 (s, 1 H), 3.92 (app q, J = 7.2 Hz, 2 H), 3.36 (q, 
J = 7.1 Hz, 1 H), 2.75 (s, 1 H), 1.40 (d, J = 7.1 Hz, 3 H), 1.321.26 (m, 12 H), 1.14 (app t, J = 
7.2 Hz, 3 H); 13C NMR (151 MHz, CDCl3) 173.9, 144.8, 141.5, 139.8, 128.7, 127.9, 127.8, 
127.5, 126.8, 126.2, 83.8, 80.9, 61.8, 47.7, 24.8, 24.6, 15.4, 13.9; IR (thin film): 3541, 2979, 
2933, 1732, 1614 cm–1; HRMS: (ESI+): Calcd. for C26H33BO5: ([M+Na]): 459.2319, Found: 
459.2315; mp: 116118 °C; TLC (EtOAc/hexane = 10/90): Rf = 0.25. 
 
Ethyl (2R,3R)-2-hydroxy-2-phenethyl-3-phenylbutanoate (1.25): A flame 
dried vial was cooled under a stream of N2, and charged with 1.21a (30.8 mg, 
0.1 mmol, 1 equiv), ethyl acetate (1 mL, [1.21a]0 = 0.1 M), and Pd/C (3.8 mg, 
10 weight % Pd). The vial was sparged with a balloon of hydrogen gas, then stirred under a 
balloon of hydrogen gas for 16 h. The reaction mixture was loaded onto a short plug of Celite, 
and the plug was washed with ethyl acetate (3 × 2 mL). The solution was concentrated in 
vacuo. The crude material was purified by column chromatography on silica gel 
(EtOAc/hexanes = 2.5/97.5 to EtOAc/hexanes = 5/95) to afford 31.0 mg (99%) of the title 
compound as a clear and colorless liquid: 1H NMR (600 MHz, CDCl3) 7.357.21 (m, 10 H), 
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4.133.97 (m, 2 H), 3.26 (s, 1 H), 3.14 (q, J = 7.1 Hz, 1 H), 2.85 (app td, J = 12.8, 2.6 Hz, 1 
H), 2.35 (app td, J = 12.7, 4.9 Hz, 1 H), 2.26 (app td, J = 12.4, 4.5 Hz, 1 H), 2.162.09 (m, 1 
H), 1.41 (d, J = 7.1 Hz, 3 H), 1.25 (app t, J = 3 H); 13C NMR (151 MHz, CDCl3) 175.7, 
142.2, 141.7, 128.4, 128.4, 128.3, 128.0, 126.9, 125.9, 79.7, 61.8, 47.1, 39.0, 30.5, 14.8, 14.1; 
IR (thin film): 3517, 3027, 2978, 2936, 1730, 1603 cm–1; HRMS: (ESI+): Calcd. for C20H24O3: 




















Procedure for the Gram Scale Enantioconvergent Terminal Alkyne Addition: A flame 
dried scintillation vial was cooled under a stream of N2, and charged with ligand C (378.2 mg, 
1.07 mmol, 0.22 equiv). The vial was transferred to a N2 filled glovebox, and charged with 
Zn(OTf)2 (363.5 mg, 0.97 mmol, 0.2 equiv). The vial was removed from the glovebox, and 
charged with phenylacetylene (800 L, 7.27 mmol, 1.5 equiv), NEt3 (340 L, 2.42 mmol, 0.5 
equiv), and toluene (800 L, 7.53 mmol, 1.55 equiv). The mixture was stirred under N2 for 30 
min to generate the active catalyst. -Keto ester 1.19a (1.00 g, 4.85 mmol, 1 equiv) was then 
added to the solution, and the solution was stirred at 40 °C for 24 h. The crude material was 
purified by column chromatography on silica gel (EtOAc/hexanes = 2.5/97.5 to 
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Palladium-Catalyzed β-Arylation of α-Keto Esters* 
 
2.1 Motivation 
 In the previous chapter, access to certain classes of -keto ester substrates was limited 
due to the few broadly applicable methods to synthesize -stereogenic -keto esters.1 
Specifically, substrates containing -substitution and heterocyclic aromatic groups were 
inaccessible, and the analogous tert-butyl esters required lengthy and indirect sequences to 
synthesize. Many known methods for the generation of -keto esters were tested in an attempt 
to broaden the number of viable substrates for the acetylide addition described in Chapter One. 
For example, obtaining heterocyclic substrates proved to be particularly challenging. A broad 
survey of oxidants failed to convert pyridinyl glycolate 2.1 to desired -heterocyclic -keto 
ester 2.2, proving the difficulty of arriving at these products (Scheme 2-1). At this juncture, 
we began to consider new methodologies for the construction of these compounds.  




                                                          
*Reprinted with permission from Zavesky, B. P.; Bartlett, S. L.; Johnson, J. S. Org. Lett. 2017, 




 The synthesis of -keto acids and their derivatives has garnered substantial attention 
due to their importance in biochemistry2,3 and natural product synthesis.4–7 Furthermore, this 
versatile functional group can serve as a precursor for substituted glycolate products and -
amino acid derivatives via the enantioselective transfer hydrogenation of -imino esters8 or 
transamination of -keto esters.9 The latter constitutes an area of substantial interest.10,11,20,12–
19 Chiral -aryl -keto esters are useful electrophiles in dynamic kinetic resolution (DKR) 
reactions, including Ru-catalyzed asymmetric transfer hydrogenation reactions16,17 and Rh-
catalyzed enantioconvergent arylation reactions (Scheme 2-2A).21 These reactions allow for 
the construction of complex, stereochemically defined glycolate products from racemic 
starting materials. Unfortunately, current methods to prepare these substrates have some 
limitations that have hampered efforts to fully explore the scope of these projects.22 For 
example, the sequence of Lewis acid-catalyzed alkylation of active methylene compounds with 
benzylic alcohols23,24 and subsequent aerobic deacylation used by our lab to access -aryl -
keto esters has proven to be intolerant of tert-butyl esters, bulky -alkyl substituents, and 
electron-poor, hindered, or heterocyclic aryl groups (Scheme 2-2B). While other methods for 









Scheme 2-2 Aryl eto Esters: Synthetic Utility and Preparation 
 
 To gain entry to a wider array of -aryl -keto esters, we considered the development 
of a palladium catalyzed -arylation reaction of n-alkyl -keto esters.27,28 Formation of a 
carbon-carbon bond by utilizing the acidic nature of -keto esters would constitute an 
underutilized consonant disconnection of these compounds. Additionally, if successful, this 
method would allow for a variety of electronically diverse -aryl -keto esters to be generated 
from a single, easily accessible substrate. 
 Since the first example of a carbonyl enolate arylation reaction, reported in 1973 by 
Semmelhack and coworkers,29 the scope of this reaction has been dramatically expanded. The 
reaction has grown to include the use of ketones, aldehydes, amides, esters, amino acids, 
nitriles, and activated methylene compounds as enolate substrates.30–34 We were especially 
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encouraged by the widespread use of tetralones in -arylation reactions,35–44 a class of 
compounds which should have acidities similar to -keto esters. However, n-alkyl -keto 
esters present a unique set of challenges. A slow reductive elimination from a Pd-enolate 
species could lead to competitive -hydride elimination.45 Furthermore, our laboratory has 
observed that -keto esters with enolizable protons decompose in basic media.   
2.3 Optimization Studies 
 With all of these considerations in mind, we set out to explore the Pd-catalyzed -
arylation reaction of n-alkyl -keto esters. tert-Butyl -keto ester 2.3a (Table 2-1) was chosen 
as a model substrate in hopes that the steric effects of the bulky ester would disfavor the 
competitive Claisen condensation reaction, which was never observed using the shown 
conditions. We first chose to probe the effect of the supporting ligand, beginning with the 
electron rich and sterically hindered ligand tricyclohexylphosphine (entry 1), shown previously 
to be an effective ligand in Pd-catalyzed enolate arylation reactions.46 When no appreciable 
quantity of desired coupled product 2.5a was obtained, we moved on to the more sterically 
encumbered ligand cataCXium A®, which delivered keto ester 2.5a in reasonable yield (entry 
2). Encouraged by this result, we switched to the Buchwald-type ligand DavePhos (entry 3), 
which is also well-precedented to work in this reaction type.47 When a slight decrease in yield 
was observed, we took inspiration from Hartwig’s arylation of malonate derivatives,48 
employing tri-tert-butylphosphine. This ligand provided product 2.5a in an isolated yield of 
85% (entry 4). The disparity between this isolated yield and the pristine 1H NMR spectrum of 
the crude reaction mixture led us to believe that some base promoted decomposition to 
intractable materials was occurring. Taking this into consideration, we sought to find a more 
optimal base, and found that the less basic potassium carbonate improved the isolated yield of 
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the reaction to 95% (entry 6). Halving the catalyst loading resulted in a slightly diminished 
yield (entry 7). 











aReaction conditions: 1.0 equiv of 2.3a, 2.0 equiv of 2.4a, 3.0 equiv of base, 2 mol % Pd2dba3, 
8 mol % ligand, 110 °C, PhMe ([2.3a]0 = 0.2 M), 12 h. 
bReaction conducted with 1 mol % 






































































2.4 Scope of Arylation Reaction 
 With optimal conditions in hand, we next turned to analyzing the scope of the Pd-
catalyzed cross-coupling reaction (Table 2-2). First, a variety of aryl bromides were tested. 
Both electron-rich and electron-poor aryl groups gave excellent results. For instance, -keto 
esters 2.5c and 2.5d, which would have been difficult compounds to access using our previous 
routes (vide supra), were obtained in excellent yields. The reaction also tolerated various types 
of aryl groups, allowing the synthesis of products with meta-substituents (2.5e) and ortho-
substituents (2.5f). Of particular interest to us was the use of heterocyclic aryl bromides. We 
were pleased to find that 3-bromopyridine and unprotected 5-bromoindole proved to be viable 
coupling partners (2.5g and 2.5h). The use of alkenyl halides resulted in decomposition of the 
starting materials. 
 In addition to the parent substrate 2.3a, other -keto esters were evaluated in the enolate 
arylation reaction. As seen with product 2.5j, this method allowed facile entry to keto esters 
with bulky -alkyl substituents. Additionally, decreasing the size of the -alkyl substituent did 
not significantly decrease yields (2.5k). Finally, in order to test the chemoselectivity of this 
reaction, a substrate containing both an ester and an -keto ester was tested. Product 2.5l was 
generated without any noticeable formation of a bis-arylated product, highlighting the gentle 
nature of these reaction conditions. When -disubstituted -keto esters were used in this 
reaction, decomposition of the starting materials and low conversion to the tertiary -






Table 2-2 Scope of -Keto Ester Enolate Arylation Reactiona 
 
aReaction conditions: 1.0 equiv of 2.3, 2.0 equiv of 2.4, 3.0 equiv of K2CO3, 2 mol % Pd2dba3, 
8 mol % PtBu3, PhMe (0.2 M), 110 °C, 12 h. 
bReaction gave 69% yield when scale was 
increased to 2.7 mmol. cReaction conducted on 1 g scale. 
 
2.5 Synthetic Utility 
 The syntheses of products 2.5k (Table 2-2) and 2.5g (Scheme 2-3A) were 
accomplished on one-gram scale with yields almost identical to those obtained in experiments 
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on a smaller scale. Furthermore, the reaction could be carried out without the use of a glovebox 
when PtBu3•HBF4 was used in place of the air sensitive P
tBu3 (Scheme 2-3B).
49 The latter can 
be synthesized in house from cheap starting materials.50 
Scheme 2-3 Practical Considerations Associated with the Title Reaction 
 
aPd2(dba)3, P
tBu3•HBF4, K2CO3, and PhMe were mixed for 2 h prior to addition of 2.3a and 




 In conclusion, we have developed a Pd-catalyzed -arylation reaction of -keto esters 
that allows for the generation of a wide array of aryl pyruvate derivatives. These reactions 
typically proceed in excellent yield, and provide access to previously inaccessible β-heteroaryl 
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2.8 Experimental Details 
Methods  
General: Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform infrared 
spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were 
recorded on a Bruker model Avance 400 (19F NMR at 376 MHz), Bruker Avance III 500 (1H 
NMR at 500 MHz), or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 151 
MHz) spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 
ppm; 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, br s = broad singlet, d = doublet, br d = broad doublet, t = triplet, app 
t = apparent triplet, q = quartet, m = multiplet), coupling constants (Hz), and integration. Mass 
spectra were obtained using a Thermo LTqFT mass spectrometer with electrospray 
introduction and external calibration. All samples were prepared in methanol. Analytical thin 
layer chromatography (TLC) was performed on Sorbent Technologies 0.20 mm Silica Gel TLC 
plates. Visualization was accomplished with UV light, KMnO4, and/or Seebach’s stain (2.5 g 
phosphomolybdic acid, 1.0 g Ce(SO4)2, 6.0 mL conc. H2SO4, 94 mL H2O) followed by heating. 
Purification of the reaction products was carried out by flash column chromatography using 
Siliaflash-P60 silica gel (40-63μm) purchased from Silicycle. Unless otherwise noted, all 
reactions were carried out under an atmosphere of dry nitrogen in flame-dried glassware with 
magnetic stirring. Yield refers to isolated yield of pure material unless otherwise noted. Yields 
are reported for a specific experiment and as a result may differ slightly from those found in 






General: Tetrahydrofuran (THF), diethyl ether (Et2O), methylene chloride (CH2Cl2), and 
toluene (PhMe) were dried by passage through a column of neutral alumina under nitrogen 
prior to use. Tri-tert-butylphosphonium tetrafluoroborate,50 2.3i,51 and 2.3l52 and were 






















Preparation and Characterization of -Keto Ester Substrates 
General Procedure for the Synthesis –Keto Ester Substrates: The addition of Grignard 
reagents to di-tert-butyl oxalate is a modification of a procedure published by Sodeoka.51 A 
flame-dried 2-neck round-bottomed flask equipped with a stirbar and reflux condenser was 
cooled under a stream of N2, and charged with magnesium turnings (1.9 equiv), a crystal of 
iodine, and enough THF to cover the magnesium turnings. A small portion of the alkyl bromide 
(typically less than 0.1 equiv) was then added dropwise until the yellow color of the reaction 
mixture turned to clear and colorless, indicating initiation of the Grignard reagent. Additional 
THF was added to the mixture ([magnesium turnings]0 = 1.5 M), and the rest of the alkyl 
bromide (1.8 equiv in total) was added dropwise, while maintaining a gentle reflux. The 
reaction mixture was stirred for 1 h at rt. A separate flame-dried round-bottomed flask 
equipped with a stirbar was cooled under a stream of N2, and charged with di-tert-butyl oxalate 
(1.0 equiv), and a 5:3 mixture of methylene chloride:THF (to give a solution with [di-tert-butyl 
oxalate] = 0.37 M). The solution was cooled to -78 °C, and the solution of Grignard reagent 
was added to it dropwise. The reaction mixture was stirred for 4 h at -78 °C, then quenched 
with saturated aqueous NH4Cl (3 mL/mmol substrate) and diluted with methylene chloride (1.5 
mL/mmol substrate). The biphasic mixture was added to a separatory funnel, and the layers 
were separated. The aqueous layer was extracted with methylene chloride (2 × 3 mL/mmol 
substrate). The combined organic extracts were dried over Na2SO4, and concentrated in vacuo. 




tert-Butyl 2-oxo-4-phenylbutanoate (2.3a): The general procedure was 
employed for the reaction of (2-bromoethyl)benzene (2.5 mL, 18.0 mmol) 
and di-tert-butyl oxalate (2.20 g, 10.0 mmol). The crude material was purified by column 
chromatography (methylene chloride/hexane = 30/70 to 70/30) to afford 2.34 g (57%) of the 
title compound as a white solid. Spectroscopic properties were identical to those previously 
reported:51 1H NMR (400 MHz, CDCl3) δ 7.32–7.25 (m, 2 H), 7.23–7.18 (m, 3 H), 3.12 (t, J 
= 8.0 Hz, 2 H), 2.94 (t, J = 7.6 Hz, 2 H), 1.53 (s, 9 H). 
 
tert-Butyl 2-oxo-4-phenylbutanoate (2.3k): The general procedure was 
employed for the reaction of bromoethane (4.0 mL, 54.0 mmol) and di-tert-
butyl oxalate (6.07 g, 30.0 mmol). The crude material was purified by column chromatography 
(methylene chloride/hexane = 30/70 to 70/30) to afford 4.75 g (44%) of the title compound as 
a clear and colorless liquid. Spectroscopic properties were identical to those previously 
reported:51 1H NMR (400 MHz, C6D6) δ 2.36 (q, J = 7.2 Hz, 2 H), 1.28 (s, 9H), 0.81 (t, J = 7.3 
Hz, 3H). 
 
tert-Butyl 4-methyl-2-oxopentanoate (2.3j): A flame-dried round-
bottomed flask equipped with a stirbar was cooled under a stream of N2, 
and charged with ethyl 4-methyl-2-oxopentanoate53 (4.51 g, 28.5 mmol, 1.0 equiv), methanol 
(91 mL, 0.31 M), and water (30 mL, 0.94 M). Powdered KOH (9.60 g, 171.0 mmol, 6.0 equiv) 
was added to the solution portion-wise in order to control the resulting exotherm. The solution 
was stirred for 30 min at rt before being concentrated in vacuo to remove the methanol. The 
reaction mixture was cooled to 0 °C, then diluted with concentrated HCl until pH = 1 was 
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reached. The mixture was diluted with methylene chloride (40 mL), and added to a separatory 
funnel. The layers were separated, and the aqueous layer was extracted with methylene 
chloride (2 × 40 mL). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo to afford the crude carboxylic acid intermediate.  
The crude carboxylic acid, methylene chloride (57 mL, [carboxylic acid]0 = 0.5 M), and DMF 
(44 μL, 0.6 mmol, 0.02 equiv) were added to a flame-dried round-bottom flask equipped with 
a stirbar. The solution was cooled to 0 °C, and oxalyl chloride (4.9 mL, 57.0 mmol, 2.0 equiv) 
was added dropwise at a rate such that gas evolution was controlled. The solution was warmed 
to rt slowly overnight. The solution was then concentrated in vacuo, taking care to ensure that 
all residual oxalyl chloride was removed.  
The crude acid chloride was dissolved in methylene chloride (43 mL, [acid chloride]0 = 0.67 
M) and cooled to 0 °C. tert-Butyl alcohol (5.4 mL, 57.0 mmol, 2.0 equiv) was added dropwise 
to the solution. Pyridine (2.3 mL, 28.5 mmol, 1.0 equiv) was added dropwise to the solution. 
The solution was stirred at 0 °C for 6 h, after which time it was quenched by water (30 mL). 
The biphasic mixture was added to a separatory funnel, and the layers were separated. The 
aqueous layer was extracted with methylene chloride (2 × 30 mL). The combined organic 
extracts were dried over Na2SO4, and concentrated in vacuo. Purification by column 
chromatography on silica gel (EtOAc/hexane = 2.5/97.5) afforded 1.98 g (37% over 3 steps) 
of the title compound as a clear and colorless liquid.54 Analytical data for 2.3j: 1H NMR (400 
MHz, CDCl3) δ 2.64 (d, J = 6.8 Hz, 2 H), 2.21-2.12 (m, 1 H), 1.54 (s, 9 H), 0.96 (d, J = 6.7 
Hz, 6 H); 13C NMR (151 MHz, CDCl3) δ 195.5, 160.9, 83.8, 47.7, 27.8, 24.2, 22.5; IR (thin 
film): 2962, 2936, 2874, 1722.1, 1395, 1272, 1138, 1052 cm–1; HRMS: (ESI+): Calcd. for 
C10H18O3: ([M+Na]): 209.1154, Found: 209.1145. TLC (EtOAc/hexane = 10/90): Rf = 0.5. 
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Preparation and Characterization of –Aryl –Keto Ester Products  
General Procedure for the Pd-Catalyzed Arylation of –Keto Ester Enolates: A flame-
dried 1-dram vial was cooled under a stream of N2, and charged with the appropriate –keto 
ester (0.2 mmol, 1.0 equiv) and aryl halide (0.4 mmol, 2.0 equiv). This vial and a separate 
flame-dried 1-dram vial equipped with a stirbar were transferred to a N2-filled glovebox. The 
vial equipped with only a stirbar was charged with Pd2(dba)3 (0.004 mmol, 0.02 equiv), a 1.0 
M solution of PtBu3 in toluene (0.016 mmol, 0.08 equiv), and K2CO3 (0.6 mmol, 3.0 equiv). 
To the 1-dram vial containing the –keto ester and aryl halide was added toluene (1 mL, [–
keto ester ]0 = 0.2 M). This solution was transferred to the 1-dram vial containing the base and 
catalyst. The vial was capped with a red PTFE/silicone cap, removed from the N2 filled 
glovebox, and heated at 110 °C (external oil bath temperature) for 12 h. The reaction mixture 
was transferred to a separatory funnel filled with methylene chloride (50 mL/mmol substrate) 
and saturated aqueous NH4Cl (50 mL/mmol substrate). The 1-dram vial was washed with 
methylene chloride (2 × 5 mL/mmol substrate), saturated aqueous NH4Cl (1 x 5 mL/mmol 
substrate), and methylene chloride (2 × 5 mL/mmol substrate). The layers were separated, and 
the aqueous layer was extracted with methylene chloride (2 × 50 mL/mmol substrate). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The 
crude material was purified by column chromatography on silica gel.  
 
tert-Butyl 2-oxo-3,4-diphenylbutanoate (2.5a): The general procedure 
was employed for the coupling of 2.3a (46.9 mg, 0.2 mmol) and 
bromobenzene (62.8 mg, 42 μL, 0.4 mmol). The crude material was 
purified by column chromatography (EtOAc/hexanes = 1/99 to 2.5/97.5) to afford 62.0 mg 
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(99%) of the title compound as an off-white amorphous solid: 1H NMR (400 MHz, CDCl3) δ 
7.32–7.14 (m, 8 H), 7.07–7.02 (m, 2 H), 4.55 (app t, J = 7.4 Hz, 1 H), 3.44 (dd, J = 13.9, 6.9 
Hz, 1 H), 2.96 (dd, J = 13.9, 7.9 Hz, 1 H), 1.31 (s, 9 H); 13C NMR (151 MHz, CDCl3) δ 193.9, 
160.4, 138.8, 135.9, 129.1, 128.8, 128.2, 127.6, 126.2, 84.0, 56.2, 37.6, 27.5; IR (thin film): 
2981, 2932, 1742, 1722, 1455, 1160 cm–1; HRMS: (ESI+): Calcd. for C20H22O3: ([M+Na]): 
333.1467, Found: 333.1453. TLC (EtOAc/hexane = 10/90): Rf = 0.45.  
 
tert-Butyl 3-(4-methoxyphenyl)-2-oxo-4-phenylbutanoate (2.5b): The 
general procedure was employed for the coupling of 2.3a (46.9 mg, 0.2 
mmol) and 1-bromo-4-methoxybenzene (74.8 mg, 50 μL, 0.4 mmol). The 
crude material was purified by column chromatography (EtOAc/hexanes 
= 2.5/97.5 to 5/95) to afford 65.3 mg (96%) of the title compound as a light-yellow amorphous 
solid. Analytical data for 2.5b: 1H NMR (400 MHz, CDCl3) δ 7.23–7.10 (m, 3 H), 7.07–7.01 
(m, 4 H), 6.84–6.79 (m, 2 H), 4.51 (app t, J = 7.4 Hz, 1 H), 3.78 (s, 3 H), 3.40 (dd, J = 13.9, 
6.8 Hz, 1 H), 2.94 (dd, J = 13.9, 8.1 Hz, 1 H), 1.34 (s, 9 H); 13C NMR (151 MHz, CDCl3) δ 
193.8, 160.6, 159.0, 138.9, 130.2, 129.1, 128.2, 127.6, 126.2, 114.2, 83.9, 55.2, 55.2, 37.6, 
27.6; IR (thin film): 2980, 2934, 2837, 1721, 1609, 1511, 1253 cm–1; HRMS: (ESI+): Calcd. 




(2.5c): The general procedure was employed for the coupling of 2.3a (46.9 
mg, 0.2 mmol) and methyl 4-bromobenzoate (86.0 mg, 0.4 mmol). The 
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crude material was purified by column chromatography (EtOAc/hexanes = 2.5/97.5 to 5/95) 
to afford 70.5 mg (96%) of the title compound as an off-white amorphous solid. Analytical 
data for 2.5c: 1H NMR (400 MHz, CDCl3) δ 7.98–7.93 (m, 2 H), 7.22–7.11 (m, 5 H), 7.03–
6.99 (m, 2 H), 4.63 (dd, J = 8.4, 6.6 Hz, 1 H), 3.90 (s, 3 H), 3.43 (dd, J = 13.9, 6.6 Hz, 1 H), 
2.97 (dd, J = 13.9, 8.4 Hz, 1H), 1.33 (s, 9 H); 13C NMR (151 MHz, CDCl3) δ 193.3, 166.6, 
159.9, 141.2, 138.1, 130.0, 129.4, 129.1, 129.0, 128.3, 126.4, 84.4, 56.1, 52.2, 37.7, 27.5; IR 
(thin film): 2981, 2953, 1723, 1608, 1282, 1112 cm–1; HRMS: (ESI+): Calcd. for C22H24O5: 
([M+Na]): 391.1522, Found: 391.1510. TLC (EtOAc/hexane = 10/90): Rf = 0.3. 
 
tert-Butyl 2-oxo-4-phenyl-3-(4-(trifluoromethyl)phenyl)butanoate 
(2.5d): The general procedure was employed for the coupling of 2.3a (46.9 
mg, 0.2 mmol) and 1-bromo-4-(trifluoromethyl)benzene (90.0 mg, 55 μL, 
0.4 mmol). The crude material was purified by column chromatography 
(column 1: EtOAc/hexanes = 1/99 to 2.5/97.5, column 2: methylene chloride) to afford 74.5 
mg (98%) of the title compound as an off-white amorphous solid. Analytical data for 2.5d: 1H 
NMR (600 MHz, CDCl3) δ 7.55 (d, J = 8.1 Hz, 2 H), 7.27 (d, J = 8.0 Hz, 2 H), 7.24–7.19 (m, 
2 H), 7.19–7.15 (m, 1 H), 7.05–7.01 (m, 2 H), 4.67 (dd, J = 8.2, 6.8 Hz, 1 H), 3.44 (dd, J = 
13.9, 6.8 Hz, 1 H), 2.97 (dd, J = 13.9, 8.2 Hz, 1 H), 1.35 (s, 9H); 13C NMR (151 MHz, CDCl3) 
δ 193.3, 159.9, 140.2 (d, J13C-19F = 1.7 Hz), 138.0, 129.9 (q, J13C-19F  = 32.4 Hz), 129.3, 129.0, 
128.4, 126.5, 125.7 (q, J13C-19F  = 3.9 Hz), 123.9 (q, J13C-19F  = 270.3 Hz), 84.5, 55.8, 37.8, 27.5; 
IR (thin film): 2982, 2935, 1723, 1327, 1165, 1126, 1068 cm–1; HRMS: (ESI+): Calcd. for 




tert-Butyl 3-(3,5-dimethylphenyl)-2-oxo-4-phenylbutanoate (2.5e): 
The general procedure was employed for the coupling of 2.3a (46.9 mg, 
0.2 mmol) and 1-bromo-3,5-dimethylbenzene (74.0 mg, 54 μL, 0.4 mmol). 
The crude material was purified by column chromatography (EtOAc/hexanes = 2.5/97.5) to 
afford 66.8 mg (99%) of the title compound as an off-white amorphous solid. Analytical data 
for 2.5e: 1H NMR (400 MHz, CDCl3) δ 7.24–7.13 (m, 3 H), 7.19–7.15 (m, 1 H), 7.12–7.06 
(m, 2 H), 6.88 (s, 1 H), 6.76 s, 2 H) 4.50 (app t, J = 7.3 Hz, 1 H), 3.43 (dd, J = 14.0, 7.6 Hz, 1 
H), 2.94 (dd, J = 13.9, 7.1 Hz), 2.26 (s, 6 H), 1.32 (s, 9 H); 13C NMR (151 MHz, CDCl3) δ 
193.9, 160.5, 139.1, 138.3, 135.7, 129.3, 129.1, 128.2, 126.8, 126.2, 83.8, 56.0, 37.5, 27.5, 
21.2; IR (thin film): 2980, 2921, 1743, 1722, 1160, 700 cm–1; HMRS: (ESI+): Calcd. for 
C22H26O3: ([M+Na]): 361.1780, Found: 361.1765. TLC (EtOAc/hexane = 10/90): Rf = 0.45.  
 
tert-Butyl 3-(naphthalen-1-yl)-2-oxo-4-phenylbutanoate (2.5f): The 
general procedure was employed for the coupling of 2.3a (46.9 mg, 0.2 
mmol) and 1-bromonaphthalene (82.8 mg, 56 μL, 0.4 mmol). The crude 
material was purified by column chromatography (EtOAc/hexanes = 2.5/97.5) to afford 65.2 
mg (89%) of the title compound as a light-yellow liquid. Analytical data for 2.5f: 1H NMR 
(400 MHz, CDCl3) δ 8.01–7.95 (m, 1 H), 7.88–7.82 (m, 1 H), 7.78 (d, J = 8.2 Hz, 1 H), 7.52–
7.45 (m, 2 H), 7.44–7.38 (m, 1 H), 7.20–7.10 (m, 6 H), 5.33–5.23 (m, 1 H), 3.60 (dd, J = 13.9, 
7.6 Hz, 1 H), 3.04 (dd, J = 13.9, 6.4 Hz, 1 H), 1.04 (s, 9 H); 13C NMR (151 MHz, CDCl3) δ 
194.0, 160.3, 139.2, 134.1, 133.0, 131.5, 129.1, 128.9, 128.4, 128.3, 126.5, 126.3, 125.9, 
125.4, 123.2, 83.8, 51.9, 37.7, 27.2; IR (thin film): 3061, 3029, 2980, 2932, 1742, 1724, 1153 
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cm–1; HRMS: (ESI+): Calcd. for C24H24O3: ([M+Na]): 383.1623, Found: 383.1608. TLC 
(EtOAc/hexane = 10/90): Rf = 0.5. 
 
tert-Butyl 2-oxo-4-phenyl-3-(pyridin-3-yl)butanoate (2.5g): The 
general procedure was employed for the coupling of 2.3a (46.9 mg, 0.2 
mmol) and 3-bromopyridine (63.2 mg, 39 μL, 0.4 mmol). The crude 
material was purified by column chromatography (EtOAc/hexanes = 20/80 to 30/70) to afford 
58.6 mg (94%) of the title compound as a light-yellow amorphous solid, existing as a 93:7 
mixture of ketone:enol tautomers. Analytical data for 2.5g: 1H NMR (400 MHz, CDCl3) δ 8.52 
(d, J = 4.8 Hz, 1 H), 8.41 (s, 1 H), 7.53–7.48 (m, 1 H), 7.30–7.14 (m, 4 H), 7.07–7.02 (m, 2 
H), 4.65 (dd, J = 8.4, 6.7 Hz, 1 H), 3.46 (dd, J = 13.9, 6.7 Hz, 1 H), 2.99 (dd, J = 13.9, 8.4 Hz, 
1 H) 1.38 (s, 9 H); 13C NMR (151 MHz, CDCl3) δ 193.3, 159.8, 150.5, 148.9, 137.8, 136.0, 
132.0, 129.0, 128.5, 126.6, 123.6, 84.6, 53.4, 37.7, 27.6; IR (thin film): 3061, 3030, 2980, 
2933, 1723 cm–1; HRMS: (ESI+): Calcd. for C19H21NO3: ([M+H
+]): 312.1600, Found: 
312.1597. TLC (EtOAc/hexane = 30/70): Rf = 0.3. 
 
tert-Butyl 3-(1H-indol-5-yl)-2-oxo-4-phenylbutanoate (2.5h): The 
general procedure was employed for the coupling of 2.3a (46.9 mg, 0.2 
mmol) and 5-bromo-1H-indole (78.4 mg, 0.4 mmol). The crude material 
was purified by column chromatography (EtOAc/hexanes = 10/90 to 
15/85) to afford 52.5 mg (75%) of the title compound as an off-white amorphous solid. 
Analytical data for 2.5h: 1H NMR (400 MHz, CDCl3) δ 8.16 (br s, 1 H), 7.43 (s, 1 H), 7.30 (d, 
J = 8.4 Hz, 1 H), 7.22–7.06 (m, 6 H), 6.98–6.94 (m, 1 H), 6.51–6.47 (m, 1 H), 4.66 (app t, J = 
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7.4 Hz, 1 H), 3.50 (d, J = 13.9, 7.1 Hz, 1 H), 3.04 (d, J = 13.9, 7.6 Hz, 1 H), 1.28 (s, 9 H); 13C 
NMR (151 MHz, CDCl3) δ 194.1, 160.8, 139.4, 135.2, 129.1, 128.2, 128.2, 126.8, 126.1, 
124.8, 123.2, 121.4, 111.4, 102.6, 83.7, 56.1, 37.9, 27.5; IR (thin film): 3420 (br), 2980, 2931, 
1723, 1156, 1091 cm–1; HRMS: (ESI+): Calcd. for C22H23NO3: ([M+Na]): 372.1576, Found: 
372.1561. TLC (EtOAc/hexane = 20/80): Rf = 0.35. 
 
tert-butyl 4-(4-methoxyphenyl)-2-oxo-3-phenylbutanoate 
(2.5i): The general procedure was employed for the coupling of 
2.3i (52.9 mg, 0.2 mmol) and bromobenzene (62.8 mg, 42 μL, 0.4 
mmol). The crude material was purified by column chromatography (EtOAc/hexanes = 
2.5/97.5 to 5/95) to afford 57.9 mg (85%) of the title compound as a light-yellow liquid. 
Analytical data for 2.5i: 1H NMR (400 MHz, CDCl3) δ 7.31–7.22 (m, 3 H), 7.15–7.11 (m, 2 
H), 6.96 (d, J = 8.6 Hz, 2 H), 6.74 (d, J = 8.6 Hz, 2 H), 4.51 (app t, J = 7.4 Hz, 1 H), 3.75 (s, 3 
H), 3.37 (dd, J = 14.0, 6.9 Hz, 1 H), 2.91 (dd, J = 14.0, 7.9 Hz, 1 H), 1.32 (s, 9 H); 13C NMR 
(151 MHz, CDCl3) δ 194.0, 160.4, 158.0, 136.0, 130.8, 130.0, 129.1, 128.8, 127.6, 113.6, 83.9, 
56.5, 55.1, 36.8, 27.5; IR (film) 2980, 2934, 2836, 1722, 1513, 1248.7 cm–1; HRMS: (ESI+): 
Calcd. for C21H24O4: ([M+Na]): 363.1573, Found: 363.1818. TLC (EtOAc/hexane = 10/90): 
Rf = 0.35. 
 
tert-Butyl 4-methyl-2-oxo-3-phenylpentanoate (2.5j): The general 
procedure was employed for the coupling of 2.3j (37.3 mg, 0.2 mmol) and 
bromobenzene (62.8 mg, 42 μL, 0.4 mmol). The crude material was 
purified by column chromatography (EtOAc/hexanes = 1/99 to 2.5/97.5) to afford 47.3 mg 
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(90%) of the title compound as a clear, colorless liquid. Analytical data for 2.5j: 1H NMR (400 
MHz, CDCl3) δ 7.36–7.24 (m, 3 H), 7.23–7.18 (m, 2 H), 4.03 (d, J = 9.8 Hz, 1 H), 2.52–2.39 
(m, 1 H), 1.39 (s, 9 H), 1.04 (d, J = 6.5 Hz, 3 H), 0.74 (d, J = 6.7 Hz, 3 H); 13C NMR (151 
MHz, CDCl3) δ 194.6, 160.8, 135.5, 129.6, 128.7, 127.5, 83.8, 61.6, 29.8, 27.6, 21.5, 20.1; IR 
(thin film): 2977, 2935, 2873, 1742, 1724, 1370, 1256 cm–1; HRMS: (ESI+): Calcd. for 
C16H22O3: ([M+Na]): 285.1467, Found: 285.1454. TLC (EtOAc/hexane = 10/90): Rf = 0.55.  
 
tert-butyl 2-oxo-3-(pyridin-3-yl)butanoate (2.5k): The general procedure 
was employed for the coupling of 2.3k (31.6 mg, 0.2 mmol) and 3-
bromopyridine (63.2 mg, 39 μL, 0.4 mmol). The crude material was purified 
by column chromatography (EtOAc/hexanes = 30/70 to 40/60) to afford 37.9 mg (81%) of the 
title compound as a light-yellow amorphous solid. Analytical data for 2.5k. 1H NMR (400 
MHz, CDCl3) δ 8.55–8.51 (m, 2 H), 7.55–7.50 (m, 1 H), 7.30–7.25 (m, 1 H), 4.42 (q, J = 7.0 
Hz, 1 H), 1.48 (d, J = 7.1 Hz, 3 H), 1.39 (s, 9 H); 13C NMR (151 MHz, CDCl3) δ 194.3, 160.3, 
150.1, 148.8, 135.5, 134.0, 123.7, 84.5, 46.0, 27.6, 16.7; IR (thin film): 2981, 2936, 1723, 
1576, 1479, 1455 cm–1; HRMS: (ESI+): Calcd. for C13H17NO3: ([M+H
+]): 236.1287, Found: 
236.1282. TLC (EtOAc/hexane = 30/70): Rf = 0.2. 
 
Di-tert-butyl 2-oxo-3-phenylpentanedioate (2.5l): The general 
procedure was employed for the coupling of 2.3l (51.7 mg, 0.2 mmol) 
and bromobenzene (62.8 mg, 42 μL, 0.4 mmol). The crude material 
was purified by column chromatography (column 1: EtOAc/hexanes = 1/99 to 2.5/97.5, 
column 2: EtOAc/hexanes = 1/99 to 2.5/97.5) to afford 56.9 mg (85%) of the title compound 
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as a clear and colorless liquid. Analytical data for 2.5l. 1H NMR (500 MHz, CDCl3) δ 7.36–
7.26 (m, 3 H), 7.24–7.17 (m, 2 H), 4.79 (dd, J = 9.5, 5.6 Hz, 1 H), 3.12 (dd, J = 16.8, 9.5 Hz, 
1 H), 2.61 (dd, J = 16.8, 5.7 Hz, 1 H), 1.41 (s, 9 H), 1.38 (s, 9 H); 13C NMR (151 MHz, CDCl3) 
δ 193.1, 170.5, 159.8, 135.2, 129.0, 128.9, 127.9, 84.0, 81.1, 50.2, 37.7, 27.9, 27.6; IR (thin 
film): 2980, 2933, 1727, 1369, 1255, 1157 cm–1; HRMS: (ESI+): Calcd. for C19H26O5: 



















Procedure for the Gram Scale Pd-Catalyzed Arylation: A flame-dried 150 mL pressure 
vessel equipped with a stirbar was cooled under a stream of N2, and charged with 2.3a (1.00 
g, 4.27 mmol, 1.0 equiv) and 3-bromopyridine (1.35 g, 820 μL, 8.54 mmol, 2.0 equiv). The 
vessel was transferred to a N2 filled glovebox. The vessel was then charged with Pd2(dba)3 (78 
mg, 0.09 mmol, 0.02 equiv), a 1.0 M solution of PtBu3 in toluene (340 μL, 0.34 mmol, 0.08 
equiv), K2CO3 (1.77 g, 12.8 mmol, 3.0 equiv), and toluene (21 mL, [2.3a]0 = 0.2 M). The vessel 
was capped, removed from the N2 filled glovebox, and heated at 110 °C (external oil bath 
temperature) for 12 h. The reaction mixture was transferred to a separatory funnel filled with 
diethyl ether (30 mL) and saturated aqueous NH4Cl (30 mL). The pressure vessel was washed 
with diethyl ether (2 × 5 mL), saturated aqueous NH4Cl (1 × 5 mL), and diethyl ether (2 × 5 
mL). The layers were separated, and the aqueous layer was extracted with diethyl ether (2 × 
40 mL). The organic extracts were combined, washed with brine, dried over Na2SO4, filtered, 
and concentrated in vacuo. The crude material was purified by column chromatography on 
silica gel (EtOAc/hexanes = 20/80 to 30/70) to afford 1.33 g (90%) of 2.5g as a white 










Procedure for the Air-Tolerant Pd-Catalyzed Arylation: A flame-dried 1-dram vial was 
cooled under a stream of N2, and charged with Pd2(dba)3 (3.7 mg, 0.004 mmol, 0.02 equiv), 
tri-tert-butylphosphonium tetrafluoroborate (4.6 mg, 0.016 mmol, 0.08 equiv), K2CO3 (83 mg, 
0.6 mmol, 3.0 equiv), and toluene (1 mL, [K2CO3]0 = 0.6 M). The reaction mixture was purged 
under a stream of N2, capped with a red PTFE/silicone cap, and stirred at rt for 2 h. The cap 
was removed, and the vial was charged with 2.3a (47 mg, 0.2 mmol, 1.0 equiv) and 
bromobenzene (62.8 mg, 42 μL, 0.4 mmol, 2.0 equiv). The reaction mixture was purged under 
a stream of N2, capped, and stirred at 110 °C (external oil bath temperature) for 12 h. The 
reaction mixture was transferred to a separatory funnel filled with methylene chloride (20 mL) 
and saturated aqueous NH4Cl (20 mL). The 1-dram vial was washed with methylene chloride 
(2 × 1 mL), saturated aqueous NH4Cl (1 × 1 mL), and methylene chloride (2 × 1 mL). The 
layers were separated, and the aqueous layer was extracted with methylene chloride (2 × 20 
mL). The combined organic extracts were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude material was purified by column chromatography (EtOAc/hexanes = 1/99 to 
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Progress Towards a Convergent, De Novo Synthesis of Jervine 
 
3.1 Isolation 
 The Veratrum alkaloids comprise more than twenty unique natural product scaffolds, 
many of which exhibit cardiovascular, neuromuscular, and respiratory actions. These 
poisonous plants have garnered attention as therapeutics as early as the Middle Ages, finding 
applications such as fever medications, sedatives, cardiotonics, and emetics.1 In 1837, it was 
shown that the plant Veratrum album contained an alkaloidal base, which was given the name 
jervine (3.1, Figure 3.1),2 but it took until 1879 for jervine to be isolated as a single compound, 
when it was extracted from the same source by Luff and Alder Wright.3  
 The isolation of jervine’s deoxygenated relative, cyclopamine (3.2, Figure 3-1), did 
not occur until nearly 100 years later. In 1957, sheep ranchers in Idaho noticed that some of 
their sheep were being born with one eye and underdeveloped brains, and contacted the United 
States Department of Agriculture for assistance. The cause of this birth defect was found to 
arise from pregnant sheep grazing on the plant Veratrum californicum.4–6 The alkaloids present 
in the plant were extracted, and a new steroidal alkaloid was discovered. This new compound 
was compared to deoxygenated jervine (formed via the Wolff-Kishner reduction), and was 
found to be identical in every characterization method tested. Therefore, any synthesis of 
jervine constitutes a formal synthesis of cyclopamine. In accordance with the molecule’s 
dramatic effect as a teratogen, the new steroidal alkaloid was coined cyclopamine.7 At the time, 
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the biological mechanism of action for cyclopamine was unknown, but since its first 
characterization, many groundbreaking discoveries have been made. 
Figure 3-1 Veratrum Alkaloids Jervine (3.1) and Cyclopamine (3.2) 
 
3.2 The Hedgehog Signaling Pathway 
 Of the approximately 14,000 genes possessed by a fruit fly, over fifty of them have a 
direct effect on embryonic development. When one of these genes was mutated in the fruit fly 
Drosophilia melanogaster, the fruit fly’s larvae grew a hedgehog-like coat of spines on their 
undersides. Thus, this specific gene was named the hedgehog gene (hh).8 
 The hedgehog gene encodes for three proteins, named Shh (Sonic hedgehog), Ihh 
(Indian hedgehog), and Dhh (Desert hedgehog). These proteins have the function of ligating 
the membrane-bound receptor protein Patched (Figure 3-2). When these hh ligands are not 
present, the membrane-bound protein Patched1 (Ptch1) is located at the base of the primary 
cilia, which function as cellular antennae, sensing chemical signals for the cell. When Ptch1 
is in this location, it inhibits the translocation of a membrane-bound receptor protein called 
Smoothened (Smo) from intracellular compartments to the cilium. This allows SuFu (the 
suppressor of the protein Fused) to stay active, which leads to the transformation of 
transcription factors Gli2 and Gli3 into their repressor forms. The repressor forms of Gli2 and 
Gli3 do not allow the transcription of hedgehog-response genes.4 Thus, in the absence of Shh, 
Ihh, and Dhh, the transcription of the hedgehog-response genes is repressed. 
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 In the presence of Shh, Ihh, and Dhh, the Patched protein is ligated, causing Ptch1 to 
exit the cilium. This allows Smo to enter the cilium, preventing cleavage of Gli2 and Gli3. The 
unaffected Gli2 and Gli3 can now bind to Gli promotors in the nucleus, which lead to the 
transcription of hedgehog-response genes.9–14 Therefore, when the proteins Shh, Ihh, and Dhh 
are present (these proteins are encoded by the hedgehog gene), the pathway is activated.  
Figure 3-2 The Hedgehog Signaling Pathway (Figure Reproduced with Permission from 
Reference 14)  
 
 In mammals, the hedgehog gene regulates embryonic development by inducing 
bilateral symmetry. This gene is also responsible for correctly developing limbs, skeleton, 




3.3 The Veratrum Alkaloids and Hedgehog Signaling 
 During the initial study of this hedgehog signaling, methods of controlling this pathway 
were desired. One option was gene knockout, but this strategy is difficult and time consuming. 
A desirable alternative would be the use of small molecules to influence hedgehog signaling. 
In 1998, Beachy and coworkers made a key discovery to accomplish this goal. It was shown 
that cyclopamine interacts with the protein Smo (Figure 3-3), causing a conformation change 
in Smo. This inhibits the hedgehog signaling pathway, even in the presence of the activating 
ligands Shh, Ihh, and Dhh.15–21 
Figure 3-3 Crystal Structure of Cyclopamine/Smoothened Complex (Figure Modified with 
Permission from Reference 20) 
 
 In addition to the hedgehog signaling pathway’s role in embryonic development, 
undesired overexpression of this pathway in adults can lead to certain types of cancers, such 
as basal cell carcinoma, medulloblastoma, rhabdomyosarcoma, and prostate, pancreatic and 
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breast cancers. Though the seminal of discovery of a small molecule regulating the hedgehog 
signaling pathway was only 20 years ago, hedgehog-pathway inhibitors have already shown 
promise as anti-cancer therapeutics.22–29 The hh-signaling pathway is intimately involved in 
nearly all pancreatic cancers,30 and as such, analogues of the Veratrum alkaloids have shown 
promise in the treatment of pancreas cancer (Figure 3-4).31–33 These analogues are prepared 
from extracted cyclopamine, limiting the amount of chemical space that can be explored, which 
demonstrates the need for a de novo synthesis of these alkaloids.  
Figure 3-4 Potential Pancreatic Cancer Treatments Derived from Veratrum Alkaloids 
 
3.4 Structural Features 
 Along with their biological profiles, the complex structural features of these molecules 
have attracted significant attention from the synthetic community. The C-nor-D-homo steroid 
skeleton found in both alkaloids contains an unusual 6-6-5-6 ABCD core (Figure 3-1), 
compared to the more commonly observed 6-6-6-5 ABCD steroidal structure. Additionally, 
grafted onto the D ring via spirocyclic linkage exists a densely functionalized tetrahydrofuran 
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(E ring) and substituted piperidine (F ring). The underrepresentation of this heterocyclic motif 
in the literature piqued our interest, and at the onset of the project we believed that it could 
drive the development of new reactions. Further complicating synthetic considerations is the 
sensitivity of the tetrahydrofuran ring to acidic conditions; the D,E spirocycle has been shown 
to cleave below pH 3 or upon treatment with Lewis acids.34   
3.5 Previous Syntheses 
 Due to the importance of these compounds, a great deal of effort has been focused on 
their synthesis. The first synthesis of jervine was completed by Masamune in 1967,35 
employing intermediate 3.8, a compound which had been previously prepared by Johnson and 
co-workers (Scheme 3-1).36,37 This was a landmark achievement in the synthesis of the 
Veratrum alkaloids, and proved the viability of a convergent approach towards these 
molecules. However, consistently poor yields and stereoselectivities throughout the synthesis 
precluded this route from practical applications. For example, a diastereomeric salt resolution 
is used en route to Johnson’s intermediate (3.8), and a sodium borohydride reduction of 
Johnson’s intermediate provides a diastereomeric ratio (dr) of 1:1, giving both steps a 
maximum yield of only 50%.  




 A related formal synthesis was reported eight years after Masamune’s initial synthesis 
by Warnock et al. (Scheme 3-2).38,39 Looking to improve the yield of the key fragment 
coupling reaction, a modified approach was taken. Instead of an enamine alkylation reaction, 
lithiated pyridine 3.14 was added to ketone 3.15, which proceeded in a higher yield (62%) 
compared to Masamune’s enamine alkylation (16%). Aromatization of the D ring and 
hydrogenation of the piperidine ring afforded advanced intermediate 3.17, which after acetate 
deprotection, intercepted the Masamune synthesis and constituted a formal synthesis of jervine. 
While the fragment coupling proceeded in good yield, a key trait to any convergent synthesis, 
this route hardly improved upon the efficiency of the Masamune synthesis and could be 
considered only a small advance in the synthesis of the Veratrum alkaloids. 
Scheme 3-2 Warnock’s Formal Synthesis of Jervine (1975) 
 
 Wright and coworkers have since developed an innovative approach to the 
jervine/cyclopamine D,E,F ring fusions via a furan Diels-Alder 
reaction/dehalogenation/amination sequence (Scheme 3-3).40 This strategy generated 
compound 3.20 via the Diels-Alder reaction of furan 3.18 and ynoate 3.19, which was followed 
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by a one pot dehalogenation/amination reaction sequence to afford bicycle 3.21.  A subsequent 
domino metathesis reaction catalyzed by the second-generation Grubbs catalyst (G-II) gave 
tricycle 3.22. This route constitutes a racemic, four-step synthesis of 3.22 bearing promising 
functional handles for synthesis completion. However, this model system fell short by failing 
to demonstrate the requisite change in oxidation state at C21, epimerization of C20, and 
incorporation of the methyl group attached to C25. Furthermore, there exists no obvious 
functionality to enable the coupling of this fragment to the western steroidal fragment of the 
Veratrum alkaloids.    
Scheme 3-3 Wright’s Model Study of Jervine/Cyclopamine 
 
 Giannis and co-workers recently reported a synthesis of cyclopamine, fashioning the 
target molecule in only 20 steps from the commercially available steroid 
dehydroepiandrosterone (3.23, Scheme 3-4).40 Giannis was able to modify the 6-6-6-5 ABCD 
core of dehydroepiandrosterone to the desired 6-6-5-6 ABCD core via a stereoselective 
hydroxylation reaction by the copper-catalyzed C-H activation of C12, setting up a key cationic 
ring contraction/expansion of the C and D rings to arrive at lactone 3.25. This rearrangement 
sequence was followed by the linear installation of the tetrahydrofuran and piperidine moieties. 
While this route is extremely short considering the size and complexity of cyclopamine, the 
deployment of steroid 3.23 as starting material limits the types of derivatives that can be formed 
for the purpose of SAR studies. For this reason, we believe that a de novo synthesis of jervine 
would be of great use for preparing analogues of jervine with the intention of studying the 
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impact of these modifications in therapeutic development. Our synthesis would be designed to 
allow maximum flexibility for modular incorporation of functional and stereochemical 
elements. Furthermore, a convergent approach would enable this work to proceed in higher 
chemical yield than the analogous linear strategy, and would allow the activity of each 
fragment to be tested.  
Scheme 3-4 Giannis’s Partial Syntheses of Cyclopamine 
 
3.6 Butenolide/Imine Diene [4+2] Strategy 
 With the strategy of a convergent synthesis in mind, we began our retrosynthetic 
analysis by disconnecting jervine (3.1) into two fragments, targeting alkaloid fragment 3.26 
first, due to its proposed greater importance to the biological activity of jervine (Scheme 3-5). 
We also wished to use this interesting fused heterocyclic motif to drive the development of 
new reactions, proposing a novel [4+2] reaction of butenolide (3.27) and an appropriately 
protected imine diene (3.28), and the stereocorrection of -amino ester 3.30 through a retro-





Scheme 3-5 Butenolide/Imine Diene [4+2] Route 
 
 Our first task, the development of the racemic [4+2] reaction of butenolide (3.27) and 
imine diene 3.28, proceeded smoothly.  We discovered that the desired cycloaddition reaction 
could be promoted by triethylamine in toluene at room temperature (Table 3-1, entry 10), but 
were unable to achieve good yields due to the competitive decomposition of both starting 
materials. Despite thoroughly testing various classes of tertiary amine organocatalysts under 
the optimized reaction conditions (Figure 3-5), we were unable to develop a practical 








Table 3-1 Optimization of [4+2] Reaction 
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Figure 3-5 Survey of Chiral Catalysts Tested Under Optimized Conditions 
 
  
 Undeterred by this setback, we decided to pursue this route with racemic material in 
order to determine its viability. Taking advantage of the cis bicycle allowed for a 
diastereoselective hydrogenation of alkene 3.29 (Scheme 3-6). Gratifyingly, lactone 3.30 
could be epimerized to give the desired trans bicycle 3.31, presumably occurring via a retro-
Michael/Michael reaction. Despite our best efforts, however, we were unable to methylate 
compound 3.31 due to the instability of its corresponding enolate, and as a result, decided to 




Scheme 3-6 Exploration of Butenolide/Imine Diene [4+2] Route 
 
3.7 Semmelhack Strategy 
 After analyzing the shortcomings of the previously described route, we decided to 
assemble the densely functionalized tetrahydrofuran ring through a Semmelhack reaction, a 
proven strategy for the construction of tetrahydrofurans in complex molecule synthesis 
(Scheme 3-7).41 Our initial goal was to demonstrate the feasibility of this transformation using 
a model system. Accordingly, tertiary alcohols 3.33 were synthesized by direct addition of 













Scheme 3-7 Semmelhack Route 
 
 With expedient access to a range of protected tertiary alcohols (Table 3-1), the 
Semmelhack reaction of alcohols 3.33 could be tested.  We opted to first test the more easily 
accessible trichloroacetamide protected amine substrate, and discovered trace conversion to an 
unexpected product (entry 1). After increasing the amount of palladium reagent, we were able 
to obtain enough material to characterize the unknown product, determining its identity to be 
acetals 3.35, presumably formed through a Wacker-type process. Changing the amine 
protecting group to Cbz (entry 3) and tosyl (entry 4) provided small amounts of desired 







Table 3-2 Attempts at Model Semmelhack Reaction  
 






















 With compounds 3.33 in hand, we decided to further explore their application towards 
the synthesis of a model fragment system (Scheme 3-8). After screening alternative cyclization 
reactions, we discovered that the ozonolysis of 3.33 provided acetals 3.36, which were both 
able to undergo a BF3•OEt2-promoted Hosomi-Sakarai allylation reaction.
45,46  
Scheme 3-8 Alternate Application of Tertiary Alcohols 3.33 
 
3.8 Hosomi-Sakurai Strategy 
 After proving the feasibility of the key Hosomi-Sakarai allylation, we turned our 
attention to formulating a complete retrosynthetic analysis of jervine (Scheme 3-9). In 
continuation of our goal of a highly convergent synthesis, initial focus was placed on 
constructing tricycle 3.38. This molecule could be simplified through a Hosomi-Sakarai 
allylation using linchpin reagent 3.40. We hoped to arrive at lactol 3.39 via the oxidative 
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lactonization of amino acid 3.41, followed by reduction. Finally, amino acid 3.41 initially 
appeared to be a clear retron for an Ireland-Claisen rearrangement.47,48 This synthetic pathway 
could be traced back to the known enantiopure ketol 3.43. 
Scheme 3-9 Retrosynthetic Analysis 
 
 To arrive at amino acid 3.46 with the correct relative stereochemistry, two 
combinations of alkene and enolate geometry could be carried out: (E)-alkene combined with 
forming the anti-enolate, or (Z)-alkene combined with forming the syn-enolate (Scheme 3-10). 
Due to ease of substrate synthesis, we decided to pursue the former option. After many attempts 
to utilize an Ireland-Claisen rearrangement of E-alkene 3.45, it became clear that the generation 
of the requisite E-enolate would not proceed with high selectivity. This result was attributed to 
the strong driving force of chelation, regardless of the protecting groups on the amine. 
Accordingly, our next goal was to take advantage of the molecule’s preference for Z-enolate 
formation and synthesize Z-alkene 3.42. The known nitrosobenzene aldol reaction49 using 
ketone 3.44 delivered -oxygenated product 3.47 in excellent enantioselectivity (97:3 er). We 
were pleased to discover that after a simple aqueous workup, NO bond cleavage could be 
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achieved using copper (II) sulfate pentahydrate in methanol, an economical alternative to the 
known NO bond cleavage using Pd/C and hydrogen gas.50 Concerned with the stability of 
ketol 3.43, the crude compound was immediately silyl protected to afford the stable silyl-
protected ketol 3.48 in 43% yield over three steps. The Wittig olefination of ketone 3.48 was 
found to proceed in good selectivity when the alcohol was protected with bulky protecting 
groups.51 Subsequent silyl deprotection and esterification provided Z-allylic ester 3.42 in 
excellent yield. Initial attempts to carry out the Claisen rearrangement of 3.42 were performed 
by transmetallation of the generated lithium enolate using strongly chelating metals, but these 
conditions also provided poor yields and diastereoselectivities. This known issue with 
Kazmaier-Claisen rearrangements can be rationalized by the syn-pentane interaction present 
in the chair-like transition state of the rearrangement, which leads to a competitive boat-like 
transition state.52 As a result of this phenomenon, the Eschenmoser-Claisen reaction was 
developed to avoid this issue.53 To our surprise, classic Ireland-Claisen conditions employed 
on Boc-protected glycinate 3.42 smoothly delivered rearranged amino acid product 3.41a in 











Scheme 3-10 Synthesis of Ireland-Claisen Rearrangement Substrate 3.41a 
 
 Our success was short-lived, however, as the halolactonization of amino acid 3.41a 
proceeded with the incorrect relative stereochemical outcome (Scheme 3-11). After a thorough 
screen of unsuccessful lactonization reactions, we gained inspiration from work by the 
Lipshutz group regarding the 5-endo-trig cyclizations of homoallylic alcohols53 and discovered 
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that the diastereoselectivity of the lactonization reaction could be reversed if the reaction was 
promoted by phenylselenium bromide. 






 The DIBAL reduction of lactone 3.52 smoothly afforded the long sought after Hosomi-
Sakarai allylation substrate 3.55a (Scheme 3-12). At the time of these experiments, we were 
unaware of the relative stereochemistry of the bromolactonization reaction of 3.41a, but 
believed it would be inconsequential to the success of the Hosomi-Sakurai reaction. When the 
attempted allylation reaction was performed with chelating Lewis acids, incorrect 
chemoselectivity was observed, affording lactol 3.56. Coordinating Lewis acids were able to 
ionize the lactol at the correct position, but intramolecular attack of the carbamate protecting 
group led to the formation of undesired oxazolidinone 3.57. In hopes that a Cbz protected 
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amine would prevent ionization of the alkyl group of the carbamate, lactol 3.55b was prepared. 
Despite its similarity to the successful model substrate 3.36 (Scheme 3-7), a Lewis acid screen 
only led to the decomposition of the starting material. Activating the hydroxyl group of lactols 
3.55a and 3.55b via the formation of the corresponding trichloroacetamide provided no 
amounts of desired allylated product as well.   
Scheme 3-12 Failed Hosomi-Sakarai Allylations 
 
3.9 Alkaloid Fragment Completion via Grignard Reagent Addition 
 While lactol allylation was an unproductive direction forward, we were encouraged by 
the fact that we had scalable access to amino acid 3.41a in high enantioselectivity. At this 
juncture, we decided to modify our order of operations in order to gain access to other reliable 
methods of carbon-carbon bond formation (Scheme 3-13). If cyclization to form the 
tetrahydrofuran ring could occur at the alcohol oxidation state by means of a 
selenoetherifcation reaction, the difficult carbon-carbon bond formation event could be formed 
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prior to cyclization by the addition of an appropriate organometallic reagent to Weinreb amide 
3.60. A chelation controlled ketone reduction to form alcohol 3.61 should proceed with the 
correct diastereoselectivity, and if the selenoetherification reaction behaved similarly to the 
selenolactonization reaction, all stereocenters should be formed in the correct configuration. 
Scheme 3-13 Proposed Alternate Order of Operations 
 
 Our first task was to enantioselectively synthesize alkyl halide 3.63 (Scheme 3-14) for 
its application in an organometallic addition to Weinreb amide 3.60. While conventional 
methods for fashioning similar structures utilized the Roche ester (3.65), we eschewed this 
strategy for a more economical one. We opted to first pursue the benzyl protected substrate 
(3.63a), which was constructed via the diastereoselective alkylation of 3.66, followed by imide 
reduction to reveal the corresponding primary alcohol, and finally conversion of the alcohol to 






Scheme 3-14 Synthesis of Alkyl Iodide 3.63a  
 
 In order to test the reaction on small scale, we initially chose to study the addition of 
an organolithium reagent, and were pleased to see ketone product 3.64a formed in 73% yield 
(Scheme 3-15). The selenoetherification of 3.61a proceeded in good yield and 
stereoselectivity, and was tentatively determined to be the correct diastereomer after careful 
NOESY 1H NMR experiments. A chelation controlled reduction using DIBAL afforded 
tetrahydrofuran 3.62a, but unfortunately this route came to a halt when the benzyl ether could 









Scheme 3-15 Application of Benzyl Protected Alkyl Iodide 3.63a 
 
 Despite the inability of 3.62a to undergo deprotection, our ability to reach that 
advanced intermediate was a large step forward. We hypothesized that changing protecting 
groups from a benzyl ether to a p-methoxy-benzyl ether (PMB) would allow for a smoother 
deprotection. First, however, we would need to develop a scalable synthesis of the requisite 
alkyl bromide reagent (Scheme 3-16). We began with the kinetic resolution of 2-methyl-1,3,-
propanediol.54 Despite the low yield of enantioenriched acetate 3.69, the low price of the 
reagents was quite attractive. Unfortunately, direct conversion of alcohol 3.69 to its 
corresponding alkyl bromide via the Appel reaction was not feasible due to a degradation of 
enantioselectivity in the reaction. Instead, alcohol 3.69 was first tosylated in 85%, which was 
followed by a protecting group swap of the alternate alcohol from acetate to PMB, which 
afforded a quantitative yield of PMB ether 3.72. Refluxing tosylate 3.72 in the presence of 
LiBr cleanly afforded enantioenriched alkyl bromide 3.63b in 93% yield. This route proved to 






Scheme 3-16 Scalable Synthesis of Enantioenriched Alkyl Bromide 3.63b 
 
 With alkyl bromide 3.63b in hand, we applied it to the previously developed reaction 
sequence of its benzyl protected analogue (Scheme 3-15). We were able to eliminate the use 
of tBuLi in favor of making the corresponding Grignard reagent instead, and found that the 
Grignard reaction to afford ketone 3.64b proceeded in higher yield (86%, Scheme 3-17). The 
following ketone reduction and selenoetherification reaction behaved similarly to the 
previously developed route, giving access to tetrahydrofuran 3.62c. Closure of the piperidine 
ring was accomplished by deprotection of PMB ether 3.62c and subsequent conversion of the 
free primary alcohol into a mesylate, which under basic conditions formed piperidine 3.73 in 
72% yield over 2 steps. All that remained was modification of the D ring, which was 
accomplished by hydrolysis of the dioxolane protecting group and selenoxide elimination, 
forming eastern fragment 3.74 (1.77 g obtained in one pass). An X-ray crystallography 
experiment was performed on this compound, which confirmed the molecule’s connectivity 





Scheme 3-17 Completion of Alkaloid Fragment 
 
 
3.10 Steroid Fragment Completion  
 With a scalable, completed route to fashion the eastern fragment of jervine, we began 
to develop an efficient synthesis of western fragment 3.75 (Scheme 3-18). We believed that 
the most effective strategy would be attempting to trace enal 3.75 back to the Wieland-
Miescher ketone (3.78), a compound commonly employed in many steroid total syntheses.55 
This left two major operations to be accomplished: alkene migration and reduction of the 
southwestern ketone, and homologation of the northeastern ketone. We foresaw complications 
with homologation of the northeastern ketone due to a proposed propensity of a skipped diene 
in conjugation with an aldehyde to move into conjugation, and sought to develop a route that 
formed the aldehyde last using mild conditions. As such, the aldehyde in 3.75 was disconnected 
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first via a cross-coupling reaction between vinyl triflate 3.76 and an appropriate 
hydroxymethylene synthetic equivalent. Ketone 3.77 could be traced back to the Wieland-
Miescher ketone (3.78) by alkene migration and reduction of the southwestern ketone. We 
believed that we could regioselectively functionalize the enone of 3.78 without affecting the 
northeastern ketone due to the higher Lewis basicity of the enone.  
Scheme 3-18 Western Fragment Retrosynthetic Analysis 
 
 Accordingly, the Wieland-Miescher ketone was treated with acetic anhydride and 
catalytic p-toluenesulfonic acid, which selectively provided vinyl acetate 3.79 (Scheme 3-19). 
Exposure of this compound to sodium borohydride set the alkene in the correct position, and 
diol 3.80 was next selectively protected as a TBS silyl ether in 99% yield. The Swern oxidation 
of alcohol 3.80 prepared us for the homologation of the resulting ketone. Synthesis of the vinyl 
triflate proceeded smoothly, as did the critical Stille cross-coupling reaction to afford allylic 
alcohol 3.82. Oxidation using the Dess-Martin periodinane afforded western fragment 3.75 in 









Scheme 3-19 Completion of Western Fragment  
 
3.11 Future Directions 
 Future directions will commence with fragment coupling via the addition of an 
organocuprate to enone fragment 3.74, followed by trapping via an aldol reaction with 
aldehyde 3.75 (Scheme 3-20). After formation of the corresponding vinyl triflate, an oxidative 
Heck reaction should provide ketone 3.84. Completion of the synthesis will be accomplished 






























General: Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform infrared 
spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were 
recorded on a Bruker model Avance 400 (19F NMR at 376 MHz), Bruker Avance III 500 (1H 
NMR at 500 MHz), or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 151 
MHz) spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 
ppm; 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, br s = broad singlet, d = doublet, br d = broad doublet, t = triplet, app 
t = apparent triplet, q = quartet, dd = doublet of doublets, app p = apparent pentet, ddd = doublet 
of doublet of doublets, app ddt = apparent doublet of doublet of triplets, app td = apparent 
triplet of doublets, app dt = apparent doublet of triplets, m = multiplet), coupling constants 
(Hz), and integration. Mass spectra were obtained using a Thermo LTqFT mass spectrometer 
with electrospray introduction and external calibration. All samples were prepared in methanol. 
Analytical thin layer chromatography (TLC) was performed on Sorbent Technologies 0.20 mm 
Silica Gel TLC plates. Visualization was accomplished with UV light, KMnO4, and/or 
Seebach’s stain (2.5 g phosphomolybdic acid, 1.0 g Ce(SO4)2, 6.0 mL conc. H2SO4, 94 mL 
H2O) followed by heating. Purification of the reaction products was carried out by flash column 
chromatography using Siliaflash-P60 silica gel (40-63μm) purchased from Silicycle. Unless 
otherwise noted, all reactions were carried out under an atmosphere of dry nitrogen in flame-
dried glassware with magnetic stirring. Yield refers to isolated yield of pure material unless 





General: Tetrahydrofuran (THF), diethyl ether (Et2O), methylene chloride (CH2Cl2), and 
toluene (PhMe) were dried by passage through a column of neutral alumina under nitrogen 
prior to use. Nitrosobenzene,56 2-methylcyclohexane-1,3-dione,57 the Wieland-Miescher 
ketone,58 and (tributylstannyl)methanol59 were synthesized according to known procedures. 
Amano Lipase from Pseudomonas fluorescens (beige-brown, ≥20,000 U/g) was purchased 






















Preparation and Characterization of Weinreb Amide 3.60 
 
 
(S)-7-((tert-Butyldimethylsilyl)oxy)-1,4-dioxaspiro[4.5]decan-8-one (3.48): The reported 
procedure of Hayashi et al. was employed:60 A flame-dried 500 mL round-bottomed flask 
equipped with a stir bar was cooled under a stream of N2, and charged with 1,4-
cyclohexanedione monoethylene acetal (26.69 g, 171 mmol, 1.2 equiv), D-proline (1.64 g, 14.3 
mmol, 10 mol %), and DMF (205 mL). The solution was cooled to 0 °C, and a solution of 
nitrosobenzene (15.61 g, 143 mmol, 1 equiv) in DMF (40 mL) was added via syringe pump 
over 24 h. After complete addition of nitrosobenzene, the solution was further stirred for 30 
min at the same temperature. The solution was poured into a 2 L Erlenmeyer containing a 
stirring pH 7 buffer solution (5.83 g potassium phosphate monobasic, 15.46 g potassium 
phosphate dibasic, 1 L water). The mixture was diluted with EtOAc (400 mL), and added to a 
separatory funnel. The layers were separated, and the aqueous layer was extracted with EtOAc 
(2 × 400 mL). The combined organic extracts were washed with water (4 × 1 L), then with 
brine (400 mL). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo to afford the crude product as a golden liquid. 
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The crude α-oxygenated ketone and methanol (143 mL) were added to a 500 mL round-
bottomed flask equipped with a stirbar. The solution was cooled to 0 °C, and CuSO4•5H2O 
(10.71 g, 42.9 mmol, 30 mol %) was added in 4 portions. The black solution was stirred at 0 
°C for 3 h. The solution was transferred to a 1 L round-bottomed flask containing 80 g Celite®, 
and diluted with CH2Cl2 (200 mL). The mixture was concentrated and azeotroped with hexanes 
(200 mL), then Et2O (200 mL). The Celite® was filtered through a fritted funnel, then washed 
with Et2O (2 L). The solution was concentrated to afford the crude α-hydroxy ketone as a thick, 
black liquid. The enantiomeric ratio was determined to be 97:3 as determined by HPLC 
analysis of the benzoylated product.  
The crude α-hydroxy ketone, imidazole (48.68 g, 715 mmol, 5 equiv), and DMF (143 mL) 
were added to a flame-dried 500 mL round-bottomed flask equipped with a stir bar. The 
solution was cooled to 0 °C, and tert-butyldimethylsilyl chloride (53.72 g, 358 mmol, 2.5 
equiv) was added in 6 portions. The cooling bath was removed, and stirred for 3 h at rt. The 
solution was diluted in Et2O (1 L), and added to a separatory funnel. The layers were separated, 
and the organic layer was washed with water (3 × 1 L), 0.5 M HCl (3 × 800 mL), and brine 
(400 mL). The combined organic layer was collected, dried over Na2SO4, filtered, and 
concentrated in vacuo. The crude product was then distilled (70 °C, 1 torr) in order to remove 
volatile silanols. The crude material remaining in the distillation flask was further purified by 
column chromatography on silica gel (EtOAc/hexanes = 2.5/97.5 to 5/95 to 10/90) to afford 
17.41 g (43% over 3 steps) of the title compound as a dark red liquid. Spectroscopic properties 
were identical to those previously reported:61 1H NMR (500 MHz, CDCl3) 4.42 (dd, J = 12.4, 
6.7 Hz, 1H), 4.11–3.99 (m, 4H), 2.58 (app td, J = 14.3, 6.4 Hz, 1H), 2.37 (ddd, J = 14.4, 4.9, 
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2.5 Hz, 1H), 2.27 (ddd, J = 12.9, 6.7, 3.6 Hz, 1H), 2.09–1.88 (m, 3H), 0.90 (s, 9H), 0.14 (s, 
3H), 0.03 (s, 3H). 
 
(S)-8-oxo-1,4-dioxaspiro[4.5]decan-7-yl benzoate (Sx): A flame-dried 1 dram vial equipped 
with a stirbar was cooled under a stream of N2, and charged with ketol 3.43 (21.0 mg, 0.122 
mmol, 1.0 equiv), CH2Cl2 (1 mL), and triethylamine (68 L, 0.488 mmol, 4 equiv). The 
solution was cooled to 0 °C, and benzoyl chloride (43 L, 0.366 mmol, 3 equiv) was added. 
The solution was warmed to rt stirred for 4 h. The solution was absorbed onto Celite®, and 
purified by column chromatography on silica gel (EtOAc/hexanes = 20/80) to afford 33.7 mg 
(87%) of the title compound as a yellow amorphous solid. Spectroscopic properties were 
identical to those previously reported:62 1H NMR (500 MHz, CDCl3) 8.13–8.02 (m, 2H), 
7.61–7.52 (m, 1H), 7.44 (t, J = 7.8 Hz, 2H), 5.68 (dd, J = 13.3, 6.9 Hz, 1H), 4.19–4.00 (m, 
4H), 2.86–2.74 (m, 1H), 2.52–2.44  (m, 2H), 2.27 (app t, J = 12.8 Hz, 1H), 2.15–1.98 (m, 2H). 
HPLC (90:10 hexanes:iPrOH, Daicel CHIRALPAK IA): 97:3 er, tR (minor) = 8.5 min, tR (major) = 
10.0 min (note: product decomposition is observed if dissolved in MeOH). 
 
 
Ethyltriphenylphosphonium bromide: A flame-dried 500 mL round-bottomed flask 
equipped with a stirbar was cooled under a stream of N2, and charged with triphenylphosphine 
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(57.70 g, 220 mmol, 1.1 equiv), toluene (143 mL), and bromoethane (14.8 mL, 200 mmol, 1 
equiv). The solution was stirred at reflux for 16 h, then cooled to rt. The solids were collected 
on a fritted funnel, and washed with toluene (250 mL) and Et2O (3 × 250 mL). The solids were 
collected and dried in vacuo, affording 58.71 g (79%) of the title product as a white powder 
solid. Spectroscopic properties were identical to those previously reported:63 1H NMR (500 
MHz, CDCl3)  7.887.76 (m, 9H), 7.727.66 (m, 6H), 3.93 (dq, J = 12.4, 7.4 Hz, 2H), 1.39 
(dt, J = 20.1, 7.4 Hz, 3H). 
 
 
(S,Z)-8-Ethylidene-1,4-dioxaspiro[4.5]decan-7-ol (3.50): A flame-dried 500 mL round-
bottomed flask equipped with a stir bar was cooled under a stream of N2, and charged with 
THF (152 mL) and ethyltriphenylphosphonium bromide (2.3 equiv, 139.6 mmol, 2.3 equiv). 
The mixture was cooled to -78 °C, and 2.5 M nbutyllithium in hexanes (53.4 mL, 133.6 mmol, 
2.2 equiv) was added dropwise. The cold bath was removed, and the reaction mixture was 
stirred at rt for 2 h, after which a blood red solution had formed. The solution was cooled to -
78 °C, and a solution of ketone 3.48 (17.39 g, 60.71 mmol, 1 equiv) in THF (24 mL) was added 
dropwise. The flask previously containing ketone 3.48 was washed with THF (3 × 4 mL), the 
cold bath was removed, and the solution was stirred at rt for 1 h. The solution was cooled to 0 
°C, and water (250 mL) was added. The mixture was diluted with Et2O (200 mL), and added 
to a separatory funnel. The layers were separated, and the organic layer was extracted with 
Et2O (3 × 200 mL). The combined organic extracts were washed with brine (200 mL), dried 
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over Na2SO4, and concentrated in vacuo. In order to remove triphenylphosphine oxide, the 
crude product was added to a 500 mL round-bottomed flask equipped with a stir bar, and PhMe 
was added (73 mL). The mixture was rapidly stirred, and MgCl2 (14.45 g, 151.8 mmol, 2.5 
equiv) was slowly added to the solution. The reaction mixture was heated to 65 °C. Heptane 
(73 mL) was slowly added to the reaction mixture, and the mixture of finely dispersed solids 
was stirred at 65 °C for 2 h (if the solids form clumps, the clumps should be broken apart to 
afford a finely dispersed mixture). The mixture was cooled to rt, and the solids were filtered 
on a fritted funnel, which were washed with a 1:1 mixture of PhMe:heptane (3 × 125 mL). The 
filtrate was dried over Na2SO4, filtered, and concentrated in vacuo to afford the crude product 
as a 14:1 mixture of Z:E alkenes as determined by 1H NMR spectroscopy (the ratio diminishes 
if the crude product is purified by column chromatography on silica gel).  
A flame-dried 500 mL round-bottomed flask equipped with a stir bar was cooled under a 
stream of N2, and charged with the crude product of the Wittig reaction and THF (202 mL). 
The solution was cooled to 0 °C, and tetra-nbutylammonium fluoride hydrate (50.90 g, 182.1 
mmol, 3 equiv) was added in 6 portions. The solution was warmed to rt slowly overnight. The 
solution was cooled to 0 °C, and water (250 mL) was added. The mixture was diluted with 
Et2O (200 mL), and added to a separatory funnel. The layers were separated, and the aqueous 
layer was extracted with Et2O (3 × 200 mL). The combined organic extracts were washed with 
brine (200 mL), dried over Na2SO4, filtered, and concentrated in vacuo. The crude material 
was purified by column chromatography on silica gel (EtOAc/hexanes = 10/90 to 30/70) to 
afford 10.24 g (92% over 2 steps) of the title compound as a red brown liquid, existing as a 
9.1:1 mixture of Z:E alkene isomers as determined by 1H NMR spectroscopy. 1H NMR (600 
MHz, CDCl3)  5.33 (q, J = 6.7 Hz, 1H), 4.76 (d, J = 7.5 Hz, 1H), 4.06–3.92 (m, 4H), 3.74 (d, 
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J = 9.3 Hz, 1H), 2.69–2.60 (m, 1H), 2.13–2.03 (m, 2H), 1.84–1.73 (m, 2H), 1.66 (dd, J = 7.0, 
2.0 Hz, 3H), 1.64–1.54 (m, 1H) (signal is convoluted due to presence of allylic CH3 signal of 
minor alkene isomer); 13C NMR (151 MHz, CDCl3) 137.8, 120.4, 109.6, 65.0, 64.8, 64.3, 
40.7, 36.1, 29.0, 12.9; IR (thin film): 3519 (br), 2952, 2887, 1119, 1072 cm–1; HRMS: (ESI+): 
Calcd. for C10H16O3: ([M+Na]): 207.0997, Found: 207.0992. []D: 117.5 (c = 0.01, CHCl3); 
TLC (EtOAc/hexane = 30/70): Rf = 0.25. 
 
 
(S,Z)-8-ethylidene-1,4-dioxaspiro[4.5]decan-7-yl (tert-butoxycarbonyl)glycinate (3.42): A 
flame-dried 500 mL round-bottomed flask equipped with a stir bar was cooled under a stream 
of N2, and charged with Boc-glycine (19.45 g, 111.1 mmol, 2 equiv), and THF (185 mL). 
While the reaction mixture was stirring vigorously at rt, 1,1’-carbonyldiimidazole (18.01 g, 
111.1 mmol, 2 equiv) was added in 6 portions, in order to control gas evolution. After addition, 
the reaction mixture was stirred at rt for 30 min, after which a solution of allylic alcohol 3.50 
was added as a solution in THF (24 mL). The flask previously containing 3.50 was washed 
with THF (3 × 4 mL). The reaction mixture was cooled to 0 °C, and 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) (16.7 mL, 111.1 mmol, 2 equiv) was added dropwise. 
The cooling bath was removed, and the reaction mixture was stirred at rt for 1 h 30 min. The 
reaction mixture was cooled to 0 °C, and 1 M HCl (150 mL) was added carefully. The reaction 
mixture was diluted with Et2O (500 mL), and added to a separatory funnel. The layers were 
separated, and the organic layer was washed with additional 1 M HCl (2 × 150 mL). The 
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combined aqueous layers were extracted with Et2O (2 × 150 mL). The combined organic 
extracts were washed with saturated aqueous sodium bicarbonate (2 × 150 mL) and brine (150 
mL). The organic layer was dried over Na2SO4, filtered, and concentrated. The crude material 
was purified by column chromatography on silica gel (EtOAc/hexanes = 15/95 to 20/80 to 
25/75) to afford 18.68 g (99%) of the title compound as a golden-yellow thick liquid, existing 
as an 8.2:1 mixture of Z:E alkene isomers as determined by 1H NMR spectroscopy. 1H NMR 
(600 MHz, CDCl3) 5.84 (s, 1H), 5.44 (q, J = 6.6 Hz, 1H), 5.16 (s, 1H), 3.99–3.81 (m, 6H), 
2.60–2.46 (m, 1H), 2.13 (dd, J = 36.0, 14.3 Hz, 2H), 1.90–1.65 (m, 5H), 1.63–1.51 (m, 
1H)(signal is convoluted due to presence of allylic CH3 signal of minor alkene isomer), 1.43 
(s, 9H); 13C NMR (151 MHz, CDCl3)  169.6, 155.7, 133.8, 123.6, 108.2, 79.8, 68.6, 64.8, 
64.1, 43.1, 38.9, 36.1, 29.8, 28.5, 13.2; IR (thin film): 3369, 2977, 2932, 2885, 1745, 1717, 
1168 cm–1; HRMS: (ESI+): Calcd. for C17H27NO6: ([M+Na]): 364.1736, Found: 364.1728. 




acid (3.41a): A flame-dried 2-necked 500 mL round-bottomed flask equipped with a stir bar 
and reflux condenser was cooled under a stream of N2, and charged with THF (202 mL) and 
diisopropylamine (23.9 mL, 169.3 mmol, 3.1 equiv). The solution was cooled to 0 °C, and a 
2.5 M solution of nbutyllithium in hexanes (65.6 mL, 163.9 mmol, 3 equiv) was added by 
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cannula transfer. The reaction mixture was stirred at 0 °C for 30 min, then cooled to -78 °C. A 
solution of glycinate 3.42 (18.65 g, 54.63 mmol, 1 equiv) in THF (24 mL) was added dropwise. 
The flask previously containing 3.42 was washed with THF (3 × 4 mL). The reaction mixture 
was stirred vigorously at -78 °C for 30 min, before TMS-Cl (20.8 mL, 163.9 mmol, 3 equiv) 
was added rapidly. The mixture was warmed to rt, then stirred at reflux for 16 h. The reaction 
mixture was cooled to 0 °C, and 1 M HCl (300 mL) was added. The reaction mixture was 
diluted with EtOAc (200 mL), and added to a separatory funnel. The organic layer was 
collected, and the aqueous layer was extracted with EtOAc (2 × 200 mL). The combined 
organic extracts were washed brine (150 mL), dried over Na2SO4, filtered, and concentrated. 
The crude material (8.2:1 mixture of diastereomers as determined by 1H NMR spectroscopy) 
was purified by column chromatography on silica gel (column 1: EtOAc/hexanes = 15/85 to 
20/80 to 30/70 to 100/0; column 2: EtOAc/hexanes = 20/80 to 30/70 to 100/0) to afford 17.98 
g (80%) of the title compound as a white foam solid, existing as an 8.2:1 mixture of 
diastereomers as determined by 1H NMR spectroscopy. 1H NMR (600 MHz, CDCl3)  9.45 
(s, 1H), 5.44 (s, 1H), 4.97 (d, J = 8.0 Hz, 1H), 4.14 (app t, J = 8.0 Hz, 1H), 3.99–3.90 (m, 4H), 
2.63–2.03 (m, 4H), 1.81–1.65 (m, 2H), 1.42 (s, 9H), 1.11 (d, J = 7.0 Hz, 3H); 13C NMR (151 
MHz, CDCl3) 176.8, 155.7, 137.2, 122.1, 108.0, 80.3, 64.5, 64.5, 56.7, 43.3, 35.9, 31.1, 28.4, 
24.4, 16.1; IR (thin film): 3328, 2977, 2932, 1714, 1506 cm–1; HRMS: (ESI+): Calcd. for 
C17H27NO6: ([M+Na]): 341.1838 or 364.1736, Found: 364.1728. []D: 2.1 (c = 0.01, CHCl3); 






yl)butan-2-yl)carbamate (3.60): A flame-dried 500 mL round-bottomed flask equipped with 
a stir bar was cooled under a stream of N2, and charged with amino acid 3.41a (14.95 g, 43.79 
mmol, 1 equiv) and CH2Cl2 (146 mL). 1,1’-Carbonyldiimidazole (7.811 g, 48.17 mmol, 1.1 
equiv) was added in 4 portions. The solution was stirred at rt for 20 min, then stirred at 0 °C 
for 15 min. N,O-Dimethylhydroxylamine hydrochloride (6.834 g, 70.06 mmol, 1.6 equiv) was 
added in 4 portions, and the mixture was allowed to warm to rt slowly overnight and stirred 
for a total of 16 h. The reaction mixture was diluted with EtOAc (500 mL) and 1 M HCl (150 
mL) and added to a separatory funnel. The layers were separated, and the organic layer was 
washed with additional 1 M HCl (2 × 150 mL) and brine (150 mL). The organic layer was 
dried over Na2SO4, filtered, and concentrated. The crude material was purified by column 
chromatography on silica gel (EtOAc/hexanes = 30/70 to 40/60) to afford 15.17 g (90%) of the 
title compound as an off-white amorphous solid, existing as a 7.0:1 mixture of diastereomers 
as determined by 1H NMR spectroscopy. 1H NMR (600 MHz, CDCl3) 5.40 (s, 1H), 4.98 (d, 
J = 9.6 Hz, 1H), 4.74 (app t, J = 9.5 Hz, 1H), 3.98–3.89 (m, 4H), 3.78 (s, 3H), 3.20 (s, 3H), 
2.45 (app p, J = 8.5, 7.7 Hz, 1H), 2.32– 2.09 (m, 4H), 1.79–1.66 (m, 2H), 1.39 (s, 9H), 0.99 (d, 
J = 7.0 Hz, 3H). 13C NMR (151 MHz, CDCl3) 173.1, 155.3, 137.7, 121.6, 108.1, 79.5, 64.5, 
64.5, 61.8, 51.7, 44.9, 36.0, 32.0, 31.2, 28.5, 24.1, 15.6; IR (thin film): 3328, 2975, 2934, 1710, 
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1656 cm–1; HRMS: (ESI+): Calcd. for C19H32N2O6: ([M+H
+]): 385.2339, Found: 385.2331. 


























Preparation and Characterization of Alkyl Bromide 3.63b 
 
 
(S)-3-hydroxy-2-methylpropyl acetate (3.69): A modified literature procedure was used to 
afford alcohol 3.69.64 A 2 L round-bottomed flask equipped with a stir bar was charged with 
chloroform (1.20 L), 2-methylpropane-1,3-diol (53.3 mL, 600 mmol, 1 equiv), vinyl acetate 
(221 mL, 2.40 mol, 4 equiv), and Amano Lipase from Pseudomonas fluorescens (≥20,000 U/g, 
3.00 g). The reaction mixture was stirred at 30 °C for 96 h, after which the reaction had reached 
a 71/29 mixture of bis-acetate to mono-acetate as judged by 1H NMR analysis of an aliquot of 
the reaction mixture. The reaction mixture filtered through a fritted funnel, and the solid was 
rinsed with CH2Cl2 (3 × 30 mL). The filtrate was absorbed onto Celite®, and purified by 
column chromatography on silica gel (EtOAc/hexanes = 5/95 to 10/90 to 50/50) to afford 26.39 
g (33%) of the title compound as a clear and colorless liquid. The enantiomeric ratio was 
determined to be 97:3 as determined by HPLC analysis of the p-nitro benzoylated product. 
Spectroscopic properties were identical to those previously reported:64 1H NMR (500 MHz, 
CDCl3) 4.10 (dd, J = 11.1, 5.2 Hz, 1H), 4.03 (dd, J = 11.0, 6.5 Hz, 1H), 3.53 (dd, J = 11.1, 






(R)-3-acetoxy-2-methylpropyl 4-nitrobenzoate (S3.2): A flame-dried 1 dram vile equipped 
with a stir bar was cooled under a stream of N2, and charged with alcohol 3.69 (19.8 mg, 0.15 
mmol, 1 equiv), CH2Cl2 (1 mL), and triethylamine (84 L, 0.60 mmol, 4 equiv). The solution 
was cooled to 0 °C, and p-nitrobenzoyl chloride (83.5 mg, 0.45 mmol, 3 equiv) was added in 
one portion. The cooling bath was removed, and the solution was stirred at rt for 70 min. The 
solution was absorbed onto Celite®, and purified by column chromatography on silica gel 
(EtOAc/hexanes = 10/90 to 15/85) to afford 41.9 mg (99%) of the title compound as a clear 
and colorless liquid. 1H NMR (600 MHz, CDCl3) 8.30–8.26 (m, 2H), 8.22–8.17 (m, 2H), 
4.36–4.27 (m, 2H), 4.14–4.05 (m, 2H), 2.39–2.30 (m, 1H), 2.05 (s, 3H), 1.09 (d, J = 7.0 Hz, 
3H). 13C NMR (151 MHz, CDCl3) 171.1, 164.7, 150.7, 135.6, 130.8, 123.7, 67.3, 65.8, 32.6, 
21.0, 14.0. IR (thin film): 2968, 1727, 1607, 1529, 1469 cm–1; HRMS: (ESI+): Calcd. for 
C13H15N2O6: ([M+H
+]): 282.0978, Found: 282.0985. HPLC (98:2 hexanes:iPrOH, Daicel 
CHIRALPAK IA): 97:3 er, tR (minor) = 14.7 min, tR (major) = 15.5 min;  []D: 5.8 (c = 0.01, 
CHCl3); TLC (EtOAc/hexane = 20/80): Rf = 0.45. 
 
 
(R)-2-methyl-3-(tosyloxy)propyl acetate (3.70): A flame-dried 1 L round-bottomed flask 
equipped with a stir bar was cooled under a stream of N2, and charged with alcohol 3.69 (26.34 
g, 199.3 mmol, 1 equiv), CH2Cl2 (400 mL), 4-dimethylaminopyridine (3.65 g, 29.9 mmol, 0.15 
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equiv) and triethylamine (83.3 mL, 597.9 mmol, 3 equiv). The solution was cooled to 0 °C, 
and p-toluenesulfonyl chloride (75.99 g, 398.6 mmol, 2 equiv) was added in 8 portions. The 
reaction mixture was stirred at 0 °C for 1 h 10 min. Aqueous saturated sodium bicarbonate was 
added (300 mL), and the reaction was warmed to rt. The reaction mixture was added to a 
separatory funnel, and the organic layer was collected. The aqueous layer was extracted with 
CH2Cl2 (2 × 300 mL), and the combined organic extracts were dried over Na2SO4, filtered, and 
concentrated. The crude material was purified by column chromatography on silica gel 
(EtOAc/hexanes = 5/95 to 10/90 to 15/85 to 25/75 to 30/70) to afford 48.3 g (85%) of the title 
compound as a white crystalline solid.  1H NMR (600 MHz, CDCl3) 7.77 (d, J = 8.3 Hz, 
2H), 7.34 (d, J = 7.9 Hz, 2H), 3.98–3.91 (m, 3H), 3.89 (dd, J = 11.1, 6.8 Hz, 1H), 2.44 (s, 3H), 
2.20–2.10 (m 1H), 1.95 (s, 3H), 0.93 (d, J = 7.0 Hz, 3H). 13C NMR (151 MHz, CDCl3) 170.8, 
145.0, 132.9, 130.0, 128.0, 71.4, 65.0, 32.7, 21.7, 20.8, 13.5. IR (thin film): 2972, 1739, 1598, 
1361, 1176 cm–1; HRMS: (ESI+): Calcd. for C13H18O5S: ([M+H
+]): 287.0953, Found: 




4-Methoxybenzyl 2,2,2-trichloroacetimidate (3.71): A flame-dried 1 L round-bottomed 
flask equipped with a stir bar was cooled under a stream of N2, and charged with CH2Cl2 (280 
mL), 4-methoxybenzyl alcohol (42.1 mL, 338 mmol, 1 equiv), and trichloroacetonitrile (37.3 
mL, 372 mmol, 1.1 equiv). The solution was cooled to 0 °C, and 1,8-diazabicyclo[5.4.0]undec-
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7-ene (DBU) (5.1 mL, 33.8 mmol, 0.1 equiv) was added dropwise. The solution was stirred at 
0 °C, after which 0.5 M HCl (200 mL) was added. The solution was warmed to rt, and added 
to a separatory funnel. The solution was diluted with EtOAc (500 mL), and the layers were 
separated. The organic layer was collected, and washed with 0.5 M HCl (200 mL), saturated 
aqueous sodium bicarbonate (200 mL), and brine (200 mL). The organic layer was dried over 




(R)-3-((4-methoxybenzyl)oxy)-2-methylpropyl 4-methylbenzenesulfonate (3.72):  
A 1 L round-bottomed flask equipped with a stir bar was charged with tosylate 3.70 (48.3 g, 
169 mmol, 1 equiv), and methanol (422 mL). The reaction mixture was cooled to 0 °C, and 
K2CO3 (46.6 g, 337 mmol, 2 equiv) was added in 4 portions. The reaction mixture was stirred 
at 0 °C for 1 h 40 min. The reaction mixture was diluted with water (400 mL), added to a 
separatory funnel, and extracted with CH2Cl2 (3 × 300 mL). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated to afford crude alcohol S3.5, which was 
used directly in the next step. 
A flame-dried 1 L round-bottomed flask equipped with a stir bar was cooled under a stream of 
N2, and charged with CH2Cl2 (338 mL), crude alcohol S3.5, and crude imidate 3.71 (if a 
quantitative yield is assumed: 95.50 g, 338 mmol, 2 equiv). The solution was cooled to 0 °C, 
and a solution of pyridinium p-toluenesulfonate (5.1 mL, 33.80 mmol, 0.1 equiv) in CH2Cl2 
(11 mL) was added dropwise. The reaction mixture was warmed to rt slowly overnight, and 
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stirred for a total of 112 h. The reaction mixture was added to a separatory funnel, then diluted 
with Et2O (700 mL) and 1 M HCl (300 mL). The layers were separated, and the organic layer 
was collected. The organic extract was washed with 1 M HCl (300 mL), saturated aqueous 
sodium bicarbonate (300 mL), and brine (200 mL). The organic extract was dried over Na2SO4, 
filtered, and concentrated. The crude material was purified by column chromatography on 
silica gel (column 1: EtOAc/hexanes = 10/90 to 15/85; column 2: EtOAc/hexanes = 2.5/97.5 
to 5/95 to 10/90 to 15/85; column 3: EtOAc/hexanes = 5/95 to 10/90) to afford 60.75 g (99%) 
of the title compound as a clear and colorless liquid. Spectroscopic properties were identical 
to those previously reported:65 1H NMR (600 MHz, CDCl3) 7.78 (d, J = 8.3 Hz, 2H), 7.32 
(d, J = 8.3 Hz, 2H), 7.19–7.14 (m, 2H), 6.88–6.83 (m, 2H), 4.33 (s, 2H), 4.02 (dd, J = 9.3, 5.5 
Hz, 1H), 3.97 (dd, J = 9.3, 5.7 Hz, 1H), 3.81 (s, 3H), 3.34–3.26 (m, 2H), 2.43 (s, 3H), 2.13–




(R)-1-((3-bromo-2-methylpropoxy)methyl)-4-methoxybenzene (3.63b): A flame-dried 1 L 
round-bottomed flask equipped with a stir bar and reflux condenser was cooled under a stream 
of N2, and charged with tosylate 3.72 (61.56 g, 168.9 mmol, 1 equiv) and THF (422 mL). The 
solution was cooled to 0 °C, and lithium bromide (44.00 g, 506.7 mmol, 3 equiv) was added 
to the solution. The cooling bath was removed, and the reaction mixture was heated to reflux 
for 16 h. The solution was then cooled to rt, added to a separatory funnel, and diluted with 
water (400 mL) and ether (100 mL). The layers were separated, and the organic layer was 
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collected. The aqueous layer was extracted with ether (2 × 300 mL). The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, and concentrated. The crude 
material was purified by column chromatography on silica gel (EtOAc/hexanes = 1/99 to 
2.5/97.5) to afford 42.74 g (93%) of the title compound as a yellow/orange liquid. 
Spectroscopic properties were identical to those previously reported:66 1H NMR (500 MHz, 
CDCl3)  7.28–7.24 (m, 2H), 6.91–6.86 (m, 2H), 4.45 (s, 2H), 3.81 (s, 3H), 3.53–3.46 (m, 2H), 

























dioxaspiro[4.5]dec-7-en-8-yl)heptan-3-yl)carbamate (3.64b): A flame-dried 250 mL 2-
necked round-bottomed flask equipped with a stir bar and reflux condenser was cooled under 
a stream of N2, and charged with magnesium turnings (2.679 g, 110.2 mmol, 2.8 equiv), a few 
crystals of iodine, and THF (9 mL). A small portion of alkyl bromide 3.63b (322 mg, 1.18 
mmol, 0.03 equiv) was then added dropwise until the brown/yellow color of the reaction 
mixture turned to dark gray and cloudy, indicating initiation of the Grignard reagent. 
Additional THF was then added (40 mL), and the rest of alkyl bromide 3.63b (26.54 g, 97.20 
mmol, 2.47 equiv) was added dropwise, while maintaining a gentle reflux. The reaction 
mixture was stirred for 1 h at rt.  
A separate flame-dried 1 L round-bottomed flask equipped with a stir bar and reflux condenser 
was cooled under a stream of N2, and charged with Weinreb amide 3.60 (15.13 g, 39.35 mmol, 
1 equiv), and Et2O (395 mL). The flask was equipped with a venting needle, the solution was 
cooled to 0 °C, and a solution of ethylmagnesium bromide (3.0 M in Et2O, 12.5 mL, 37.39 
mmol, 0.95 equiv) was added dropwise while maintaining vigorous stirring. The reaction 
mixture was stirred at 0 °C for 1 h, before the solution of 3.63b in THF was added dropwise, 
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while maintaining vigorous stirring (occasionally, the flask was manually swirled to dislodge 
the stir bar). The flask previously containing 3.63b was washed with Et2O (2 × 10 mL). The 
reaction mixture was warmed to rt slowly overnight, and stirred for a total of 18 h. The reaction 
mixture was cooled to 0 °C, and saturated aqueous ammonium chloride (350 mL) was added 
carefully. The biphasic mixture was added to a separatory funnel, the layers were separated, 
and the organic layer was collected. The aqueous layer was extracted with Et2O (2 × 300 mL). 
The combined organic extracts were washed with brine, dried over Na2SO4, filtered, and 
concentrated. The crude material was purified by column chromatography on silica gel 
(column 1: EtOAc/hexanes = 10/90 to 15/85; column 2: EtOAc/hexanes = 5/95 to 10/90 to 
15/85) to afford 17.44 g (86%) of the title compound as a yellow liquid, existing as a mixture 
of rotamers and 5.4:1 mixture of diastereomers as determined by 1H NMR spectroscopy. 1H 
NMR (600 MHz, CDCl3)  7.25–7.20 (m, 2H), 6.89–6.83 (m, 2H), 5.347 (s, 1H), 5.09 (d, J = 
7.2 Hz, 1H), 4.39 (s, 2H), 4.19 (app t, J = 7.4 Hz, 1H), 3.98–3.90 (m, 4H), 3.79 (s, 3H), 3.32–
3.16 (m, 2H), 2.71–2.59 (m, 1H), 2.55–2.44 (m, 1H), 2.41–2.06 (m, 5H), 1.77–1.69 (m, 1H), 
1.41 (s, 9H), 0.98 (d, J = 6.9 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H). 13C NMR (151 MHz, CDCl3) 
209.2, 159.2, 155.5, 137.7, 130.8, 129.3, 121.6, 113.8, 108.0, 74.5, 72.6, 64.5, 64.5, 61.7, 
55.4, 45.8, 42.8, 35.9, 31.2, 29.3, 28.5, 25.2, 17.3, 15.4. IR (thin film): 3362 (br), 2965, 2932, 
2877, 1707, 1613, 1586, 1514 cm–1; HRMS: (ESI+): Calcd. for C29H43NO7: ([M+Na
+]): 
540.2937, Found: 540.2958.  []D: 12.5 (c = 0.01, CHCl3); TLC (EtOAc/hexane = 30/70): 






dioxaspiro[4.5]dec-7-en-8-yl)heptan-3-yl)carbamate (3.61b): A flame-dried 500 mL round-
bottomed flask equipped with a stir bar was cooled under a stream of N2, and charged with 
ketone 3.64b (17.26 g, 33.34 mmol, 1 equiv) and toluene (53 mL). The solution was cooled to 
-78 °C, and a 25 wt. % solution of DIBAL in toluene (67.3 mL, 100.0 mmol, 3 equiv) was 
added dropwise via cannula transfer. After the DIBAL was added, the solution was stirred for 
45 min. The flask was equipped with a venting needle, and acetone (9.8 mL, 133 mmol, 4 
equiv) was added dropwise. The solution was warmed to 0 °C, and 1 M HCl (100 mL) was 
added carefully while ensuring the reaction mixture was stirring vigorously. The reaction 
mixture was added to a separatory funnel, diluted with addition 1 M HCl (250 mL) and EtOAc 
(50 mL), and the layers were separated. The aqueous layer was extracted with CH2Cl2 (2 × 300 
mL). The combined organic layers were washed with brine, dried over Na2SO4, filtered, and 
concentrated to afford the crude product. The diastereoselectivity of the reaction was 
determined to be 19:1, as determined by analysis of the 1H NMR spectrum of the crude product. 
The crude material was purified by column chromatography on silica gel (column 1: 
EtOAc/hexanes = 20/80 to 30/70 to 40/60; column 2: EtOAc/hexanes = 20/80 to 30/70) to 
afford 14.38 g (83%) of the title compound as a clear and colorless liquid, existing as a mixture 
of rotamers and 5.4:1 mixture of diastereomers as determined by 1H NMR spectroscopy. 1H 
NMR (600 MHz, CDCl3)  7.27–7.21 (m, 2H), 6.89–6.83 (m, 2H), 5.36 (s, 1H), 4.52 (d, J = 
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8.1 Hz, 1H), 4.47–4.40 (m, 2H), 3.99–3.88 (m, 4H), 3.80 (s, 3H), 3.75–3.66 (m, 1H), 3.65–
3.56 (m, 1H), 3.42–3.23 (m, 2H), 2.34–1.95 (m, 6H), 1.78–1.65 (m, 2H), 1.42 (s, 9H), 1.21–
1.13 (m, 1H), 1.09–0.86 (m, 7H). 13C NMR (151 MHz, CDCl3) 159.2, 157.4, 139.5, 130.6, 
129.4, 121.3, 113.9, 108.1, 76.3, 72.7, 70.6, 64.5, 64.4, 58.8, 55.4, 42.2, 36.6, 35.9, 31.2, 30.5, 
28.5, 24.1, 17.3, 17.2. IR (thin film): 3415 (br), 2960, 2932, 1704, 1514 cm–1; HRMS: (ESI+): 
Calcd. for C29H45NO7: ([M+H
+]): 520.3274, Found: 520.3274.  []D: 3.0 (c = 0.01, CHCl3); 





(3.62b): A flame-dried 250 mL round-bottomed flask equipped with a stir bar was cooled 
under a stream of N2, and charged with diphenyl diselenide (3.09 g, 9.90 mmol, 0.75 equiv) 
and CH2Cl2 (66 mL). Bromine (476 L, 9.24 mmol, 0.7 equiv) was added to the solution 
dropwise, and the solution stirred for 1 h at rt. A separate flame-dried 250 mL round-bottomed 
flask equipped with a stir bar was cooled under a stream of N2, and charged with alcohol 3.61b 
(6.86 g, 13.2 mmol, 1 equiv), pyridine (1.8 mL, 22.4 mmol, 1.7 equiv), and CH2Cl2 (33 mL), 
then cooled to 0 °C. The solution of phenyl selenium bromide was added to the solution of 
alcohol 3.61b dropwise via cannula transfer, and the solution was stirred at 0 °C for 1 h. The 
solution was quenched with saturated aqueous sodium thiosulfate (200 mL), and added to a 
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separatory funnel. The organic layer was collected, and the aqueous layer was extracted with 
CH2Cl2 (2 × 200 mL). The combined organic extracts were concentrated, added to a separatory 
funnel, diluted with Et2O (400 mL), and washed with 1 M HCl (2 × 200 mL) and brine (150 
mL). The organic layer was dried over Na2SO4, filtered, and concentrated to afford the crude 
product. The diastereoselectivity of the reaction was determined to be >20:1, as determined by 
analysis of the 1H NMR spectrum of the crude product. The crude material was purified by 
column chromatography on silica gel (EtOAc/hexanes = 10/90 to 15/85 to 20/80) to afford 
7.47 g (84%) of the title compound as a clear and colorless thick liquid, existing as a mixture 
of rotamers and a 5.4:1 mixture of diastereomers as determined by 1H NMR spectroscopy. 1H 
NMR (600 MHz, CDCl3)  7.56–7.47 (m, 2H), 7.29–7.15 (m, 5H), 6.916.84 (m, 2H), 4.52 
(d, J = 9.4 Hz, 1H), 4.48–4.30 (m, 2H), 4.08–3.88 (m, 4H), 3.823.75 (m, 4H), 3.66–3.33 (m, 
2H), 3.29–3.17 (m, 2H), 2.682.55 (m, 1H), 2.25–1.82 (m, 5H), 1.71–1.45 (m, 3H), 1.40 (s, 
9H), 1.291.16 (m, 1H), 1.010.92 (m, 3H), 0.89 (d, J = 6.7 Hz, 3H). 13C NMR (151 MHz, 
CDCl3) 159.2, 155.5, 132.9, 130.9, 129.4, 129.3, 129.2, 129.2, 127.1, 113.9, 108.1, 85.1, 
79.5, 79.3, 75.7, 72.7, 64.5, 64.4, 59.8, 55.4, 51.9, 41.5, 38.6, 38.4, 31.4, 30.7, 28.5, 16.8, 11.1. 
IR (thin film): 2962, 2931, 1703, 1513, 1366 cm–1; HRMS: (ESI+): Calcd. for C35H49NO7Se: 
([M+H+]): 676.2752, Found: 676.2752.  []D: 17.1 (c = 0.01, CHCl3); TLC (EtOAc/hexane 






(phenylselanyl)-1,4,9-trioxadispiro[4.2.48.25]tetradecan-11-yl)carbamate (3.62d): A 250 
mL round-bottomed flask equipped with a stir bar was charged with compound 3.62c (7.47 g, 
11.1 mmol, 1 equiv), CH2Cl2 (56 mL), and water (5.6 mL). The reaction mixture was cooled 
to 0 °C, and DDQ (2.89 g, 12.7 mmol, 1.15 equiv) was added in 4 portions. The reaction 
mixture was stirred for 1.5 h, then quenched with saturated aqueous sodium bicarbonate (100 
mL). The reaction mixture was added to a separatory funnel, diluted with water (300 mL) and 
CH2Cl2 (300 mL), and the organic layer was collected. The aqueous layer was extracted with 
CH2Cl2 (3 × 300 mL). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated to afford the crude product. The crude material was purified by column 
chromatography on silica gel (EtOAc/hexanes = 30/70 to 40/60 to 50/50) to afford 6.07 g 
(99%) of the title compound as an amorphous white solid, existing as a mixture of rotamers 
and a 5.4:1 mixture of diastereomers as determined by 1H NMR spectroscopy. 1H NMR (600 
MHz, CDCl3)  7.55 (d, J = 6.7 Hz, 2H), 7.29–7.19 (m, 3H), 4.47 (d, J = 9.6 Hz, 1H), 4.04–
3.81 (m, 4H), 3.62–3.24 (m, 4H), 2.73 (br s, 1H), 2.61–2.43 (m, 1H), 2.34 (app t, J = 7.6 Hz, 
1H), 2.21–1.99 (m, 2H), 1.97–1.86 (m, 1H), 1.85–1.52 (m, 4H), 1.41 (s, 9H), 0.99 (d, J = 7.3 
Hz, 3H), 0.94–0.89 (m, 1H), 0.85 (d, J = 6.8 Hz, 3H). 13C NMR (151 MHz, CDCl3)  155.4, 
133.0, 132.6, 129.3, 127.2, 107.9, 86.2, 79.9, 79.7, 68.6, 64.5, 64.4, 59.2, 51.5, 40.7, 39.1, 38.6, 
34.7, 31.7, 28.4, 17.7, 17.2, 11.2; IR (thin film): 3324, 2931, 2966, 2882, 1697, 1506 cm–1; 
HRMS: (ESI+): Calcd. for C27H41NO6Se: ([M+H
+]): 556.2177, Found: 556.2197.  []D: 13.7 







(phenylselanyl)-1,4,9-trioxadispiro[4.2.48.25]tetradecan-11-yl)carbamate (S3.6): A flame-
dried 250 mL round-bottomed flask equipped with a stir bar was cooled under a stream of N2, 
and charged with alcohol 3.62c (6.07 g, 10.9 mmol, 1 equiv), CH2Cl2 (55 mL), and 
triethylamine (5.3 mL, 38.3 mmol, 3.5 equiv). The solution was cooled to 0 °C, and mesyl 
chloride (1.7 mL, 21.9 mmol, 2 equiv) was added dropwise, and the reaction mixture was 
stirred at 0 °C for 1 h 10 min. Saturated aqueous sodium bicarbonate (200 mL) was added to 
the reaction mixture, which was then warmed to rt and added to a separatory funnel. The 
organic layer was collected, and the aqueous layer was extracted with CH2Cl2 (2 × 200 mL). 
The combined organic extracts were dried over Na2SO4, filtered, and concentrated to afford 
the crude product. The crude material was purified by column chromatography on silica gel 
(EtOAc/hexanes = 30/70 to 40/60 to 50/50) to afford 6.92 g (99%) of the title compound as an 
amorphous white solid, existing as a mixture of rotamers and a 5.4:1 mixture of diastereomers 
as determined by 1H NMR spectroscopy. 1H NMR (600 MHz, CDCl3)  7.59–7.51 (m, 2H), 
7.29–7.20 (m, 3H), 4.45 (d, J = 9.6 Hz, 1H), 4.12 (dd, J = 9.5, 5.8 Hz, 1H), 4.06–3.90 (m, 5H), 
3.88–3.78 (m, 1H), 3.59–3.33 (m, 2H), 2.99 (s, 3H), 2.60–2.51 (m, 1H), 2.30–1.89 (m, 5H), 
1.72–1.50 (m, 3H), 1.47–1.32 (m, 10H), 1.05–0.94 (m, 6H). 13C NMR (151 MHz, CDCl3)  
155.4, 133.0, 129.3, 127.2, 108.0, 85.7, 79.8, 78.9, 74.9, 64.5, 64.5, 59.3, 51.9, 41.1, 38.5, 37.5, 
37.3, 31.7, 31.5, 31.0, 28.4, 27.7, 16.3, 11.2; IR (thin film): 3383 (br), 2973, 2935, 2883, 1702, 
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1508 cm–1; HRMS: (ESI+): Calcd. for C28H43NO8SSe: ([M+H
+]): 634.1953, Found: 634.1977.  





A flame-dried 500 mL round-bottomed flask equipped with a stir bar was cooled under a 
stream of N2, and charged with mesylate S3.6 (6.88 g, 10.9 mmol, 1 equiv) and THF (133 mL). 
The solution was cooled to 0 °C, and a solution of potassium tert-butoxide (1.95 g, 17.4 mmol, 
1.6 equiv) in THF (30 mL) was added dropwise, and the reaction mixture was stirred at 0 °C 
for 16 h. Saturated aqueous ammonium chloride (200 mL) was added to the reaction mixture, 
which was then warmed to rt, added to a separatory funnel, and diluted with Et2O (100 mL). 
The organic layer was collected, and the aqueous layer was extracted with Et2O (2 × 200 mL). 
The combined organic extracts were washed with brine, dried over Na2SO4, filtered, and 
concentrated to afford the crude product. The crude material was purified by column 
chromatography on silica gel (column 1: EtOAc/hexanes = 10/90 to 20/80; column 2: EtOAc 
in hexanes = 10/90 to 60/40; minor diastereomer elutes first) to afford 4.25 g (73%) of the title 
compound as an amorphous white solid, existing as a >20:1 mixture of diastereomers as 
determined by 1H NMR spectroscopy. 1H NMR (600 MHz, CDCl3)  7.57–7.50 (m, 2H), 7.25–
7.16 (m, 3H), 3.97–3.84 (m, 5H), 3.75 (d, J = 11.2 Hz, 1H), 3.71–3.63 (m, 2H), 2.89–2.79 (m, 
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1H), 2.67 (app t, J = 12.6 Hz, 1H), 2.32 (app d, J = 11.3 Hz, 1H), 2.09–1.97 (m, 2H), 1.97–
1.76 (m, 3H), 1.75–1.64 (m, 1H), 1.59–1.48 (m, 2H), 1.41 (s, 9H), 1.00–0.89 (m, 6H). 13C 
NMR (151 MHz, CDCl3)  156.1, 132.5, 131.9, 129.1, 126.7, 108.0, 87.0, 80.1, 72.0, 64.5, 
64.4, 61.0, 51.0, 47.5, 40.3, 39.6, 33.0, 32.8, 28.6, 28.3, 27.8, 20.1, 10.3; IR (thin film): 2956, 
2876, 1696, 1477 cm–1; HRMS: (ESI+): Calcd. for C27H39NO5Se: ([M+H
+]): 538.2072, 




4'H-spiro[cyclohexane-1,2'-furo[3,2-b]pyridine]-4'-carboxylate (S3.7): A 500 mL round-
bottomed flask equipped with a stir bar was charged with mesylate 3.73 (4.25 g, 7.92 mmol, 1 
equiv), CH2Cl2 (119 mL), and acetone (39.6 mL). FeCl3•6H2O (7.49 g, 27.7 mmol, 3.5 equiv) 
was added in 4 portions, and the reaction mixture was stirred at rt until the reaction was judged 
to be complete by TLC (typically less than 1 h, immediate quenching is required or lower 
yields are observed). Saturated aqueous sodium bicarbonate (400 mL) was added to the 
reaction mixture, which was then added to a separatory funnel, and diluted with CH2Cl2 (200 
mL). The organic layer was collected, and the aqueous layer was extracted with CH2Cl2 (3 × 
400 mL). The combined organic extracts were dried over Na2SO4, filtered, and concentrated 
to afford the crude product. The crude material was purified by column chromatography on 
silica gel (EtOAc/hexanes = 10/90 to 20/80) to afford 3.44 g (88%) of the title compound as 
an amorphous white solid. 1H NMR (500 MHz, CDCl3)  7.57–7.52 (m, 2H), 7.34–7.26 (m, 
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3H), 4.08 (app td, J = 10.8, 7.4 Hz, 1H), 3.78 (d, J = 11.8 Hz, 1H), 3.63–3.55 (m, 1H), 3.50 
(dd, J = 11.1, 7.0 Hz, 1H), 3.42–3.30 (m, 2H), 2.79–2.60 (m, 2H), 2.47–2.32 (m, 2H), 2.17–
1.88 (m, 3H), 1.78–1.60 (m, 2H), 1.50 (s, 9H), 1.03–0.90 (m, 6H). 13C NMR (151 MHz, 
CDCl3)  209.1, 155.9, 135.8, 129.4, 128.4, 128.0, 84.7, 80.3, 73.2, 60.3, 53.3, 47.7, 43.2, 42.7, 
37.9, 33.6, 29.7, 28.6, 27.8, 20.1, 9.9; IR (thin film): 2971, 2873, 2359, 2341,1697 cm–1; 
HRMS: (ESI+): Calcd. for C25H35NO4Se: ([M+H
+]): 494.1810, Found: 494.1827. []D: 34.2 




spiro[cyclohexane-1,2'-furo[3,2-b]pyridin]-2-ene-4'-carboxylate (3.74): A 250 mL round-
bottomed flask equipped with a stir bar was charged with compound S3.7 (3.42 g, 6.94 mmol, 
1 equiv), CH2Cl2 (35 mL), and pyridine (1.7 mL, 20.8 mmol, 3 equiv). The solution was cooled 
to 0 °C, and a 30% aqueous solution of hydrogen peroxide (1.4 mL, 13.9 mmol, 2 equiv) was 
added dropwise. The solution was stirred at 0 °C until the reaction was judged to be complete 
by TLC (typically about 1 h). Saturated aqueous sodium thiosulfate (150 mL) was added to the 
reaction mixture, which was then added to a separatory funnel, and diluted with Et2O (250 
mL). The organic layer was collected, and the organic layer was washed with 1 M HCl (3 × 
150 mL), then brine (100 mL). The organic layer was dried over Na2SO4, filtered, and 
concentrated to afford the crude product. The crude material was purified by column 
chromatography on silica gel (EtOAc/hexanes = 20/80 to 25/75) to afford 1.77 g (76%) of the 
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title compound as a clear and colorless liquid, which crystallizes if stored at -20 °C. 1H NMR 
(600 MHz, CDCl3)  6.70 (d, J = 10.1 Hz, 1H), 5.82 (d, J = 10.1 Hz, 1H), 4.06 (app dt, J = 
11.2, 8.9 Hz, 1H), 3.74–3.65 (m, 1H), 3.46 (dd, J = 11.1, 6.3 Hz, 1H), 2.84–2.74 (m, 2H), 2.69 
(ddd, J = 16.8, 8.2, 6.1 Hz, 1H), 2.40 (app dt, J = 16.8, 5.3 Hz, 1H), 2.18–2.07 (m, 3H), 1.74–
1.68 (m, 2H), 1.46 (s, 9H), 1.01–0.96 (m, 6H). 13C NMR (151 MHz, CDCl3)  199.4, 155.8, 
153.1, 127.3, 81.1, 80.4, 73.1, 60.5, 48.2, 44.4, 35.1, 33.8, 30.9, 28.5, 27.7, 19.9, 9.6; IR (thin 
film): 2973, 2875, 1693, 1456 cm–1; HRMS: (ESI+): Calcd. for C19H29NO4: ([M+H
+]): 






















(S)-4a-methyl-5-oxo-3,4,4a,5,6,7-hexahydronaphthalen-2-yl acetate (3.79): A flame-dried 
250 mL round-bottomed flask equipped with a stir bar was cooled under a stream of N2, and 
charged with Wieland-Miescher ketone 3.78 (4.25 g, 23.85 mmol, 1 equiv), PhMe (80 mL), 
acetic anhydride (13.5 mL, 143.1 mmol, 6 equiv), and p-toluenesulfonic acid monohydrate 
(136 mg, 0.72 mmol, 3 mol %). The solution was stirred at reflux for 5.5 h, then cooled to rt. 
This solution was added carefully to an Erlenmeyer flask containing a stirred solution of 
sodium bicarbonate (16.03 g, 190.8 mmol, 8 equiv) in water (200 mL). After gas evolution had 
ceased, the mixture was poured into a separatory funnel, and the organic layer was collected. 
The aqueous layer was extracted with Et2O (2 × 200 mL), and the combined organic extracts 
were washed with brine, dried over Na2SO4, filtered, and concentrated to afford the crude 
product. The crude material was purified by column chromatography on silica gel 
(EtOAc/hexanes = 10/90 to 15/85 to collect product, and 40/60 to collect starting material) to 
afford 4.23 g (81%) of the title compound as a yellow liquid, which existed in an 
inconsequential 7.4:1 ratio with bis-vinyl acetate product S3.8, and 754.3 mg (18%) of 
Wieland-Miescher ketone 3.78 starting material as a light brown solid. 1H NMR (600 MHz, 
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CDCl3)  5.82 (d, J = 2.3 Hz, 1H), 5.64 (t, J = 4.5 Hz, 1H), 2.76 (ddd, J = 15.5, 7.3, 6.0 Hz, 
1H), 2.66–2.57 (m, 1H), 2.57–2.41 (m, 2H), 2.36 (app dt, J = 15.4, 7.0 Hz, 1H), 2.20–2.11 (m, 
4H), 1.98 (ddd, J = 13.4, 5.8, 1.6 Hz, 1H), 1.70–1.62 (m, 1H), 1.25 (s, 3H).13C NMR (151 
MHz, CDCl3)  214.6, 169.3, 148.5, 137.8, 123.2, 115.8, 45.0, 35.6, 28.8, 24.6, 24.3, 22.7, 
21.2; IR (thin film): 2966, 2931, 1758, 1710 cm–1; []D: 31.9 (c = 0.01, CHCl3); TLC 
(EtOAc/hexane = 10/90): Rf = 0.2. 
 
 
(1S,6S,8aS)-8a-methyl-1,2,3,5,6,7,8,8a-octahydronaphthalene-1,6-diol (3.80): A flame-
dried 500 mL round-bottomed flask equipped with a stir bar was cooled under a stream of N2, 
and charged with vinyl acetate 3.79 (4.19 g, 19.0 mmol, 1 equiv) and EtOH (127 mL). The 
solution was cooled to 0 °C, and sodium borohydride (4.32 g, 114 mmol, 6 equiv) was added 
in three portions. The ice bath was removed and the reaction mixture was left to stir at rt for 
16 h. The reaction mixture was cooled to 0 °C, and carefully diluted with saturated aqueous 
NH4Cl (125 mL). The reaction mixture was diluted with CH2Cl2 (150 mL) and added to a 
separatory funnel. The organic layer was collected, and the aqueous layer was extracted with 
CH2Cl2 (4 × 200 mL). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated to afford the crude product. The crude material was purified by column 
chromatography on silica gel (EtOAc/hexanes = 30/70 to 100/0) to afford 3.12 g (90%) of the 
title compound as an off-white amorphous solid, which existed as a 9:1.3:1 mixture of 
diastereomers and 17:1 mixture of alkene isomers. 1H NMR (600 MHz, CD3OD) 5.28–5.24 
131 
 
(m, 1H), 3.40–3.32 (m, 2H), 3.28–3.26 (m, 1H), 2.25 (ddd, J = 13.0, 4.8, 2.3 Hz, 1H), 2.18–
1.93 (m, 4H), 1.82–1.74 (m, 1H), 1.72–1.58 (m, 2H), 1.47 (dddd, J = 14.6, 12.7, 11.1, 3.8 Hz, 
1H), 1.14–1.06 (m, 1H), 1.01 (s, 3H).13C NMR (126 MHz, CD3OD)  141.3, 122.0, 78.8, 
72.3, 42.3, 40.3, 37.5, 32.0, 27.9, 25.9, 17.8; IR (thin film): 3337 (br), 2934, 2860, 1456, 1436 




octahydronaphthalen-1-ol (3.81): A flame-dried 500 mL round-bottomed flask equipped 
with a stir bar was cooled under a stream of N2, and charged with diol 3.80 (3.08 g, 16.9 mmol, 
1 equiv), imidazole (2.30 g, 33.8 mmol, 2 equiv), and CH2Cl2 (169 mL). TBSCl (3.82 g, 25.3 
mmol, 1.5 equiv) was added to the reaction mixture in one portion, and the reaction mixture 
was stirred at rt for 8 h. The reaction mixture was diluted with Et2O (300 mL) and 1 M HCl 
(200 mL), and added to a separatory funnel. The organic layer was collected, and the aqueous 
layer was extracted with Et2O (2 × 200 mL). The combined organic extracts were washed with 
brine, dried over Na2SO4, filtered, and concentrated to afford the crude product. The crude 
material was purified by column chromatography on silica gel (EtOAc/hexanes = 5/95 to 10/90 
to 15/85) to afford 4.94 g (99%) of the title compound as an off-white amorphous solid, which 
existed as a 29:2.2:1 mixture of diastereomers. 1H NMR (500 MHz, CDCl3) 5.29–5.25 (m, 
1H), 3.53–3.42 (m, 2H), 2.24–2.18 (m, 2H), 2.15–1.91 (m, 3H), 1.81–1.65 (m, 3H), 1.56 (dddd, 
J = 14.5, 13.1, 10.9, 3.7 Hz, 1H), 1.45 (d, J = 4.6 Hz, 1H), 1.16 (td, J = 13.7, 3.8 Hz, 1H), 1.05 
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(s, 3H), 0.88 (s, 9H), 0.05 (s, 6H). 13C NMR (126 MHz, CDCl3) 140.3, 121.0, 78.3, 72.5, 
42.2, 39.2, 36.4, 31.9, 27.3, 26.1, 25.0, 18.4, 17.3, -4.5; IR (thin film): 3372 (br), 2933, 2898, 
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Progress Towards the First Asymmetric Synthesis of Matrine 
 
4.1 Biological Activity 
 Matrine, an alkaloid present in the traditional Chinese medical herb Sophora 
flavescens,1 exhibits a broad array of interesting biological activity (Figure 4-1). It has been 
shown to inhibit the growth of various tumor tissues both in vitro and in vivo,2,3 including 
cervical cancer, leukemia, gastric cancer, lung cancer, and breast cancer.4–6 Matrine also holds 
potential as a therapeutic for hepatitis C,7 arrhythmia,8–11 and skin inflammations.12 
Furthermore, matrine induces antinociceptive effects through the activation of the  and -
opioid receptors.13,14 -Opioid receptors have attracted attention recently, as this method of 
inducing analgesic activity can mitigate the negative side-effects characteristic of morphine 
and its derivatives.15–17 Finally, matrine shows antifeedant and toxic effects against the 
Formosan subterranean termite18 and pine wood nematode,19 making it an effective wood 
treatment agent,18 as well as toxicity toward certain pathogenic nematodes.19,20  







4.2 Previous Syntheses 
 The first synthesis of ()matrine was reported in 1963 by Mandell and coworkers.21 
They began by applying their previously developed quinolizidine synthesis to achieve efficient 
construction of 4.4.22 The authors were then able to build the carbon skeleton of the southern 
piperidine rings by application of the Stork enamine procedure using acrylonitrile. 
Hydrogenation provided the racemic natural product, which matched the infrared spectrum of 
natural matrine. While this synthesis boasts a short step count using cheap stoichiometric 
reagents, it is limited by a low yielding enamine alkylation (< 6% yield). 
Scheme 4-1 First Synthesis of ()Matrine 
 
 Over 20 years later, the Chen group utilized an impressive N-acyliminium ion 
cyclization in their synthesis of ()matrine (Scheme 4-2).23 The authors were able to carry 
known cyanoquinolizidone acetal 4.624 to the N-acetyliminium ion cyclization substrate 4.8 in 
four steps. The desired acid-promoted cyclization reaction afforded the correct diastereomer 
of tetracyclic product 4.9, which was deacetalized and reduced to form ()matrine (4.1) in 
four subsequent steps. Despite the increased step count of this route compared to the 
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aforementioned route (12 steps compared to 7 steps, respectively), the sequence provided a 
higher overall yield.   
Scheme 4-2 Chen’s N-Acyliminium Ion Cyclization Based Synthesis of ()Matrine 
 
 The third and final synthesis of ()matrine was presented by the Zard group in 1998.25 
Zard and coworkers were able to develop a highly convergent radical cascade cyclization 
reaction between alkene 4.9 and xanthate 4.10, which formed 2 new rings and 3 new carbon-
carbon bonds. Following this key cascade cyclization, a series of functional group 
manipulations afforded the natural product. This approach utilized a brilliant and creative 
disconnection in order to form the skeleton of matrine (4.11) from simple and readily 
accessible starting materials (4.9 and 4.10). However, rendering this route asymmetric would 







Scheme 4-3 Zard’s Radical Cascade Synthesis of ()Matrine 
 
 An asymmetric synthesis of the epimeric tetracyclic alkaloid ()allomatrine was 
recently reported by Brown et al. (Scheme 4-4). The first key carbon-carbon bond forming 
event, a Mannich addition using Ellman’s chiral N-sulfinyl imine, formed two new 
stereocenters with excellent stereocontrol, but generated the incorrect relative stereochemistry 
for matrine. In five additional steps, the authors fashioned N-acetyliminium ion cyclization 
substrate 4.15. The authors took a similar ionic cyclization strategy to the Chen group,23 except 
rather than proceeding via the cyclization of a transient enol ether, an allyl-silane nucleophile 
cyclized onto the formed N-acetyliminium ion. After ring closing metathesis and 
hydrogenation, the natural product was isolated. While this approach contains a higher step 
count than other approaches to matrine, this is the only asymmetric synthesis of allomatrine, 
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and no asymmetric synthesis of matrine exists. Consequently, we concluded that developing 
the first asymmetric synthesis of matrine would be of high value. 
Scheme 4-4 Brown’s Asymmetric Synthesis of ()Allomatrine 
 
 
4.3 Retrosynthetic Analysis 
  Our retrosynthetic analysis of matrine (4.1) commenced with disassembly of the 
lactam ring to arrive at tricyclic Weinreb amide 4.18 (Scheme 4-5). The southeastern ring was 
disconnected via a tandem Appel reaction of a primary alcohol and amine alkylation, and the 
southwestern ring could be constructed by the Staudinger reduction of azide 4.19, followed by 
a spontaneous aza-Wittig reaction and imine reduction. Compound 4.19 could be arrived at 
through the oxidation of diene 4.20, which we imagined forming through an enamine bis-
alkylation. Finally, piperidone 4.21 could be made by the Dieckmann cyclization of aspartic 





Scheme 4-5 Retrosynthetic Analysis of ()Matrine 
 
4.4 Forward Synthesis 
 In the forward direction, our route commenced with the scalable synthesis of piperidone 
4.2426 (Scheme 4-6). After formation of Weinreb amide 4.21, Stork enamine alkylation 
provided bis-allylated ketone 4.20 in 50% yield and 6:1 dr. A chemoselective 
hydroboration/oxidation of 4.20 using freshly prepared dicyclohexylborane provided lactols 











Scheme 4-6 Synthesis of Lactols 4.25 
 
 Due to the difficulty of interpreting 1H NMR data of compound 4.25 and its derivatives 
(including the Cbz-protected analogue), during the optimization of further chemistry, studies 
using model lactol 4.26 were carried out. While standard Mitsunobu conditions for the 
azidation of alcohol 4.26 were unsuccesful, the reaction proceeded in 62% yield in the presence 
of diphenylphosphoryl azide, DBU, and sodium azide. The yield of this transformation, which 
suffered from incomplete conversion, could be improved to near quantitative amounts by 
utilizing a two-step sequence involving the mesylation and azidation of alcohol 4.26. While a 
one-pot Staudinger reduction/aza-Wittig reaction/imine reduction of aminal 4.27 could be 
accomplished, crude aminal 4.28 was isolated after Staudinger reduction in order to more 
easily study the stereoselectivity of the subsequent imine reduction.  




 With aminal 4.28 in hand, we turned our attention to exploring the proposed 
diastereoselective imine reduction (Table 4-1). As a starting point, sodium borohydride was 
chosen for the reaction (entry 1). While the reaction afforded desired amino alcohol 4.29, 
diastereoselectivity was poor (1.4:1). Following seminal work by the Hutchins group,26 we 
next turned our attention to reagents shown to stereoselectively reduce 2-methylcyclohexyl 
imines, beginning with bulkier boron-based reducing agents (entries 2-5). In this system, both 
L-selectride (entries 2-4) and super hydride (entry 5) provided no reaction, perhaps due to an 
unfavorable aminal/imine tautomerization in pure THF as a solvent. We were pleased to see a 
slight improvement in diastereoselectively when tert-butylamine borane was used as the 
reducing agent (entry 6). Due to the poor selectivity and reactivity exhibited by the reducing 
agents disclosed by Hutchins,26 we have begun the search for a less precedented and highly 
selective imine reduction, which is still ongoing. 
Table 4-1 Reduction of Aminal 4.28 
 







NaBH4, THF/MeOH, 0 °C to rt 
L-selectride, THF, -78 °C 
L-selectride, THF, -78 °C to rt 
L-selectride, THF, 0 °C to reflux 










 As proof of concept, compound 4.29 was cyclized to tricycle 4.30 using Appel 
conditions and triethylamine. While the reaction proceeded with an 1H NMR yield of 81%, the 
product could not be isolated due to coelution of triethylamine and product 4.30 during column 
chromatography. In the future, various bases will be screened in order to circumvent this 
purification issue. 
Scheme 4-8 Formation of Tricycle 4.30  
 
 After failing to diastereoselectively reduce aminal 4.28, we briefly explored other 
options for setting the -amine stereocenter. First, direct installation of the amine was 
examined by applying classic reductive amination conditions to compounds 4.31 and 4.26 
(Scheme 4-9), but only complex mixtures of products were obtained. Additionally, the 
reduction of oximes 4.33 and 4.35 were investigated, but both compounds proved to be 
unreactive, perhaps due to the steric effects of the vicinal tertiary centers. Finally, a pyridine 
dearomatization approach was taken in an approach to tricycle 4.40. Bromination and a 
subsequent Heck reaction using ethyl acrylate provided bis-alkene 4.38 in 42% yield. 
Hydrogenation and spontaneous lactamization afforded lactam 4.39, but borane reduction 







Scheme 4-9 Miscellaneous Attemps at Acessing Diastereopure Tricyle 
 
4.5 Future Directions 
 In the event that conditions cannot be found for the diastereoselective reduction of 
compound 4.28 (Table 4-1), the reduction of N-diphenylphosphinyl imine 4.42 will be 
attempted (Scheme 4-10). Excellent literature precedent exists for the diastereoselective 





Scheme 4-10 Proposed Stereoselective Reduction of N-Diphenylphosphinyl Imine 4.42 
 
 Finally, if a diastereoselective reduction of compound 4.28 can be identified (Table 4-
1), conditions from the model system will applied to enantioenriched Weinreb amide 4.25. 
Assuming the previously developed conditions translate from the model system, tricyclic 
compound 4.18 should be accessible (Scheme 4-11). Weinreb amide 4.18 will be carried on to 
()matrine via reduction to the corresponding aldehyde, olefination of the aldehyde, Boc 
deprotection and spontaneous lactamization, and hydrogenation of the resulting olefin.  








4.6 Experimental  
Methods  
General: Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform infrared 
spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were 
recorded on a Bruker model Avance 400 (19F NMR at 376 MHz), Bruker Avance III 500 (1H 
NMR at 500 MHz), or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 151 
MHz) spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 
ppm; 13C NMR: CDCl3 at 77.0 ppm). 
1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, br s = broad singlet, d = doublet, br d = broad doublet, t = triplet, app 
t = apparent triplet, q = quartet, m = multiplet), coupling constants (Hz), and integration. Mass 
spectra were obtained using a Thermo LTqFT mass spectrometer with electrospray 
introduction and external calibration. All samples were prepared in methanol. Analytical thin 
layer chromatography (TLC) was performed on Sorbent Technologies 0.20 mm Silica Gel TLC 
plates. Visualization was accomplished with UV light, KMnO4, and/or Seebach’s stain (2.5 g 
phosphomolybdic acid, 1.0 g Ce(SO4)2, 6.0 mL conc. H2SO4, 94 mL H2O) followed by heating. 
Purification of the reaction products was carried out by flash column chromatography using 
Siliaflash-P60 silica gel (40-63μm) purchased from Silicycle. Unless otherwise noted, all 
reactions were carried out under an atmosphere of dry nitrogen in flame-dried glassware with 








General: Tetrahydrofuran (THF), diethyl ether (Et2O), methylene chloride (CH2Cl2), and 
toluene (PhMe) were dried by passage through a column of neutral alumina under nitrogen 
























tert-Butyl (S)-2-(methoxy(methyl)carbamoyl)-4-oxopiperidine-1-carboxylate (4.21): A 
flame dried round-bottomed flask was cooled under a stream of N2, and charged with amino 
acid 4.2226 (11.81 g, 35.4 mmol, 1 equiv) and THF (47 mL). A 25 wt. % solution of NaOMe 
in MeOH was added over 15 min. The solution was heated to reflux for 3 h. After cooling to 
rt, 35 mL of solvent was distilled from the solution.  
Water (35 mL) was added and the solution was refluxed overnight. The solution was cooled to 
rt, then 0 °C, and diluted with 1 M HCl to pH = 1. The mixture was added to a separatory 
funnel, diluted with CH2Cl2, and the layers were separated. The organic layer was collected. 
The aqueous layer was extracted with CH2Cl2 (2 × 100 mL). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated to afford the crude amino acid 4.24. 
A flame dried round-bottomed flask was cooled under a stream of N2, and charged with crude 
amino acid 4.24, CH2Cl2 (80 mL), DIPEA (11.4 mL, 65.6 mmol), and DMAP (8.02 g, 65.6 
mmol). The solution was cooled to 0 °C and EDCI (12.6 g, 65.6 mmol) was added. The solution 
was stirred at that temperature for 30 min, after which N,O-dimethylhydroxylamine 
hydrochloride (6.40 g, 65.6 mmol) was added. The reaction mixture was warmed to rt slowly 
and stirred for 16 h. The reaction mixure was added to a separatory funnel, and diluted with 
EtOAc (250 mL) and 1 M HCl (300 mL). The layers were separated, and the organic layer was 
collected. The organic layer was washed with 1 M HCl (300 ml), saturated aqueous sodium 
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bicarbonate (300 mL), and brine (100 mL). The organic layer was collected, dried over 
Na2SO4, filtered, and concentrated. The crude material was purified by column 
chromatography on silica gel (30/70 EtOAc/hexanes to 40/60 EtOAc/hexanes to 50/50 EtOAc 
in hexanes) to afford 3.88 g (41% over 2 steps) of the title compound as a light yellow liquid, 
existing as a 1:1 mixture of rotameric isomers: 1H NMR (400 MHz, CDCl3) δ 5.46 (br s, 1H), 
5.20 (br s, 1H), 4.08 (br s, 1H), 3.88m(s, 6H)2.782.57 (m, 6H), 2.48 (br 




carboxylate (4.20): A flame dried round-bottomed flask was cooled under a stream of N2, and 
charged with Weinreb amide 4.21 (1.671 g, 5.84 mmol, 1 equiv), PhMe (10 mL), p-
toluenesulfonic acid monohydrate (22.2 mg, 0.12 mmol, 0.02 equiv), and pyrrolidine (960 L, 
11.7 mmol, 2 equiv). The solution was refluxed under Dean-Stark conditions for 6 h, cooled 
to rt, then concentrated in vacuo.  
A flame dried round-bottomed flask was cooled under a stream of N2, and charged with the 
crude enamine obtained from the previous step (1.981 g, 5.84 mmol, 1 equiv), CHCl3 (5.8 mL), 
DIPEA (2.0 mL, 11.67 mmol, 2 equiv), and allyl bromide (1.0 mL, 11.7 mmol, 2 equiv). The 
solution was heated to reflux for 24 h. The solution was then cooled to rt, and water (1.2 mL) 
was added. The reaction mixture was heated to reflux for 1 h, then cooled to rt. The reaction 
mixture was diluted with 1 M HCl (40 mL) and CH2Cl2 (40 mL). The mixture was added to a 
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separatory funnel, and the layers were separated. The organic layer was collected.  The aqueous 
layer was extracted with CH2Cl2 (2 × 40 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated. The crude material was purified by column 
chromatography on silica gel (20/80 EtOAc/hexanes to 25/75 EtOAc/hexanes) to afford 1.239 
g (58%) of the title compound as a light yellow liquid, existing as a 6:1 mixture of 
diastereomers (determined by TFA deprotection to the free amine), and mixture of rotameric 
isomers: 1H NMR (500 MHz, CDCl3) δ 5.85–5.66 (m, 2H), 5.22–4.88 (m, 5H), 4.08–3.94 (m, 
1H), 3.84–3.60 (m, 3H), 3.52–2.93 (m, 5H), 2.85–2.41 (m, 3H), 2.25–2.05 (m, 2H), 1.54–1.40 




c]pyridine-6(5H)-carboxylate (4.25): A flame dried round-bottomed flask was cooled under 
a stream of N2, and charged with THF (9 mL) and borane dimethylsulfide (850 L, 9.00 mmol, 
2.5 equiv). The solution as cooled to 0 °C, and cyclohexene (1.82 mL, 18.0 mmol, 5 equiv) 
was added. The reaction mixture was stirred for 1 h, and during this time, the solution went 
from clear and colorless to a white slurry. Weinreb amide 4.20 (1.219 g, 3.60 mmol, 1 equiv) 
was dissolved in THF (3.6 mL), then added to the slurry. The solution was warmed to rt, and 
stirred for 2 h. The solution was cooled to 0 °C, and a solution of sodium hydroxide (375 mg, 
9.36 mmol, 2.6 equiv) in water (3.6 mL) was added dropwise, followed by the careful, 
dropwise addition of a 30 wt. % solution of H2O2 (2.21 mL, 21.6 mmol, 6 equiv). The reaction 
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mixture was warmed to rt, and stirred for 2 h. The reaction mixture was diluted with saturated 
aqueous sodium bicarbonate (50 mL) and CH2Cl2 (50 mL), and added to a separatory funnel. 
The layers were separated, and the organic layer was collected. The aqueous layer was 
extracted with CH2Cl2 (2 × 50 mL). The combined organic extracts were dried over Na2SO4, 
filtered, and concentrated. The crude material was purified by column chromatography on 
silica gel (30/70 EtOAc/hexanes to 10/90 MeOH/CH2Cl2) to afford 1.12 g (83%) of the title 
compound as a clear and colorless foam, existing as a regiomeric mixture of hemiketals, 
diastereomeric mixture of both regiomeric hemiketals, and mixture of rotameric isomers: 1H 
NMR (500 MHz, CDCl3) δ 4.09–3.54 (m, 9H), 3.32–3.14 (m, 4H), 1.87–1.42 (m, 19H). TLC 
(MeOH/CH2Cl2 = 5/95): Rf = 0.2 and 0.3. 
 
 
tert-Butyl (3S,5R)-3,5-diallyl-4-oxopiperidine-1-carboxylate (S4.2): A flame dried round-
bottomed flask was cooled under a stream of N2, and charged with ketone S4.1 (21.0 g, 105 
mmol, 1 equiv), PhMe (84 mL), p-toluenesulfonic acid monohydrate (401 mg, 2.11 mmol, 
0.02 equiv), and pyrrolidine (17.3 mL, 211 mmol, 2 equiv). The solution was refluxed under 
Dean-Stark conditions for 6 h, cooled to rt, then concentrated in vacuo.  
A flame dried round-bottomed flask was cooled under a stream of N2, and charged with the 
crude enamine obtained from the previous step (26.50 g, 105 mmol, 1 equiv), CHCl3 (105 mL), 
DIPEA (36.6 mL, 210 mmol, 2 equiv), and allyl bromide (18.1 mL, 210 mmol, 2 equiv). The 
solution was heated to reflux for 24 h, then cooled to rt, and water (21 mL) was added. The 
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reaction mixture was heated to reflux for 1 h, then cooled to rt. The reaction mixture was 
diluted with 1 M HCl (250 mL), added to a separatory funnel, and the layers were separated. 
The organic layer was collected. The aqueous layer was extracted with CH2Cl2 (2 × 200 mL). 
The combined organic extracts were dried over Na2SO4, filtered, and concentrated. The crude 
material was purified by column chromatography on silica gel (5/95 EtOAc/hexanes) to afford 
21.14 g (64%) of the title compound as an off-white solid, existing as a >20:1 mixture of 
diastereomers (determined by TFA deprotection to the free amine): 1H NMR (500 MHz, 
CDCl3) δ 5.84–5.71 (m, 2H), 5.13–4.99 (m, 4H), 4.55–4.25 (m, 2H), 2.77–2.38 (m, 6H), 2.02–




c]pyridine-6(5H)-carboxylate (S4.3): A flame dried round-bottomed flask was cooled under 
a stream of N2, and charged with THF (190 mL) and borane dimethylsulfide (17.9 mL, 189 
mmol, 2.5 equiv). The solution as cooled to 0 °C, and cyclohexene (38.3 mL, 378 mmol, 5 
equiv) was added. The reaction mixture was stirred for 1 h, and during this time, the solution 
went from clear and colorless to a white slurry. Ketone 4.20 (21.14 g, 75.7 mmol, 1 equiv) was 
added in THF (20 mL). The solution was warmed to rt and stirred for 2 h. The solution was 
cooled to 0 °C, and a solution of sodium hydroxide (37.87 g, 197 mmol, 2.6 equiv) in water 
(76 mL) was added carefully, followed by the careful, dropwise addition of a 30 wt. % solution 
of H2O2 (46.4 mL, 454 mmol, 6 equiv) while monitoring the internal temperature of the 
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reaction. The reaction mixture was wamred to rt, and stirred for 2 h. The reaction mixture was 
diluted with saturated aqueous sodium bicarbonate (200 mL) and CH2Cl2 (200 mL), and added 
to a separatory funnel. The layers were separated, and the organic layer was collected. The 
aqueous layer was extracted with CH2Cl2 (2 × 200 mL). The combined organic extracts were 
dried over Na2SO4, filtered, and concentrated. The crude material was purified by column 
chromatography on silica gel (30/70 EtOAc/hexanes to EtOAc) to afford 18.72 g (78%) of the 
title compound as a clear and colorless foam, existing as a diastereomeric mixture of 
hemiketals and mixture of rotameric isomers: 1H NMR (500 MHz, CDCl3) δ 4.09–3.83 (m, 
2H), 3.78–3.53 (m, 4H), 2.80–2.57 (m, 2H), 1.85–1.37 (m, 19H). TLC (EtOAc/hexanes = 




c]pyridine-6(5H)-carboxylate (4.27): A flame dried round-bottomed flask was cooled under 
a stream of N2, and charged with diol 4.26 (19.15 g, 57.1 mmol, 1 equiv) and DMF (142 mL). 
The solution was cooled to 0 °C, and diphenyl phosphoryl azide (17.2 mL, 79.9 mmol, 1.4 
equiv) was added dropwise, followed by the addition of DBU (11.6 mL, 77.0 mmol, 1.35 
equiv). The solution was warmed to rt, and stirred for 1 h. Sodium azide was added (22.3 g, 
342 mmol, 6 equiv), and the solution was heated to 120 °C for 16 h. The solution was cooled 
to rt, and diluted in EtOAc (500 mL) and brine (600 mL). The layers were separated, and the 
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organic layer was collected. The aqueous layer was extracted with EtOAc (2 × 300 mL). The 
combined organic extracts were washed with brine (3 × 500 mL). The organic layer was dried 
over Na2SO4, filtered, and concentrated. The crude material was purified by column 
chromatography on silica gel (10/90 EtOAc/hexanes to 15/85 EtOAc/hexanes to 30/70 
EtOAc/hexanes to 40/60 EtOAc/hexanes) to afford 11.22 g (58%) of the title compound as a 
light-yellow liquid, existing as a diastereomeric mixture of hemiketals and mixture of 
rotameric isomers: 1H NMR (500 MHz, CDCl3) δ 4.04–3.85 (m, 2H), 3.73–3.58 (m, 2H), 
3.36–3.22 (m, 2H), 2.75–2.56 (m, 1H), 1.88–1.39 (m, 19H). TLC (EtOAc/hexanes = 30/70): 




carboxylate (4.28): A flame dried round-bottomed flask was cooled under a stream of N2, and 
charged with azide 4.27 (2.00 g, 5.88 mmol, 1 equiv), THF (30 mL), and triphenylphosphine 
(3.08 g, 11.8 mmol, 2 equiv). The solution was heated to reflux for 2.5 h, then cooled to rt. The 
solution was concentrated to afford the crude product, existing as a mixture of aminal 
diastereomers and rotomeric isomers, which was used in the subsequent reduction without 





carboxylate (4.30): A flame dried vial was cooled under a stream of N2, and charged with 
amino alcohol 4.29 (36.0 mg, 0.100 mmol, 1 equiv), CH2Cl2 (0.5 mL), triphenylphosphine 
(65.6 mg, 0.250 mmol, 2.5 mmol), and triethylamine (56 L, 0.400 mmol, 4 equiv). The 
solution was cooled to 0 °C, and a solution of CBr4 (82.9 mg, 0.250  mmol, 2.5 equiv) in 
CH2Cl2 (0.5 mL) was added dropwise. The solution was warmed to rt slowly, and when the 
reaction was judged to be complete by TLC analysis, the solution was concentrated. The 1H 
NMR yield of the reaction was determined to be 81% using phenanthrene as an internal 
standard.  The crude material was purified by column chromatography on silica gel (2/98 
MeOH/CH2Cl2 to 5/95 MeOH/CH2Cl2 to 10/90 MeOH/CH2Cl2). The product could not be 





c]pyridine-6(5H)-carboxylate (4.31): A flame dried vial was cooled under a stream of N2, 
and charged with CH2Cl2 (1 mL) and DMSO (51 L, 0.72 mmol, 6 equiv). The solution was 
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cooled to -78 °C, and oxalyl chloride (32 mL, 0.36 mmol, 3 equiv) was added dropwise 
(caution: gas evolution). The solution was stirred for 10 min at that temperature, before a 
solution of hemiketal 4.26 (37.8 mg, 0.12 mmol, 1 equiv) in CH2Cl2 (0.5 mL) was added. The 
solution was stirred for 2 h at -78 °C, after which triethylamine was added in one portion (0.17 
mL, 1.20 mmol, 10 equiv). The reaction mixture was warmed to rt and stirred for 30 min. The 
reaction mixture was added to a separatory funnel, and diluted in saturated aqueous sodium 
bicarbonate (30 mL) and CH2Cl2 (30 mL). The layers were separated, and the organic layer 
was collected. The aqueous layer was extracted with CH2Cl2 (2 × 30 mL). The organic layer 
was dried over Na2SO4, filtered, and concentrated. The crude material was purified by column 
chromatography on silica gel (30/70 EtOAc/hexanes to 40/60 EtOAc/hexanes) to afford 33.8 
mg (90%) of the title compound as a light-yellow liquid, existing as a diastereomeric mixture 
of hemiketals and mixture of rotameric isomers: 1H NMR (600 MHz, CDCl3) δ 9.76 (s, 1H), 
4.56–4.22 (m, 1H), 4.09–3.04 (m, 4H), 2.80–2.41 (m, 3H), 2.20–1.41 (m, 17H). TLC 
(EtOAc/hexanes = 40/60): Rf = 0.25 and 0.35. 
 
 
()tert-Butyl (3S,5R,Z)-3,5-diallyl-4-(hydroxyimino)piperidine-1-carboxylate (4.33): A 
round-bottomed flask was charged with ketone S4.2 (2.862 g, 10.25 mmol, 1 equiv), EtOH 
(20.5 mL), hydroxylamine hydrochloride (2.136 g, 30.74 mmol, 3 equiv), and anhydrous 
sodium acetate (2.521 g, 30.74 mmol, 3 equiv). The mixture was heated to reflux for 2 h 20 
min, then cooled to rt. The solids were filtered off, and the mother liquor was concentrated. 
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The crude material was purified by column chromatography on silica gel (30/70 
EtOAc/hexanes) to afford 2.905 g (96%) of the title compound as a clear and colorless viscous 
liquid, existing as a mixture of rotameric isomers: 1H NMR (500 MHz, CDCl3) δ 5.95–5.70 
(m, 2H), 5.25–5.02 (m, 4H), 4.30–3.96 (m, 2H), 3.41–3.23 (m, 1H), 3.07 (dd, J = 13.3, 4.1 Hz, 
1H), 3.00–2.73 (m, 1H), 2.51 (br s, 1H), 2.41–2.15 (m, 4H), 2.13 (s, 1H), 1.51 (s, 9H). TLC 




carboxylate (4.35): A round-bottomed flask was charged with hemiketal 4.26 (31.5 mg, 0.100 
mmol, 1 equiv), EtOH (1 mL), hydroxylamine hydrochloride (13.9 mg, 0.200 mmol, 2 equiv), 
and anhydrous sodium acetate (24.6 mg, 0.300 mmol, 3 equiv). The mixture was stirred at rt 
for 3.5 h. The reaction mixture was added to a separatory funnel, and diluted with saturated 
aqueous sodium bicarbonate (30 mL) and CH2Cl2 (30 mL). The layers were separated, and the 
organic layer was collected. The aqueous layer was extracted with CH2Cl2 (2 × 30 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude 
material was purified by column chromatography on silica gel to afford 29.7 mg (90%) of the 
title compound as a clear and colorless viscous liquid, existing as a mixture of rotameric 
isomers: 1H NMR (500 MHz, CDCl3) δ 4.33–3.95 (m, 2H), 3.76–3.45 (m, 4H), 3.38–3.25 (m, 
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